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Résumé
Le cancer de la prostate est le cancer le plus fréquent et la deuxième cause de mortalité
par cancer chez l’homme en Europe [Ferlay et al. (2010)a]. La détection, la localisation
et l’appréciation de l’agressivité des foyers tumoraux dans la prostate sont un enjeu clin-
ique majeur. Ces étapes diagnostiques sont essentielles pour pouvoir diriger précisément
le traitement et diminuer les risques de sur- et de sous-traitement. Bien que des nom-
breuses techniques d’imagerie soient disponibles (la tomographie par émission de positron
(TEP), la tomodensitométrie (CT), l’imagerie ultrasonore (US) ou encore l’imagerie par
résonance magnétique (IRM)), il n’existe actuellement pas de technique d’imagerie idéale
ni un consensus sur l’utilisation des techniques existantes pour évaluer les cancers de la
prostate.
Actuellement, la méthode qui permet la meilleure localisation du cancer dans la prostate
est l’IRM multi-paramétrique. Celle-ci consiste à combiner les images IRM d’une séquence
pondérée en T2 (T2-W) avec des images obtenues à l’aide de séquences de diﬀusion (DWI) et
de dynamique de prise de contraste (DCE). L’évaluation de la sensibilité et la spéciﬁcité
de chaque séquence est nécessaire pour pouvoir déterminer la combinaison optimale de
celles-ci et donc pour obtenir le diagnostic le plus précis possible du cancer de la prostate.
Les coupes histologiques de la pièce prostatique contiennent la réalité de terrain sur le
diagnostic du cancer de la prostate. Actuellement, les coupes histologiques sont la source
d’information la plus précise et la plus exhaustive concernant le grade, le stade, l’étendue et
les marges positives du cancer. Ainsi, pour pouvoir déﬁnir les caractéristiques des signaux
IRM issus du tissu cancéreux pour chaque modalité d’imagerie et chaque type de séquence,
les coupes histologiques doivent être recalées précisément avec les images acquises. Pour
chaque séquence, une analyse quantitative du signal IRM dans les zones qui correspondent
exactement aux tumeurs, délimitées par histologie, permettrait la déﬁnition du signal
caractéristique du tissu cancéreux pour ce type de séquence. Ensuite, la combinaison
optimale des séquences pourrait être déterminée.
Le but de cette thèse est le développement d’une méthode de la mise en correspondance
tridimensionnelle des coupes histologiques de la prostate et des images IRM. Cette mise en
correspondance ne peut pas être considérée comme un problème 2D car cela supposerait
qu’à chaque coupe histologique correspond une image IRM, autrement dit, que le plan
selon lequel la prostate a été découpée durant la procédure histologique est strictement le
même (en terme de hauteur et d’orientation) que le plan dans lequel les images IRM ont été
acquises. La mise en correspondance tridimensionnelle est un problème comprenant deux
étapes principales : premièrement, il faut s’assurer que les coupes histologiques soient
alignées les unes par rapport aux autres et deuxièmement, que cet ensemble de coupes
alignées soit correctement orienté par rapport aux images IRM.
Le premier chapitre présente une introduction générale du cancer de la prostate. La
glande prostatique y est décrite et l’épidémiologie du cancer de la prostate est exposée.
v
Les systèmes standards utilisés pour la classiﬁcation du grade et du stade du cancer sont
présentés. Le problème du dépistage du cancer de la prostate étant la source de nombreux
débats, les arguments «pour» et «contre» sont présentés, ainsi que les tests associés (no-
tamment le test des antigènes spéciﬁques à la prostate (PSA), le toucher rectal (DRE), les
biopsies guidées par ultrasons (TRUS)). Les diﬀérentes techniques utilisées pour traiter le
cancer de la prostate sont également détaillées, lesquelles incluent la surveillance active, la
prostatectomie radicale, la radiothérapie, l’hormonothérapie ou encore la chimiothérapie.
Enﬁn, les modalités d’imagerie disponibles actuellement sont présentées (TEP, CT, US,
IRM) ainsi que leurs avantages, désavantages et les indications spéciﬁques de chacune.
Le deuxième chapitre se focalise sur le problème de la mise en correspondance entre
l’histologie et l’IRM. Les challenges liés au recalage sont d’abord détaillés, notamment
ceux liés aux déformations qui existent entre les deux modalités. Une revue de la lit-
térature concernant les diverses méthodes proposées jusqu’alors pour réaliser la mise en
correspondance 2D entre l’histologie et l’IRM est présentée, incluant les divers dispositifs
développés pour assurer que le plan de coupe histologique est identique au plan d’imagerie.
Ensuite, une revue de la littérature concernant les méthodes proposées pour faire la mise
en correspondance 3D entre l’histologie et l’IRM est présentée, tout d’abord dans le cas où
le recalage a été considéré comme un problème à deux étapes (i.e. d’abord l’alignement des
coupes histologiques puis le recalage de celles-ci avec les images IRM) puis dans celui où
le recalage a été considéré comme un problème à une seule étape, combinant l’alignement
et le recalage dans le même algorithme.
Des images histologiques, d’IRM ex vivo et d’IRM in vivo ont été acquises au cours
de cette thèse. Le troisième chapitre détaille les techniques, routines et protocoles utilisés
pour l’acquisition et la préparation des images. Le dispositif développé pour la création
de marqueurs internes dans les prostates fraîches est présenté ainsi que le protocole qui
y est associé. La procédure de préparation des coupes histologique est également décrite
aﬁn de comprendre les déformations et les incertitudes associés aux images histologiques.
Le quatrième chapitre porte sur l’alignement des coupes histologiques. L’algorithme
développé pour aligner les coupes histologiques marquées y est présenté : celui-ci permet
de segmenter en 2D chaque coupe de la prostate, de détecter les marqueurs potentiels
dans chaque prostate segmentée, de déterminer lesquels de ces marqueurs potentiels sont
des vrais marqueurs et enﬁn d’identiﬁer par quelle aiguille chaque marqueur a été crée.
La méthode utilisée pour l’alignement et la correction du cisaillement de l’ensemble des
coupes histologiques est également présentée. Après une initialisation manuelle, l’ensemble
de l’algorithme est automatique. Les résultats des tests utilisant des images simulées ainsi
que les images acquises pour un échantillon de foie de veau et pour 10 prostates sont
présentés.
Le cinquième chapitre se focalise sur le recalage 3D des coupes histologiques, une
fois alignées, avec les images IRM. L’algorithme développé est basé sur les structures
macroscopiques présentes dans le tissu, celles-ci pouvant être soit artiﬁcielles, soit na-
turelles. Le recalage histologie - IRM n’étant pas un recalage rigide, trois phénomènes
particuliers, décrit avec cinq paramètres, doivent être pris en compte dans l’algorithme: le
rétrécissement, le cisaillement et l’inclinaison. Le rôle de chaque phénomène est expliqué
et l’algorithme de recalage développé est décrit. L’algorithme a d’abord été testé en util-
isant des marqueurs exogènes (crées par le dispositif présenté précédemment) pour guider
le recalage, puis en utilisant les canaux éjaculateurs comme marqueurs endogènes. Les
résultats de ces deux études sont rapportés.
Le sixième et dernier chapitre récapitule l’ensemble des résultats obtenus et décrit
également les travaux restants pour parvenir à un recalage 3D précis des coupes his-
tologiques avec les images IRM. Il aborde plus particulièrement, le problème du rétrécisse-
ment du tissu induit par l’histologie, qui doit être mieux compris et quantiﬁé, ainsi que
l’incertitude sur l’espacement et les angles entre les coupes histologiques.
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Introduction
Prostate cancer (PCa) is the most frequently diagnosed cancer of men in Europe and
the third leading cause of death from cancer in men [Ferlay et al. (2010)a]. The accurate
localisation and staging of PCa, enabling low- and high-risk cancers to be distinguished, is
a major clinical necessity. It is crucial to enable therapy to be directed more accurately and
reduce the risk of over- and under-diagnosis. Though numerous imaging techniques are
currently available - positron emission tomography (PET), computed tomography (CT),
ultrasonography (US), magnetic resonance imaging (MRI) - to date, no ideal imaging
method exists and no consensus exists regarding the use of imaging techniques for evalu-
ating primary prostate cancers.
Currently, the most accurate imaging method for PCa is multi-parametric MRI, that
is combining T2-weighted (T2-W) MR images with diﬀusion-weighted images (DWI) and
dynamic contrast-enhanced (DCE) images. The evaluation of the sensitivity and speciﬁcity
of each sequence is required in order to determine the optimum combination of sequences
to give the most accurate assessment of prostate cancer.
The histology slices of the prostatectomy specimen are the gold standard for prostate
cancer diagnosis. To date, they provide the most precise and comprehensive information
concerning the cancer grade, stage, tumour extent and margin status. Therefore, in order
to deﬁne the signal characteristics of prostate cancerous tissue for each imaging modality
and sequence, the histology slices must be precisely registered to the imaged data. For
each sequence, a quantitative analysis of the signal in the regions corresponding exactly
to the histology tumours would enable a deﬁnition of the signal characteristics of prostate
cancerous tissue for that sequence. The optimum combination of sequences could then be
determined.
The aim of this thesis was to develop a method to 3D register the histology slices of
radical prostatectomy specimens with MR in vivo images. The registration cannot be
considered as a 2D problem, as that would assume that every 2D histology slice has a
corresponding 2D imaged slice, that is, that the plane along which the prostate specimen
was sliced during histology processing is the same (in height and orientation) to the plane
along which the imaged data was acquired. The 3D registration is a two-step problem,
requiring ﬁrst the alignment of the stack of histology slices and then the 3D registration
of the aligned histology slices with the MR data.
1
2The ﬁrst chapter of this manuscript provides a general introduction to prostate cancer.
The prostate gland is described and the epidemiology of prostate cancer is reported. The
standardised systems used for grading and staging PCa are presented. PCa screening
is a much debated subject, the arguments for and against are presented, as well as the
tests involved (the prostate speciﬁc antigen (PSA) test, digital rectal examination (DRE),
transrectal ultrasound-guided (TRUS) biopsy). The diﬀerent techniques used to treat PCa
are detailed, including active surveillance, radical prostatectomy, radiotherapy, hormonal
therapy, chemotherapy. Finally, the diﬀerent imaging modalities currently available are
presented (PET, CT, US, MRI) and the advantages, disadvantages and speciﬁc indications
of each are considered.
The second chapter focuses on the problem of histology - MR registration. First the
registraion challenges are detailed, in particular due to the various deformations that exist
between the two modalities. A litterature review is presented of the various methods
developed to achieve the 2D histology - MR registration, including various devices that
have been created in order to ensure that the histology and imaging planes are the same.
Next, a litterature review of the developed 3D histology - MR registration techniques is
presented, ﬁrst considering the registration as a two-step problem (i.e. alignment of the
histology slices and then registration of the aligned histology slices with the MR images)
and then considering the registration as a single-step problem, combining the alignment
and registration into one algorithm.
Histology, MR ex vivo and MR in vivo images were acquired during this thesis. Chapter
three details each of the diﬀerent techniques, protocols and routines used to acquire and
prepare the images. Internal ﬁducial markers are created in the fresh prostate specimens,
the apparatus and protocol developed to create these markers is presented. The histology
processing routine is also described in order to better understand the deformations and
uncertainties associated with the histology images.
The fourth chapter deals with the alignment of the histology slices. The algorithm
developed to segment the 2D prostate in each histology slice, detect the potential ﬁducial
markers within each segmented prostate, detect which of the potential markers are true
ﬁducial markers and to identify by which needle each marker was created, is detailed. The
method to align and then shear correct the dataset of images is also presented. The results
of tests using simulated images, images acquired from a beef liver sample and 10 prostate
specimens are presented.
The ﬁfth chapter focuses on the 3D registration of the aligned histology slices with the
MR images. The algorithm developed is a feature-based technique, the features employed
are detailed. The histology - MR registration is not a rigid registration and three partic-
ular phenomena, described using ﬁve parameters, need to be included in the registration
3algorithm, they are shrinkage, tilt and shear. Each of these phenomena is explained and
the developed registration algorithm is described. The algorithm is tested ﬁrst by using
the ﬁducial needles to guide the registration and then using the ejaculatory ducts to guide
the registration. The results of both studies are reported.
The sixth and ﬁnal chapter concludes ﬁrst with a summary of the results obtained
and then more importantly, describes the further work that must be carried out before
an accurate 3D histology - MR registration can be achieved. In particular, the histology
shrinkage must be better understood and quantiﬁed, as well as the spacing and angles
between the histology slices.
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1.1 Introduction
This ﬁrst chapter provides a general introduction to prostate cancer (PCa). The
prostate gland itself is ﬁrst considered, its location, function and anatomy. We then move
onto PCa, the most frequently diagnosed cancer of men in Europe. The incidence and
mortality rates of the disease are detailed, worldwide and in Europe. We also examine the
various risks associated with the disease; not only advancing age but also family history
and ethnicity.
A fundamental objective of PCa diagnosis is to distinguish between small, clinically
insigniﬁcant tumours that present a low risk to the patient and the aggressive tumours with
lethal potential, that present a very high risk to the patient. We present the standardised
systems used to grade and stage PCa that aim to categorise the risk of the tumours,
the amount and location of cancer and the risk of the cancer having spread beyond the
prostate.
Whether asymptomatic men beneﬁt from PCa screening is an unresolved question. On
the one hand, screening enables cancers to be detected in the early stages. However, some
men will be treated unnecessarily, resulting in over-diagnosis and over-treatment. We
consider this debate, presenting the results published by various screening programs. We
also detail the techniques used to carry out PCa screening, speciﬁcally, the prostate speciﬁc
antigen (PSA) test and the digital rectal examination (DRE). Patients with suspicious PSA
and/or DRE results will be further examined by a transrectal ultrasound (TRUS) guided
biopsy.
PCa is treated using a variety of diﬀerent techniques. We present the diﬀerent treat-
ments, including active surveillance, radical prostatectomy, radiotherapy, hormonal ther-
apy, chemotherapy and also certain alternative local treatment options. Which treatment
is chosen to be used is based on the grade and stage of the cancer, as well as the age and
general health of the patient.
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An imaging technique that could identify tumour stage, volume, and location with
high speciﬁcity and sensitivity would be invaluable to the diagnosis and treatment of PCa.
Low- and high-risk cancers could be distinguished, enabling therapy to be more accurately
directed therefore limiting side-eﬀects and reducing over-diagnosis and over-treatment.
These advantages and other advantages are further detailed.
To date, no such ideal imaging method exists. We present some of the imaging modali-
ties that are currently available, including positron emission tomography (PET), computed
tomography (CT), ultrasonography (US) and magnetic resonance imaging (MRI). Many
show considerable clinical value; we consider the advantages, disadvantages and speciﬁc
indications of each.
1.2 The Prostate Gland
The prostate is a gland of the male reproductive system. In this section, we will detail
the location, anatomy and function of the gland.
1.2.1 Location
The prostate gland is located directly below the bladder and in front of the rectum, see
Figure 1.1. The seminal vesicles are located near the base of the prostate. The base refers
to the wider part of the anatomy which is located at the bladder neck. The apex is the
narrower part, located nearer the perineum, see Figure 1.2(a). The posterior surface of
the prostate is adjacent to the rectum, while the anterior surface is located on the opposite
side. The prostate surrounds the urethra just below the urinary bladder. It is within the
prostate that the urethra merges with the two ejaculatory ducts.
The normal prostate gland is a triangular ellipse that is surrounded by a thin capsule.
The normal prostate in adult males measures approximately 4 cm in length, 4 cm in
transverse diameter and 3 cm in height [Zagoria (2004)], the volume ranges from 20 to 25
mL, and the weight is approximately 20 ± 6 g [Berry et al. (1984)].
1.2.2 Anatomy
In the twentieth century, several investigators maintained that the prostate gland was
composed of diverse lobes by analogy with laboratory animals [Lowsley (1912), Franks
(1954)]. This concept became popular even though no distinct lobes can be seen in the
normal adult prostate. McNeal established the current and most widely accepted concept
of various zones rather than lobes of the prostate [McNeal (1981)]. In this model, the
prostate is divided into four distinct zones, see Figure 1.2.
The peripheral zone (PZ) constitutes over 70% of the prostate gland and comprises
all the tissue at the apex as well as all of the tissue located posteriorly near the capsule.
The central zone (CZ) constitutes 25% of the glandular prostate and is a cone-shaped
area, with the apex of the cone at the conﬂuence of the ejaculatory ducts and the urethra.
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Figure 1.1: Sagittal view of the male pelvis showing the relative placement of the male
reproductive organs. Source: Mosby, Elsevier
The transition zone (TZ) constitutes 5% of the glandular prostate in young adults,
increasing with age and with the development of benign prostatic hyperplasia (BPH). The
TZ consists of two equal portions of tissue lateral to the urethra in the midgland. The non-
glandular anterior ﬁbromuscular stroma (AFMS) forms the entire anterior surface
of the prostate. It is usually devoid of glandular components and is composed of muscle
and ﬁbrous tissue.
Figure 1.2: (a) Sagittal view of the prostate gland, illustrating the anatomical features and
zonal anatomy. Source: [Verma and Rajesh (2011)]. (b) Axial image of the prostate illus-
trating McNeal’s zonal anatomy, consisiting of the peripheral zone (PZ), transition zone
(TZ) and non-glandular anterior ﬁbromuscular stroma (AFMS). Source: [Makni (2010)].
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1.2.3 Function
The function of the prostate is to secrete prostatic ﬂuid, that is added to the ejaculatory
ﬂuid produced by the seminal vesicles. The prostatic ﬂuid usually constitutes 15 - 30% of
the ejaculate volume [Owen and Katz (2005)]. During ejaculation, the sperm produced in
the testes is transferred from the vas deferens into the urethra, collecting the secretions
from the seminal vesicles and prostate gland, forming the semen. The prostate gland
and the surrounding muscles contract and expel the semen out of the body through the
urethra. Spermatozoa expelled in prostatic ﬂuid have better motility, longer survival and
better protection of the genetic material [Björndahl (2010)].
1.3 Prostate Cancer Epidemiology
In this section we consider the epidemiology of PCa. We detail the latest estimates
of the incidence and mortality of PCa among men both in Europe and worldwide and we
compare these values to those of other prevalent cancers. We detail the identiﬁed risk
factors associated with PCa, in particular age, but also family history and ethnicity.
1.3.1 Incidence and Mortality
Europe
PCa is the most frequently diagnosed cancer of men in Europe, estimated to account
for 379,000 new cases, that is 20.9% of all new male cancer cases in Europe in 2008.
Overall, in both sexes combined, PCa is the fourth most common cancer, accounting for
11.1% of all new cancer cases in 2008 [Ferlay et al. (2010)b].
With an estimated 94,000 deaths in 2008, PCa is the third leading cause of death
from cancer in men (9.1% of the total). Overall, in both sexes combined, PCa is the sixth
leading cause of death from cancer, accounting for 5.1% of all cancer deaths in 2008 [Ferlay
et al. (2010)b].
The graph in Figure 1.3 shows the relative levels of incidence and mortality of PCa in
Europe amongst men compared to the levels of other prevalent forms of cancers.
Worldwide
PCa is the second most frequently diagnosed cancer (after lung cancer) of men, es-
timated to account for 899,000 new cases, that is 13.6% of all new male cancer cases
worldwide in 2008. Overall, in both sexes combined, PCa is the ﬁfth most common can-
cer, accounting for 7.1% of all new cancer cases in 2008 [Ferlay et al. (2010)b].
With an estimated 258,000 deaths in 2008, PCa is the sixth leading cause of death
from cancer in men (6.1% of the total). Overall, in both sexes combined, PCa is the ninth
leading cause of death from cancer, accounting for 3.4% of all cancer deaths in 2008 [Ferlay
et al. (2010)b].
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Figure 1.3: Estimated incidence and mortality (%) of the most prevalent forms of cancer
among men in Europe. PCa is the most frequently diagnosed cancer and is the third leading
cause of death from cancer in men in Europe. Source: [Ferlay et al. (2010)b]
1.3.2 Risk Factors
Age
The strongest known risk factor for PCa is age, with very low risk in men under 50
years old and rising risk with increasing age thereafter, i.e. the older the man, the higher
the risk. This is consistent with post-mortem results where approximately 80% of men by
age 90 years were shown to have cancer cells in their prostate [Haas et al. (2007)].
Family History
A family history of PCa is a strong risk factor. It has been estimated that 5 - 10% of
all PCa cases and 30 - 40% of early-onset cases (men diagnosed < 55 years) are caused by
inherited susceptibility genes [Johns and Houlston (2003)].
Ethnicity
Variation in incidence rates around the world and within countries, suggests that PCa
risk is aﬀected by ethnicity. Nearly three-quarters (71.6%, 644,000 cases) of the registered
cases occur in developed countries (deﬁned as Northern America, Eastern Asia, Europe,
Australia and New Zealand [Ferlay et al. (2010)b]). Incidence rates of PCa vary by
more than 25-fold worldwide. The highest rates are in Australia/New Zealand (104.2
per 100,000), Western (94.1 per 100,000) and Northern Europe (86.4 per 100,000) and
Northern America (85.6 per 100,000). This is largely because the practice of prostate
speciﬁc antigen (PSA) testing and subsequent biopsy has become widespread in those
regions. The lowest rates are in South-Central Asia (4.1 per 100,000).
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There is less variation in mortality rates worldwide (10-fold) than is observed for in-
cidence (25-fold). The highest rates are in the Caribbean (26.3 per 100,000), Southern
(19.3 per 100,000) and Western Africa (18.3 per 100,000). The lowest rates are in Eastern
Asia (2.5 per 100,000). The number of deaths from PCa is almost the same in developed
(136,000) and developing regions (121,000) [Ferlay et al. (2010)b]. This is due to the fact
that PSA testing has a much greater eﬀect on incidence than on mortality.
Mortality rates are generally high in predominantly black populations (e.g. the Caribbean,
26.3 per 100,000 and sub-Saharan Africa, 18 - 19 per 100,000), very low in Asia (e.g. East-
ern Asia, 2.5 per 100,000) and intermediate in Europe (10.5 - 15.7 per 100,000) and Oceania
(15.4 per 100,000).
Other Risks
Other possible risks being investigated include diet, alcohol consumption, smoking,
bodyweight, physical activity, medication, medical procedures, infections and diabetes.
1.4 Prostate Cancer Grading and Staging
A signiﬁcant proportion of PCa tumours are small, clinically insigniﬁcant and present
a low risk to the patient. However, there exist tumours that are extremely aggressive with
lethal potential, that present a very high risk to the patient. PCa grading aims to classify
the relative risk of tumours based on their histological appearance. Staging is used to
categorise the amount and location of cancer and the risk of the cancer having spread
beyond the prostate. A standardised system is used for both grading and staging.
1.4.1 Gleason Grading
The Gleason system is used to grade PCa in both radical prostatectomy specimens
and needle biopsy samples. The tissue is examined and the cancerous cells are classiﬁed
according to their histologic appearance into diﬀerent Gleason patterns. The Gleason
pattern ranges from 1 to 5, with 5 having the worst prognosis. For example, Gleason
pattern 1 is attributed to cancerous tissue that closely resembles normal prostate tissue.
The glands are small, well-formed, and closely packed. Gleason pattern 5 is attributed to
tissue that does not have recognisable glands. The diﬀerent histological aspects of the ﬁve
Gleason patterns are shown in Figure 1.4.
PCa is heterogeneous, therefore Gleason chose to incorporate both a primary and a
secondary grade into the system [Gleason (1981)]. The primary grade is the tumour pattern
of the majority of the tumour, i.e. the most prevalent pattern in the cancer. The primary
grade pattern must be greater than 50% of the total pattern seen. The secondary grade
is the next most prevalent tumour pattern in the cancer. The secondary grade pattern
must be between 5% and 50% of the total pattern seen. The Gleason score is obtained by
adding these two grades.
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So if in a speciﬁc case the primary tumour pattern is grade 3, and the secondary tumour
pattern is grade 4, the Gleason Score is 3 + 4 = 7.
The Gleason grade or pattern ranges from 1 to 5, consequently, the Gleason score
ranges from 2 (1 + 1) up to 10 (5 + 5), with 10 having the worst prognosis. For Gleason
Score 7, a Gleason 4 + 3 is a more aggressive cancer than a Gleason 3 + 4. A cancer is
considered aggressive if the Gleason score is greater than 7.
Figure 1.4: The Gleason system is used to grade PCa by classifying the cancerous cells ac-
cording to their histologic appearance into diﬀerent Gleason patterns. The Gleason pattern
ranges from 1 to 5, with 5 having the worst prognosis.
1.4.2 Cancer Staging
PCa staging is used to categorise the amount and location of cancer and the risk of the
cancer having spread beyond the prostate. The most widely used staging system is the
TNM system [Edge et al. (2010)] maintained by the American Joint Committee on Cancer
(AJCC) and the International Union for Cancer Control (UICC). The TNM staging system
is based on the extent of the primary tumour (T), the extent of spread to the lymph nodes
(L) and the presence of metastasis (M). The three diﬀerent categories of the 7th Edition
are detailed in Table 1.1. Once the T, N and M values have been determined, they are
combined and an overall ‘Stage’ of I, II, III or IV is assigned to the cancer, see Table 1.2.
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Primary Tumour (T)
TX Primary tumour cannot be assessed
T0 No evidence of primary tumour
T1 Clinically inapparent tumour neither palpable nor visible by imaging
T1a Tumour incidental histologic ﬁnding in 5% or less of tissue resected
T1b Tumour incidental histologic ﬁnding in more than 5% of tissue resected
T1c Tumour identiﬁed by needle biopsy (for example, because of elevated PSA)
T2 Tumour conﬁned within prostate
T2a Tumour involves one-half of one lobe or less
T2b Tumour involves more than one-half of one lobe but not both lobes
T2c Tumour involves both lobes
T3 Tumour extends through the prostate capsule
T3a Extracapsular extension (unilateral or bilateral)
T3b Tumour invades seminal vesicle(s)
T4 Tumour is ﬁxed or invades adjacent structures other than seminal vesicles
Regional Lymph Nodes (N)
NX Regional lymph nodes were not assessed
N0 No regional lymph node metastasis
N1 Metastasis in regional lymph node(s)
Distant Metastasis (M)
M0 No distant metastasis
M1 Distant metastasis
M1a Nonregional lymph node(s)
M1b Bone(s)
M1c Other site(s) with or without bone disease
Table 1.1: The TNM staging system is based on the extent of the primary tumour (T), the
extent of spread to the lymph nodes (L) and the presence of metastasis (M).
Stage T N M PSA Gleason
I
T1a-c N0 M0 PSA < 10 Gleason ≤ 6
T2a N0 M0 PSA < 10 Gleason ≤ 6
T1-2a N0 M0 PSA X Gleason X
IIA
T1a-c N0 M0 PSA < 20 Gleason 7
T1a-c N0 M0 10 ≤ PSA < 20 Gleason ≤ 6
T2a N0 M0 10 ≤ PSA < 20 Gleason ≤ 6
T2a N0 M0 PSA < 20 Gleason 7
T2b N0 M0 PSA < 20 Gleason ≤ 7
T2b N0 M0 PSA X Gleason X
IIB
T2c N0 M0 Any PSA Any Gleason
T1-2 N0 M0 PSA ≥ 20 Any Gleason
T1-2 N0 M0 Any PSA Gleason ≥ 8
III T3a-b N0 M0 Any PSA Any Gleason
IV
T4 N0 M0 Any PSA Any Gleason
Any T N1 M0 Any PSA Any Gleason
Any T Any N M1 Any PSA Any Gleason
Table 1.2: The ‘Stage’ of I, II, III or IV is determined from the T, N and M categories.
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1.4.3 Zonal Inﬂuence on Cancer Grade and Stage
Peripheral zone tumours account for 75% - 85% of prostate cancers. However, it has
been shown that up to 25% of prostate cancers originate in the transition zone [Akin et al.
(2006)]. Peripheral zone tumours have a preponderance of moderate-grade and high-grade
disease and are generally less well diﬀerentiated (median Gleason score of 6 - 7) than
transition zone tumours (median Gleason score of 5). They are also more likely to extend
through the capsule [Greene et al. (1991)]. Statistics appear to indicate that tumours
that arise in the transition zone have a less malignant potential than those that arise in
the peripheral zone [Greene et al. (1991)].
1.5 Prostate Cancer Screening
Whether asymptomatic men beneﬁt from screening for PCa is an unresolved question.
Proponents of screening view it as a means of detecting PCa in the early stages, when
it is amenable to local interventions with curative intent. Screening advances the time
of diagnosis (lead time) and detects cancers that would not have been diagnosed in the
absence of screening (over-detection). Opponents of screening point out that some men will
be treated unnecessarily, because they would not have been diagnosed with PCa without
screening, and that over-diagnosis results in over-treatment, i.e. the cancer left untreated
would not have caused mortality. The key question is whether screening aﬀects the overall
and PCa-speciﬁc mortality [Postma and Schröder (2005)].
Note that the deﬁnition of over-detection varies between diﬀerent studies; it can be
deﬁned as cancer diagnosed that would not have caused symptoms during the patients
lifetime [Bangma et al. (2007)], cancer diagnosed that would not have caused symptoms
or death [Welch and Black (2010)] or the detection of disease that would not have been
diagnosed in the patient’s lifetime in the absence of screening [Draisma et al. (2009),Etzioni
et al. (2002)]. The lead-time is deﬁned as the time by which screening advances diagnosis.
For a screening program with a 4-year screening interval from the age of 55 to 67, the
estimated mean lead time was 11.2 years and the over-detection rate was 48%, [Draisma
et al. (2003)]. A review of six randomised controlled trials corroborated these results
ﬁnding that screening was associated with a 46% relative increase in diagnoses of PCa
among men being screened compared to men who underwent no screening [Djulbegovic
et al. (2010)]. Furthermore, it was found that the increase was mainly due to an increase
in the number of men diagnosed with stage I PCa. Screening had no signiﬁcant impact on
the diagnosis of stage II, III and IV PCa, suggesting that screening leads to an increase in
diagnosis of early stage PCa [Djulbegovic et al. (2010)]. However, despite the increased
number of diagnoses, PCa screening was found to have no signiﬁcant impact on overall
mortality or death from PCa. This conﬁrms the concerns of over-diagnosis, i.e. the
detection of non-fatal cancers.
In summary, screening for PCa aids in earlier diagnosis and helps to detect PCa at an
15 1.5. PROSTATE CANCER SCREENING
earlier stage. However, this early detection has not been shown to have a signiﬁcant impact
on mortality and comes at the price of additional testing and the risk of over-treatment
with possible adverse eﬀects.
Currently, PCa screening is carried out using the prostate speciﬁc antigen (PSA) test
and the digital rectal examination (DRE). Patients with suspicious ﬁndings on PSA tests
and/or DRE are further examined by a transrectal ultrasound-guided (TRUS) biopsy.
1.5.1 Prostate Speciﬁc Antigen (PSA) Test
Prostate-speciﬁc antigen (PSA) is a protein produced by the prostate gland. The
PSA test measures the level of PSA in the blood. The level of PSA is often elevated in
men with PCa. However, many false positive elevations in PSA (i.e. an elevated PSA
level with no PCa) are attributable to benign prostatic hyperplasia (BPH), acute urinary
retention and acute prostatitis (inﬂammation of the prostate gland). A biopsy of the
prostate or transurethral prostatectomy can also raise PSA levels. Therefore, although
PSA is prostate-speciﬁc, it is not a cancer-speciﬁc measure.
The sensitivity and speciﬁcity of the PSA test and the threshold at which a result
should prompt a biopsy are unclear. Traditionally, a PSA value of 4.0 ng/mL has been
used as the upper limit of the normal level [Barry (2001)], however this is complicated by
the fact that PSA levels tend to increase with age.
Two large randomised clinical trials for PCa have recently published their results, in
Europe (The European Randomized Study of Screening for Prostate Cancer, ERSPC trial)
and in the USA (The Prostate, Lung, Colorectal and Ovary cancer, PLCO trial).
The ERSPC trial evaluated the eﬀect of PSA testing on PCa mortality. After a median
follow-up of 11 years of 162,388 men (55 to 69 years of age), it was estimated that the
PCa mortality rate was reduced by 21% in the group that underwent PSA-based screening
compared to the control group (absolute reduction in PCa mortality of 1.07 deaths per
1000 men). Therefore concluding that PSA-based screening signiﬁcantly reduced PCa
mortality. However, despite this reduction it was found that screening had no eﬀect on
all-cause mortality. The conclusion was that more information on the balance of beneﬁts
and adverse eﬀects, as well as the cost-eﬀectiveness of PCa screening is needed before
general recommendations can be made [Schröder et al. (2012)].
Conversely, the PLCO trial, carried out to evaluate the eﬀect of screening with PSA
testing and digital rectal examination on the rate of death from PCa, concluded that
screening was associated with no reduction in PCa mortality after 10 trial years, even
though at 7 years, screening was associated with a relative increase of 22% in the rate of
PCa diagnosis, compared with the control group. The study was carried out on 76,693
men, half of whom received annual screening and the other half, the control group, usual
care. Screening included PSA testing for 6 years and DRE for 4 years [Andriole et al.
(2009)]. They thus advise against screening all men over the age of 75 years.
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1.5.2 Digital Rectal Examination (DRE)
The digital rectal examination (DRE) involves inserting a gloved and lubricated ﬁnger
into the rectum to feel the prostate, see Figure 1.5. A suspicious outcome is deﬁned by
the presence of signiﬁcant induration, nodularity, or asymmetry. Note that only tumours
in the PZ can be detected.
The diagnostic value of DRE for PCa, estimated by averaging the results of 18 studies,
indicate that the DRE appears to be a test of high speciﬁcity (0.85) and negative predictive
value (0.88), low sensitivity (0.46) and low positive predictive value (0.39) [Tessler et al.
(2012)].
However the use of DRE as a screening tool is controversial due to its subjective nature
with high inter-observer variability. Nevertheless, DRE independently and signiﬁcantly
aﬀects the prediction of PCa risk. An abnormal DRE is a risk factor for high-grade
disease.
Furthermore, DRE does detect some prostate cancers that are missed by PSA screen-
ing. In one screening study the PSA test detected 45% more cases of cancer than DRE
alone, whereas DRE detected 18% more cases of cancer than the PSA test alone; that is,
each test detects cancers missed by the other [Richie et al. (1993)]. The area under the
curve (AUC) of PSA alone to predict PCa at initial screening was estimated to be 0.69. In
comparison, the AUC of PSA and DRE was estimated to be 0.73 [Roobol et al. (2012)].
Figure 1.5: The DRE involves inserting a gloved and lubricated ﬁnger into the rectum to
feel the prostate. A suspicious outcome is deﬁned by the presence of signiﬁcant induration,
nodularity, or asymmetry. Only tumours in the PZ can be detected. Source: National
Cancer Institute.
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1.5.3 Biopsy
The standard evaluation for men with suspicious ﬁndings on PSA tests and/or DRE
is a transrectal ultrasound-guided (TRUS) biopsy [Hara et al. (2008)].
The number of biopsies required for the optimal detection of PCa is controversial.
The traditional strategy has been to obtain a set of six biopsy specimens in a sextant
pattern. However, nearly all studies have shown a higher cancer detection rate with
a greater number of biopsies in comparison with the standard sextant technique, a 12-
sample procedure improves the cancer detection rate by 22% compared with a 6-sample
procedure [Guichard et al. (2007)]. Other studies have shown that more than 12 cores are
not signiﬁcantly more conclusive [Eichler et al. (2006)].
Prostate saturation biopsy was initially introduced by [Borboroglu et al. (2000)], and
consisted of at least 20 biopsy cores. Transrectal ultrasound-guided saturation biopsies
have a cancer detection rate of 14 - 34% [Merrick et al. (2007)]. Transperineal template-
guided prostate mapping biopsies (TTMB) are an alternative form of saturation biopsy.
As TTMB are conducted under general or regional anesthesia, a large number of cores
are typically obtained, enabling access to the entire prostate gland. Using TTMB, [Taira
et al. (2009)] report a cancer detection rate of 75.9% on initial biopsy, signiﬁcantly higher
than the 40-45% yield expected from standard TRUS biopsy. [Taira et al. (2009)] suggest
that the improvement is due to the improved sampling in the anterior and apical aspects
of the gland, areas that are not consistently sampled through a transrectal approach. The
short-comings of the TTMB technique include the need for anesthesia, added cost and the
potential for the diagnosis of biologically inconsequential cancer.
The 12-core transrectal prostate biopsy scheme is now the standard. The number of
biopsies can be adapted to the prostate volume, for example [Naughton et al. (1998)] found
that prostates of TRUS volume ≤ 30 cc required an average of 8 biopsy cores in order to
detect the cancer, compared with an average of 11 biopsy cores required for prostates of
TRUS volume > 30 cc.
The prostate is the only organ that is diagnosed by random sampling, meaning that
entire tumours can be missed. Therefore a negative biopsy result does not ensure the
absence of PCa. If the biopsy results are positive, the volume of the tumour cannot be
assessed with certainty. Due to the heterogeneity of Pca, there is signiﬁcant uncertainty
associated with the Gleason score evaluated from a biopsy sample. There is therefore a
signiﬁcant risk of over- and under-estimation of the aggressiveness of the PCa evaluated
using biopsies.
The diagnostic accuracy of TRUS biopsy is unknown as men with a negative biopsy
result do not undergo radical prostatectomy and there is therefore no conﬁrmation of the
biopsy ﬁndings. In an attempt to overcome this limitation, a study was carried out in
which 18-core needle biopsies were performed on autopsy prostates from 164 men who
had no history of PCa. Cancer was detected in 25 of the 47 cancerous prostates (53%),
representing 34 of the 87 identiﬁed tumour foci (39%) [Haas et al. (2007)]. As a negative
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biopsy does not ensure the absence of PCa, if the ﬁrst set of biopsies is negative, repeated
biopsies can be recommended, especially in the case of a rising and/or persistent PSA level
or a suspicious DRE. In the second set of biopsies, a detection rate of about 10 - 35% has
been reported in cases with a negative initial set of biopsies [Heidenreich et al. (2008)].
Technical improvements in prostate magnetic resonance imaging (MRI) have resulted
in the use of MRI to target prostate biopsies. The beneﬁts of an image-guided approach to
prostate biopsy are that fewer men are biopsied overall; men deemed to have a normal MRI
are not biopsied. The eﬃciency of the biopsies are therefore improved, i.e. the number of
clinically signiﬁcant prostate cancers detected per number of men biopsied. [Moore et al.
(2013)] estimated the eﬃciency of targeted biopsy sampling to be 70%, compared to the
standard TRUS approach at 40%. Furthermore, targeted biopsies reduced the diagnosis
of clinically insigniﬁcant cancer [Moore et al. (2013)].
1.6 Prostate Cancer Treatment
Various diﬀerent modalities of treatment for PCa exist. Factors inﬂuencing the choice
of treatment involve the grade and stage of the cancer, as well as the age and general health
of the patient. The eﬀectiveness of diﬀerent treatments are often analysed with respect to
the associated overall survival rate and PCa-speciﬁc survival rate. In order to clarify the
nuance, the overall survival rate is deﬁned as the percentage of people in a study who are
still alive for a certain period of time after they were diagnosed with or started treatment
for a disease. The PCa-speciﬁc survival rate is deﬁned as the percentage of people in a
study who have not died from PCa in a deﬁned period of time, i.e. patients who died from
causes other than PCa are not counted in the measurement.
1.6.1 Active Surveillance
Active surveillance (AS) concerns patients with very low-risk PCa. These patients are
initially not treated but are followed and treated with a curative intent if progression or
the threat of progression occurs during follow-up.
AS aims to reduce the ratio of over-treatment in patients with clinically conﬁned low-
risk PCa. It has been estimated that men with well-diﬀerentiated PCa have a 20-year
PCa-speciﬁc survival rate of 80 - 90% [Heidenreich et al. (2011)].
Inclusion criteria for AS vary among studies but include [Dall’Era et al. (2012),Hei-
denreich et al. (2011)]
• gland conﬁned PCa (T1 - T2),
• Gleason score ≤ 6,
• three or fewer biopsies involved with cancer,
• ≤ 50% of each biopsy involved with cancer,
• PSA < 10 ng/mL.
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Estimating the percentage of men eligible for surveillance is sensitive to the criteria
used. Stringent criteria will limit the number of eligible men and likely exclude some
potential candidates. The eligibility has been estimated to be between 4 - 82% [Dall’Era
et al. (2012)].
Misclassiﬁcation of insigniﬁcant disease based on entry criteria, that is patients included
for AS who were found to have high grade cancer, range from 16 - 36% [Iremashvili et al.
(2012)].
Estimating the number of men on AS who will progress to treatment is highly sensitive
to the criteria used to deﬁne cancer progression and the criteria used to select AS candi-
dates. Progression is generally deﬁned as changes in PSA over time (PSA >10 ng/mL), the
detection of higher-volume or higher-grade cancer on surveillance biopsy (Gleason score
progression to ≥ 7), or concerning changes on physical exam of the prostate. As men
are reclassiﬁed beyond the initial inclusion criteria of their institution, treatment is often
recommended. Approximately 25% (11 - 33%) of patients receive further treatment after
a median of about 2.5 years of surveillance (minimum 1.8, maximum 6.8) [Dall’Era et al.
(2012)]. PCa-speciﬁc mortality remains low (0 - 1%) [Dall’Era et al. (2012)], however
only data from non-mature randomised clinical trials of AS with follow-up <10 years are
currently available.
1.6.2 Radical Prostatectomy
Prostatectomy is the surgical removal of all (radical prostatectomy, RP) or part of
the prostate gland and is commonly used to treat localised PCa. The goals of RP are to
remove the cancer completely, minimise complications during the operation and optimise
recovery of potency and urinary continence. No surgeon uniformly achieves these results.
RP is a complex operation and outcomes are highly sensitive to technique.
A positive surgical margin (PSM) is deﬁned as prostate cancer cells touching the inked
surface of the excised prostate gland. A PSM after radical prostatectomy is associated
with an increased risk of recurrence and the need for secondary cancer treatment. Positive
margins have been reported in 11 - 38% of patients undergoing RP [Yossepowitch et al.
(2009)]. The success of surgery and the incidence of PSM vary greatly among surgeons, in a
particular study of 26 surgeons, the rate of positive surgical margins was 10 - 48% [Eastham
et al. (2003)].
Compared to AS, RP reduces disease-speciﬁc mortality (5.3%), overall mortality (5.0%),
and the risks of metastasis (10.2%) and local progression (25.1%), calculated after 10
years [Bill-Axelson et al. (2005)]. The absolute reduction in the risk of death after 10
years is small, but the reductions in the risks of metastasis and local tumour progression
are substantial.
Numerous studies have assessed urinary and sexual function one or more years after
RP, with rates of incontinence ranging from 4 - 40% and impotence from 29 - 75% [Stanford
et al. (2000)].
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1.6.3 Radiotherapy
Radiotherapy uses ionizing radiation to control or kill malignant cells. When absorbed
in tissue, ionizing radiation damages the DNA in cells, which increases the probability of
cell death. Normal cells are able to repair radiation damage, while cancer cells are not. It
can be used to treat all stages of PCa. Two diﬀerent kinds of radiation therapy are used
in PCa treatment: external beam radiation therapy and brachytherapy. The side eﬀects
of radiation therapy include diarrhea, mild rectal bleeding, as well as potential urinary
incontinence and impotence.
External Beam Radiation Therapy (EBRT)
External beam radiation therapy (EBRT) uses a linear accelerator to produce high-
energy x-rays that are directed in a beam towards the prostate. CT image data enables
the tumour to be localised and therefore the target and non-target tissue structures to
be deﬁned. Radiation therapy treatment plans are then generated to control the location
and dose of the radiation. External beam radiation therapy is generally given over several
weeks, with daily visits to a radiation therapy centre.
Studies have estimated the overall survival and PCa-speciﬁc survival outcomes to be
similar between RP and EBRT [Kupelian et al. (2002)]. The 5-year estimates of overall
survival and PCa-speciﬁc survival are 85.0% and 95.1% respectively [Shipley et al. (1999)].
Patients treated with EBRT have signiﬁcantly better urinary function, with a lower risk of
incontinence than those treated with RP. The diﬀerence in sexual function in patients who
underwent RP and in those who underwent EBRT is not statistically signiﬁcant [Frank
et al. (2007)].
Brachytherapy
Brachytherapy is a proven treatment for early, localised PCa. It involves the placement
of about 100 small ‘seeds’ containing radioactive material (such as iodine-125 or palladium-
103) directly into the tumour. The seeds emit low-energy X-rays, capable of travelling only
a short distance. Although the seeds eventually become inert, they remain in the prostate
permanently.
Brachytherapy oﬀers several advantages over EBRT in selected patients. Firstly, due to
the physics of radiation emanation from the implanted radioisotope, there is dose escalation
within the prostate, with rapid dose fall in surrounding normal tissues. Target motion,
set-up variation and localisation errors are not of major concern as they are with EBRT.
Brachytherapy is a simple, out-patient procedure that avoids hospitalisation and allows
the patient an early recovery. The 10-year estimates of overall survival and PCa-speciﬁc
survival are 74% and 96% respectively [Stock et al. (2006)]. There is no signiﬁcant diﬀer-
ence in urinary function between patients treated with brachytherapy and those treated
with RP or EBRT, however there is a signiﬁcantly lower risk of incontinence than those
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treated with RP. Patients treated with brachytherapy had signiﬁcantly better sexual func-
tion than patients treated with EBRT or RP [Frank et al. (2007)].
1.6.4 Hormonal Therapy
Both normal and cancerous cells in the prostate gland, as well as cancerous cells that
have migrated to other sites in the body, are dependent on androgens to stimulate growth,
function and proliferation. Hormonal therapy (HT), also known as androgen deprivation
therapy (ADT), inhibits the cancerous cells by reducing the levels of male hormones in
the body. Androgen deprivation can be achieved either by suppressing the secretion of
testicular androgens by means of surgical or medical castration, or by inhibiting the action
of the androgens by using competing compounds known as anti-androgens. Common side
eﬀects of hormone therapy include loss of libido and impotence.
HT prior to RP has been investigated in several trials, one study showed that patients
who received three months of HT before RP had a signiﬁcantly lower PSM rate at the
time of surgery than those who had no HT before RP. However, there was no diﬀerence
between the two groups in the biochemical recurrence rate (deﬁned as PSA greater than
0.4 ng/mL) at ﬁve years [Soloway et al. (2002)]. Another study evaluated HT after RP and
reported a 10% clinical recurrence rate at four years in the HT-treated patients compared
with a rate of 31% for those receiving placebo [Hellerstedt and Pienta (2008)].
The therapy outcome depends on the stage and grade of disease at diagnosis. In pa-
tients with advanced PCa, remission occurs in 80 - 90% of men with a median progression-
free survival of 12 to 33 months. At that time, an androgen-independent phenotype usually
emerges, leading to a median overall survival of 23 to 37 months from the time of initiation
of HT [Hellerstedt and Pienta (2008)]. Only 7% of patients are reported to live 10 years
or more [Aus et al. (2005)].
In conclusion, HT delays progression in advanced PCa cases and eﬀectively palliates
symptoms. Furthermore, it has been reported to shrink the prostate volume by up to
30% [Asha et al. (2005)], and is therefore often used to shrink tumours before radiotherapy.
Unfortunately the response to hormonal treatment lasts for a median duration of 18 - 24
months. Most men eventually become resistant to therapy and develop hormone refractory
prostate cancer (HRPC) [Calabrò and Sternberg (2007)].
1.6.5 Chemotherapy
Chemotherapy remains the only treatment option for HRPC, providing modest survival
and palliative beneﬁts. The most commonly used chemotherapy drug to treat PCa is
docetaxel, but only half of all patients will respond to docetaxel. Mitoxantrone is less
toxic but delivers only palliative beneﬁts. Inevitably, resistance to chemotherapy will
develop and the disease then becomes diﬃcult to control.
TAX327, a large randomized study, compared docetaxel-based chemotherapy to mitoxantrone-
based therapy. The data demonstrated that treatment with docetaxel can prolong life in
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a statistically signiﬁcant way in patients with HRPC, the median overall survival rates
for patients treated with docetaxel was 18.9 months, compared with 16.5 months for the
patients treated with mitoxantrone-based therapy [Tannock et al. (2004)].
The optimal timing of docetaxel-based chemotherapy is still unknown because there
are no prospective clinical trials indicating whether earlier treatment is more eﬀective than
delayed treatment.
1.6.6 Alternative Local Treatment Options
Focal therapy is an emerging alternative treatment option; the aim is to treat only
localised tumours, sparing the rest of the prostate, especially near the neurovascular bun-
dles and the urethral sphincter. Two signiﬁcant diﬃculties exist; the ﬁrst is the precise
localisation, visualisation, and characterisation of the cancer foci to be treated. The sec-
ond diﬃculty concerns the accurate guidance of the ablative energy to the area to be
targeted [Bozzini et al. (2012)].
Several of the most commonly used focal therapy techniques are presented below:
cryotherapy, high intensity focused ultrasound (HIFU), focal photodynamic therapy (PDT)
and focal laser ablation (FLA). Other focal therapy modalities inlcude: interstitial mi-
crowave thermal therapy, radiofrequency interstitial tumour ablation (RITA), electropo-
ration and nanoparticle thermotherapy.
Cryotherapy
Cryotherapy is an alternative treatment for locally conﬁned and locally advanced PCa.
It involves exposing the prostate gland to freezing temperatures by inserting 6 - 8 metal
rods transperineally into the prostate under TRUS guidance. Highly puriﬁed argon gas is
used to cool the rods, freezing the surrounding tissue at -40 ◦C. As the water within the
prostate cells freezes, the cells die. The urethra is protected from freezing by a catheter
ﬁlled with warm liquid.
The procedure is less invasive than RP with a lower risk of incontinence, of patients
who are continent before surgery, on average 84.1% regain continence after surgery with an
average recovery time of 6.1 months [Bahn et al. (2002)]. However, on average, of patients
who are potent before surgery, 94.9% are impotent after surgery, though 5.1% recovered
their potency with an average recovery time of 16.4 months [Bahn et al. (2002)].
The deﬁnition given by the American Society for Therapeutic Radiology and Oncology
(ASTRO) for biochemical failure is three successive increases of PSA level. Using this
deﬁnition, the biochemical disease-free survival probabilities ater 7 years for cryotherapy
(90%) has been shown to surpass the result for EBRT (48 - 69%) and brachytherapy
(89%) [Bahn et al. (2002)].
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High Intensity Focused Ultrasound (HIFU)
High intensity focused ultrasound (HIFU) is a minimally invasive, non-surgical treat-
ment for localised PCa. HIFU consists of focusing ultrasound waves emitted from a trans-
ducer inducing tissue damage by mechanical and thermal eﬀects as well as by cavitation.
The goal of HIFU is to heat malignant tissues above 65◦C to destroy these tissues by
coagulative necrosis. The HIFU treatment is performed under real-time monitoring with
ultrasound (US) or magnetic resonance imaging (MRI), enabling the temperature and ab-
lated area to be followed. An advantage of HIFU versus radiotherapy is that it can be
repeated if there is a proven local recurrence.
Post-HIFU, approximately 85% of control biopsies were negative at a mean of 3.5 - 6.4
years. The overall survival rate at 5 and 8 years has been estimated at 90% and 83 - 89%
respectively, and the PCa-speciﬁc survival rate at 5 and 8 years has been estimated at
100% and 98 - 99% respectively. In addition, 62 - 83% of the patients were biochemically
disease free at 7 years [Blana et al. (2008),Crouzet et al. (2010)].
Common side-eﬀects (with complications rates) after HIFU inlcude infravesical ob-
struction (19.7%), stress incontinence (7.6%) and impotence (49 - 70%) [Blana et al.
(2006),Aus et al. (2005)].
Focal Photodynamic Therapy (PDT)
Photodynamic Therapy (PDT) is based on the interaction between light supplied by
a laser ﬁbre, a photosensitive agent (PS) and the oxygen present in tissue. The photo-
sensitive agent (PS) is administrated topically, orally or intravenously. In its basic state,
the PS is pharmacologically inactive and stable. When light is delivered at an appropriate
wavelength (speciﬁc to each PS), the drug goes into an excited phase, causing a chain re-
action inducing the release of singlet oxygen and antioxidant enzymes. The singlet oxygen
can directly kill tumour cells by the induction of necrosis and/or apoptosis [Bozzini et al.
(2012)].
PDT requires the placement of intraprostatic laser ﬁbres, achieved through a transper-
ineal approach using a brachytherapy template under TRUS-guidance. Transperineal nee-
dle insertion makes access to anterior tumours diﬃcult. Advantages of PDT include lim-
ited morbidity and in the case of primary failure, the possibility of repeated treatment
or secondary radical treatment. However, as PDT alters the prostate morphology, follow-
up may be more challenging than usual. Limited clinical experience of PDT currently
exists [Bozzini et al. (2012)].
Focal Laser Ablation (FLA)
Focal laser ablation (FLA) involves delivering energy to the prostate using laser ﬁbres.
The thermal eﬀects produced by the laser energy spread from the absorption zone and
cause an increase in the temperature of surrounding tissues. Penetration of the laser
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beam varies according to optical and thermal properties of the target tissues. As the laser
ﬁbres are MR-compatible, the treatment can be monitored using MR-thermometry, or
alternatively using ﬂuoroptic thermometry [Bozzini et al. (2012)].
As for PDT, the laser ﬁbres are inserted using a transperineal approach through nee-
dles, meaning that access to anterior tumours is diﬃcult. FLA is one of the most recent
focal therapy techniques developed and limited data is available regarding oncologic and
functional outcome or reliable treatment planning [Bozzini et al. (2012)].
1.7 Prostate Cancer Imaging
Today, cancers are detected at smaller, lower stages and lower grades than ever before.
The challenge is to distinguish between the signiﬁcant portion of tumours that are small
and clinically insigniﬁcant and those that are extremely aggressive and lethal. The risk
is between overdiagnosis and over-treatment versus the under-detection of cancers with
lethal biologic potential.
If imaging could provide an accurate localisation and staging of PCa, low- and high-
risk cancers could be distinguished. This would enable PCa cases to be classiﬁed into
risk groups (low, intermediate, or high), directing therapy more accurately thus improving
patient outcome and prognosis, without the cost of over-treatment.
Accurate localisation and staging of the cancer and its margins would enable therapy
to be targeted to the cancer, sparing unaﬀected neurovascular bundles and limiting side
eﬀects such as incontinence or impotence. For example, radiation therapy usually treats
the whole prostate gland, accurate localisation and staging enable the adjustment of the
dose to focus on the tumour and minimise exposure to periprostatic tissues, thus reducing
side eﬀects.
Accurate localisation of PCa will pave the way for innovative, minimally invasive ther-
apies and it may be possible to reduce the number of men undergoing biopsy or to improve
the diagnostic yield of prostate biopsies by including an imaging method in the diagnostic
workup.
Furthermore, an accurate imaging technique would enable the eﬀects of therapy to
be better evaluated, allowing earlier cessation of ineﬀective therapies, shorter duration of
phase 2 trials to evaluate new drugs and accelerated approval in phase 3 trials.
The ideal imaging technique should be aﬀordable and minimally invasive, with little
inter-observer variability in interpretation. In addition, the test should be able to predict
tumour stage, volume, and location with high speciﬁcity and sensitivity. To date, no
such ideal imaging method exists and no consensus exists regarding the use of imaging
techniques for evaluating primary prostate cancers. Many imaging modalities currently
available show considerable clinical value, each with its own advantages, disadvantages,
and speciﬁc indications.
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1.7.1 Positron-Emission Tomography (PET)
Positron-emission tomography (PET) is a noninvasive imaging technique that com-
putes the three-dimensional distribution of radioactivity based on the detection of pho-
tons resulting from annihilation of positrons that are emitted by positron emitter-labelled
radiotracers.
The fundamental diﬀerence between PET and the various other imaging techniques
is that PET assesses functional or metabolic characteristics of the tumour, whereas the
other techniques predominantly assess the tumour’s anatomical or morphologic features
(e.g. density, size, shape).
Currently, the most commonly used PET radiotracer in oncologic clinical studies is
18F-ﬂuorodeoxyglucose (FDG). However 18F-FDG has low sensitivity for the detection
of cancer in the prostate gland and is not very eﬀective for the diagnosis or assessment
of local organ-conﬁned cancer or extracapsular extension [Bouchelouche et al. (2010)].
Furthermore, similarities in the 18F-FDG uptake in prostate tumours and benign prostatic
hyperplasia have been demonstrated [Turkbey et al. (2009)]. Molecular PET tracers with
higher sensitivity and speciﬁcity are being investigated as alternatives to 18F-FDG, in
particular 11C-acetate, 11C-choline, and 18F-ﬂuorocholine have shown promising results
[Bouchelouche and Oehr (2008)].
1.7.2 Computed Tomography (CT)
In contrast to PET, computed tomography (CT) uses an eternal X-ray beam to gen-
erate tomographic images. CT allows the visualisation of morphological and anatomic
structures with a high anatomical resolution.
CT is not used in the detection or local staging of PCa as the resolution is insuﬃcient
to accurately evaluate the margins of the prostate and the presence of focal intraprostatic
lesions [Nicolau et al. (2010)]. The major role of CT is in the nodal staging of PCa, for
which it is limited.
1.7.3 PET/CT
Integrated PET/CT combines PET and CT in a single imaging device and allows
morphological and functional imaging to be carried out in a single imaging procedure.
Anatomical and morphological information derived from CT can be used to increase the
precision of localisation, assessment of extent, and characterisation of lesions detected by
PET. Figure 1.6 shows PET/CT images of two diﬀerent patients in which a tumour is
visible, the tumour existence and location is conﬁrmed using MR images.
PET/CT has a potential value in the detection of bone metastases from PCa, the
sensitivity, speciﬁcity, and accuracy were 81%, 93%, and 86% for 18F-ﬂuoride and 74%,
99%, and 85% for 18F-choline, respectively [Beheshti et al. (2008)].
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Figure 1.6: (A-C) 73 year old man with biopsy-proven PCa, Gleason 4 + 5. (A) 11C-
choline PET/CT image, the focal radiotracer uptake (yellow arrow) indicates the tumour,
the low-level nonfocal activity in the rest of the gland indicates normal prostate tissue,
BPH, or prostatic inﬂammation. Normal activity is noted in the rectum (red arrow). (B)
T2-W and (C) T1-W MR images conﬁrm the tumour. (D-F) 78 year old man with biopsy-
proven recurrent PCa, Gleason 4 + 4. The tumour is visible in the (D) PET/CT image,
(E) T2-W and (F) T1-W MR image. Source: [Murphy et al. (2011)]
1.7.4 Ultrasonography
The classic gray scale ultrasound (US) description for PCa is a hypoechoic lesion,
however, PCa may also appear echogenic or isoechoic [Halpern (2006)]. Furthermore, pro-
statitis and benign prostatic hyperplasia mimic the gray scale appearance of PCa [Halpern
(2006)]. Given the diverse appearance of PCa and the potential for benign processes to
mimic the gray scale appearance of PCa, conventional prostate US has little advantage
over DRE for detecting malignant areas [Aarnink et al. (1998)]. Various developments
to conventional prostate US are presented below, a visual comparison is presented in Fig-
ure 1.7.
Transrectal Ultrasound (TRUS)
Transrectal ultrasound (TRUS) provides real-time imaging of the prostate gland at a
relatively low cost and is thus a standard imaging tool in PCa. However it has limited
accuracy in identifying and localising PCa. A study aimed at estimating the accuracy
of TRUS found that only 18% of sonographically suspicious quadrants were cancerous
while 65% of quandrants containing cancer were not sonographically suspicious [Flanigan
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et al. (1994)]. TRUS is thus generally considered to be insuﬃcient for the local staging of
the tumour and for the identiﬁcation of local recurrences. It is primarily used for biopsy
guidance and to estimate the volume of the prostate.
Colour Doppler Ultrasound
Ultrasound Doppler techniques demonstrate the presence of blood ﬂow by detecting a
frequency/phase shift in the ultrasound radiofrequency signal reﬂected from moving blood.
Since PCa is associated with increased perfusion, the sensitivity of US PCa detection can
be increased with colour Doppler imaging of blood ﬂow within the prostate. The results of
one particular study showed that colour Doppler US depicted 15.8% more of the cancers
present than gray-scale US [Kuligowska et al. (2001)]. However, the study concluded
that gray-scale TRUS, even coupled with colour Doppler US, remains inadequate for PCa
screening [Kuligowska et al. (2001)].
Contrast-Enhanced Ultrasound
PCa tissue is associated with increased microvessel density. Microvessels in malig-
nant tissue are smaller than those of benign prostate tissue [Halpern (2006)]. However
the microvessels in PCa are below the resolution of conventional Doppler imaging. Mi-
crobubble contrast agents have enhanced acoustic reﬂectivity, enabling the microvessels to
be visualised by the intense reﬂected signal from microbubbles within the vessels. It has
been demonstrated that the use of microbubble contrast agents can signiﬁcantly improve
the Doppler detection of PCa; the sensitivity of contrast-enhanced colour Doppler was
measured to be 93% compared to that of un-enhanced colour Doppler at 54% [Roy et al.
(2003)].
Figure 1.7: An 80 year old man with biopsy cores demonstrating Gleason 9 and Gleason 10
cancer. (a) Conventional gray scale image shows a hypoechoic (the classic description for
PCa) mass extending from the prostate (arrows). (b) Real-time elastography shows reduced
tissue elasticity (darker blue color) in the region of the mass (arrows). (c) Colour Doppler
shows increased ﬂow within and around the mass (arrows). Source: [Halpern (2006)]
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Elastography
Elastography is an alternative ultrasound-based imaging technique that evaluates the
elasticity of the tissue. PCa is characterised by a partly limited elasticity or compressibility.
In a study including 107 patients, transrectal real-time elastography had a sensitivity
evaluated as 68% compared to TRUS whose sensitivity was evaluated as 50% [Kamoi
et al. (2008)].
1.7.5 Magnetic Resonance Imaging (MRI)
Magnetic resonance imaging (MRI) provides the best 3D anatomic imaging of the
prostate among all of the imaging modalities because of its high spatial resolution, mul-
tiplanar capabilities, and excellent soft tissue contrast, making it an attractive imaging
modality for the prostate gland. The majority of the experience with prostate MRI was
obtained at 1.5 Tesla (T) with the combined use of a phased array surface coil and an en-
dorectal coil. Higher ﬁeld strength magnets (e.g. 3 T), with the same combination of coils
or with only the phased array surface coil, improve the signal-to-noise ratio (SNR), result-
ing in higher resolution images with better spatial and spectral diﬀerentiation. Various
MRI sequences are presented below, a visual comparison is presented in Figure 1.8.
T1-Weighted Imaging (T1-W)
On T1-weighted (T1-W) MRI, the prostate gland usually demonstrates diﬀuse inter-
mediate signal intensity, hence zonal anatomy and tumours cannot be delineated. T1-W
MRI is mainly used to detect the presence of biopsy-related residual hemorrhage, which
appears as a hyperintense focus relative to normal prostate peripheral zone.
T2-Weighted Imaging (T2-W)
T2-weighted (T2-W) MRI is an essential sequence as it provides an excellent display
of the zonal anatomy of the prostate. Normally, the peripheral zone (PZ) is high in
signal on T2-W images, whereas the transition zone (TZ) is generally lower in signal with
considerable heterogeneity. The surgical capsule appears as a distinct hypointense rim
surrounding the PZ.
PZ cancers are usually rounded or ill-deﬁned, low signal intensity foci surrounded by the
high signal of the normal PZ. However, this pattern can be mimicked by various conditions
such as prostatitis, benign prostatic hyperplasia, post-biopsy hemorrhage, biopsy-related
scars and the eﬀects of radiation treatment.
T2-W MRI is not sensitive in detecting cancer in regions other than the peripheral zone
of the prostate. In the TZ, the signal characteristics of cancerous tissue overlap with those
of normal TZ tissue.
T2-W alone does not achieve adequate sensitivity and speciﬁcity for PCa. Sensitivity
values have been reported in the range of 27 - 100% and speciﬁcity in the range of 32 -
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99%. The wide range of sensitivities and speciﬁcities is due to the signiﬁcant variability of
the patient populations, as well as diﬀerences in the gold standard (biopsy versus surgery)
and the level of diagnostic and technical expertise in diﬀerent studies [Bouchelouche et al.
(2010)].
Functional MRI imaging techniques, such as MR spectroscopy, diﬀusion-weighted MRI
and dynamic contrast-enhanced MRI, have been investigated for their potential to com-
plement T2-W MRI in improving PCa localisation.
Diﬀusion-Weighted Imaging (DWI)
Diﬀusion-weighted imaging (DWI) measures the water diﬀusion within tissue. Normal
glandular prostate tissue tends to allow diﬀusion of free water molecules, whereas tumours,
with their densely packed cells, tend to have restricted water diﬀusion, which results
in preserved signal within tumours compared with normal tissue on diﬀusion-weighted
images. DWI sequences are acquired using a selection of diﬀerent b values, ranging from
0 - 2000 s/mm2, enabling apparent diﬀusion coeﬃcient (ADC) maps to be generated.
Tumours show a lower ADC value than benign regions. DWI acquisition times are short,
making it a time eﬃcient sequence.
A wide range of sensitivities and speciﬁcities for prostate tumour detection have been
reported for DWI (57 - 93.3% and 57 - 100%, respectively), depending on the technology
used, ﬁeld strength, imaging parameters, patient selection, and validation method [Bouch-
elouche et al. (2010)].
The addition of an ADC map to T2-W images can improve the diagnostic performance
of MR imaging in PCa detection. In a particular study, using only T2-W images to detect
for PCa, the sensitivity, speciﬁcity and accuracy values were evaluated as 73%, 54% and
64% respectively. When T2-W and DWI images were combined, the values rose to 84%,
85% and 84% respectively [Tanimoto et al. (2006)].
Studies have shown that there exists a signiﬁcant diﬀerence between mean ADCs of low,
intermediate, and high clinical risk tumours [Turkbey et al. (2011)]. This could enable the
non-invasive assessment of the aggressiveness of prostate cancers that are visible on MR
images, aiding the selection of patients who are most appropriate for active surveillance.
Dynamic Contrast-Enhanced Imaging (DCE)
Dynamic contrast-enhanced (DCE) MRI provides quantitative kinetic parameters re-
ﬂecting the permeability and ﬂow characteristics of the vessels within a lesion. DCE-MRI
is performed with fast MR imaging sequences before, during, and after the rapid admin-
istration of a low-molecular weight contrast agent (e.g. gadolinium).
The following parameters are usually selected for processing: Ktrans (constrast agent
transfer rate between blood and tissue), kep (constrast agent backﬂux rate), maximum
slope for wash-in and wash-out, Ve (extravascular-extracellular fractional volume). These
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processed data can be analysed either visually (by generating colour maps) or quantita-
tively through straight values. The raw DCE images can also be visually analysed.
Tumours are expected to show early and increased enhancement compared with nor-
mal tissue and more rapidly washout than normal tissue. However abnormal enhancement
patterns are seen in both tumour foci and BPH nodules [Rouvière et al. (2003)]. Further-
more, smaller and low-grade tumours often do not demonstrate abnormal enhancement
on DCE MRI.
For the detection of tumours, DCE MRI alone has a sensitivity and speciﬁcity range of
46 - 96% and 74 - 96%, respectively, however these ranges are highly dependent on patient
selection, technique, and diagnostic criteria [Bouchelouche et al. (2010)].
The combination of DCE with DWI and T2-W images for the detection of PCa gave
values of 95%, 74% and 86% for the sensitivity, speciﬁcity and accuracy respectively,
compared to values of 84%, 85% and 84% for the combination of DWI and T2-W [Tanimoto
et al. (2006)].
[Girouin et al. (2007)] found that for the localisation of PCa, raw DCE images are
more sensitive than T2-W images; 50 - 60% and 78 - 81% of tumours (volume > 0.3 cc)
were correctly depicted with T2-W and raw DCE images, respectively.
MR Spectroscopy (MRS)
MR spectroscopy (MRS) is a technique that generates metabolite spectra based on the
diﬀering proton resonance frequencies of a limited number of metabolites such as choline,
creatine and citrate. Normal prostate tissue is rich in citrate and has relatively low choline
and creatine levels while this pattern is reversed in cancers.
It has been shown that the (Cho + Cr)/Cit value in a lesion increases with increasing
Gleason score. This implies that the sensitivity of MRS for cancer detection depends on
the grade. In cancer with a Gleason score of 3 + 3, MRS tumour detection sensitivity was
44.4%, and sensitivity increased to 89.5% in cancers with a Gleason score of more than 8.
A large proportion of tumours with a Gleason score of 6 did not generate abnormal voxel
metabolite ratios [Zakian et al. (2005)].
It has been shown that the addition of 3D MRS to MR imaging provides better detec-
tion and localisation of PCa in a sextant of the prostate, with sensitivity and speciﬁcity
higher than those with MR imaging alone. A combined MR imaging and 3D MRS indi-
cated the prescence of tumour with high probability (positive predictive value 89 - 92%),
whereas a negative result excluded the prescence of cancer with high probability (negative
predictive value 74 - 82%) [Scheidler et al. (1999)].
However other studies have shown that the sensitivity of MRS is low [Vargas et al.
(2012)] and that the accuracy of PCa localisation for combined MRS - MR imaging (0.54
- 0.61) is similar to MR imaging alone (0.57 - 0.63) [Weinreb et al. (2009)]. In conclusion,
MRS is a time-consuming sequence and in practice, it is often not used.
31 1.7. PROSTATE CANCER IMAGING
Figure 1.8: Multi-parametric MRI: the (A) axial T2-W and (B) ADC map of diﬀusion-
weighted MRI scans, show a hypointense lesion (arrow), (C) the MRS results show an
increased choline/citrate ratio in that region (yellow box) compared to normal adjacent
tissue (blue box). (D) Forward contrast rate, Ktrans and (E) reverse contrast rate kep
maps of DCE MRI also indicated the presence of a tumour (arrow). The tumour existance
and position is conﬁrmed in the histological whole mount slide (arrow, outlined in green),
Gleason score 3 + 3 = 6. The areas outlined in blue represent BPH. Source: [Trivedi et al.
(2012)]
1.7.6 Multimodality Imaging
No current imaging technique is capable of detecting PCa stage, volume and location
with suﬃcient speciﬁcity and sensistivity and no consensus exists regarding the use of
imaging for evaluating primary prostate cancers. The combination and fusion of diﬀerent
imaging modalities has therefore become an important research area, as each modality can
provide complementary information.
Signiﬁcant research has been undertaken to register real-time transrectal ultrasound
images with previously acquired MRI images of the prostate in order to target biopsies to
regions identiﬁed as suspicious in MR images [Singh et al. (2008),Xu et al. (2008),Pinto
et al. (2011),Kaplan et al. (2002)]. The technique allows for navigation within dynamic
contrast-enhanced maps, T2-W or MR spectroscopy images. Furthermore the technique is
a rapid way to facilitate MRI-guided prostate therapies such as external beam radiation
therapy, brachytherapy, cryoablation, high-intensity focused ultrasound ablation, or direct
injection of agents, without the cost, throughput, or equipment compatibility issues that
might arise with MRI-guided interventions inside the MRI suite [Singh et al. (2008)].
Research has also been concentrated on evaluating multi-parametric MRI, that is
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the combination of multiple MRI techniques, including T2-weighted imaging, dynamic
contrast-enhanced imaging and diﬀusion-weighted imaging, for the detection and locali-
sation of prostate cancer [Haider et al. (2007),Delongchamps et al. (2011),Langer et al.
(2009),Kurhanewicz et al. (2008)].
However, the integration of morphological and functional imaging sequences is chal-
lenging for radiologists in routine practice, especially for those not specialised in prostate
cancer imaging. Moreover, examination performance is highly reader-dependant due to
the subjective nature of the ﬁndings [Puech et al. (2009)]. Computer-aided diagnosis
(CAD) has therefore become a major research subject in medical imaging and diagnostic
radiology. With CAD, radiologists use the computer output as a ‘second opinion’ and
make the ﬁnal decisions, meaning that the performance by computers does not have to be
comparable to or better than that by physicians, but needs to be complementary to that
by physicians [Doi (2007)].
1.8 Conclusion
The accurate localisation and staging of PCa, enabling low- and high-risk cancers to
be distinguished, is a major clinical necessity. It is crucial to enable therapy to be directed
more accurately, to target therapy and reduce the risk of over- and under-diagnosis.
To date, no reliable imaging method exists. Currently, the most accurate imaging
method for PCa is multi-parametric MRI, that is combining T2-W MR images with DWI
and DCE. A challenge to the clinical utility of such a multi-parametric exam is how to
optimally combine the data to give the most accurate assessment of prostate cancer in
each patient.
Each MRI sequence modality must be evaluated. The images of each sequence must
be precisely registered to the ground-truth information, the histology slices of the prosta-
tectomy specimen. For each sequence, a quantitative analysis of the signal in the zones
corresponding exactly to the histology tumours would enable a deﬁnition of the signal
characteristics of prostate cancerous tissue for that sequence. The optimum combination
of sequences could then be determined.
The next chapter will present a review of the latest advances in histology - MR and
also histology - US registration.
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2.1 Introduction
Multi-parametric MRI (combining T2-W images with DWI and DCE images) is cur-
rently the most accurate imaging method for characterising PCa in individual patients.
The evaluation of the sensitivity and speciﬁcity of each sequence is required in order to de-
termine the optimum combination of sequences. The histology slices of the prostatectomy
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specimen remain the gold standard for prostate cancer diagnosis. To date, they provide
the most precise and comprehensive information concerning the cancer grade, stage, tu-
mour extent and margin status. Therefore, in order to deﬁne the signal characteristics
of prostate cancerous tissue for each imaging modality and sequence, the histology slices
must be precisely registered to the imaged data, enabling a quantitative analysis of the
signal in the zones corresponding exactly to the histology tumours.
There are signiﬁcant challenges associated with registering the histology slices to the
imaged data, due in particular to the many deformations that exist between the two
modalities. The diﬃculties to be considered are discussed in Section 2.2. There are two
general approaches to register the histology to the imaged data; the registration is either
considered as a 2D problem (Section 2.3) or as a 3D problem (Section 2.4 and Section 2.5).
Considering the registration as a 2D problem, that is, the registration of each histology
slice to it’s corresponding imaged slice, makes the signiﬁcant assumption that every 2D
histology slice has a corresponding 2D imaged slice. The existence of corresponding slices
implies that the plane along which the prostate specimen was sliced during histology
processing is the same (in terms of the orientation and height) as the plane along which
the imaged data was acquired. That the histology and imaging planes are at the same
orientation and height is either assumed or ensured. We consider each of these situations
in Section 2.3.1 and Section 2.3.2 respectively.
There are two main techniques to registering the histology and imaged data when
considering the registration as a 3D problem. The ﬁrst technique is a two-step method;
step 1 involves aligning the histology slices in order to reconstruct a 3D histology volume
and step 2 then consists of 3D registering the histology volume with the imaged volume.
This technique is detailed in Section 2.4; ﬁrst the diﬃculties that need to be considered
when aligning histology slices are explored, then the various methods developed to align
histology slices are presented and ﬁnally the existing 3D methods to register the aligned
histology slices to the imaged volume are detailed. The second 3D technique combines
the alignment of the histology slices and their registration with the imaged data into one
algorithm, the existing methods are detailed in Section 2.5.
Though our particular interest is the registration of histology slices to MR images,
the bibliography has been extended to include techniques developed using other image
modalities that could be adapted to the histology - MR registration problem. For example,
the aligning of histology slices could be considered more generally as the alignment of a set
of contiguous thin 2D sections. Techniques developed using autoradiography images are
thus included in the bibliography. Similarly, the ‘imaged data’ includes images acquired
using MR, ultrasound and CT imaging, both in vivo and ex vivo.
2.2 Registration Challenges
The registration of histology slices and imaged data is challenging. This is due in
particular to numerous deformations that exist between the two modalities. If MR in
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vivo pre-operative images of the prostate are being considered, it should be noted that
the acquisition is often performed using an endorectal coil (ERC) in order to improve
image quality. The ERC signiﬁcantly changes the prostate shape and volume; [Heijmink
et al. (2009)] estimated that the mean total prostate, peripheral zone, and central gland
volume decreased by 17.9%, 21.6% and 14.2% respectively after ERC introduction. The
prostatectomy operation itself causes a deformation of the specimen.
Once the prostate has been removed, the position of the seminal vesicles, vas deferens
and the contour of the prostate can be used as landmarks for quick identiﬁcation of the
base, apex, posterior and anterior surface of the specimen. However, the landmarks avail-
able are insuﬃcient for precise orientation of the specimen. Therefore, once the anatomic
orientation in the body is lost, it is diﬃcult to section the prostate in the same plane as
the images were obtained.
The histology processing induces further signiﬁcant deformations; the ﬁxation causes a
shrinkage and deformation, the consistency of the prostate makes it diﬃcult to slice evenly,
the paraﬃn-embedding and microtome slicing causes tissue loss and further deformation.
These diﬃculties are detailed in Section 2.4.1.
The signiﬁcant diﬀerence in resolution and inter-slice spacing between the histology
slices and imaged data further challenge the registration. In general, histology images have
a much higher spatial resolution than typical MR images (by several orders of magnitude),
meaning that certain structures easily visible in histology, may not be identiﬁable in MR
images.
2.3 2D Registration of Histology and Imaged Data
The 2D registration of histology slices with in vivo or ex vivo imaged data assumes
that the histology slicing plane is at the same orientation and height as the imaging plane.
This is either assumed (Section 2.3.1) or it is ensured that the histology plane is deﬁned
such as to be the same as the imaging plane (Section 2.3.2).
2.3.1 Assume that the Histolology and Imaging Planes are the Same
[Mazaheri et al. (2010)] registers MR in vivo images of the prostate to whole mount
histology slices. The digitised images of the histology slices are ﬁrst matched with the
corresponding axial MR images by a radiologist. The matching is done on the basis of
anatomical landmarks, progressive changes in the diameter of the prostate, the thickness
of the peripheral zone, the position of the pseudocapsule, and the presence, size, and shape
of the transition zone. The image pair is then registered using a non-rigid method based
on B-splines.
The manual matching of the MR images to the histological slices not only assumes that
the image acquisition plane is the same as the histology slicing plane, but also lengthens
the processing time, introduces inter-user variability and reduces the overall robustness of
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the method.
[Kozlowski et al. (2006)] aimed to determine whether the combination of DWI and
DCE MR images provided higher diagnostic sensitivity for prostate cancer than each
technique alone. This was estimated by mapping both the histology and MR results to a
standard octant biopsy map (left and right base, lateral mid-gland, medial mid-gland and
apex).
In order to identify the MRI parameters that best indicate aggressive cancer, therefore
improving the accuracy of MR tumour localisation and evaluation of aggressiveness, [Fan
et al. (2011)] registered high-resolution (9.4 T) MR ex vivo images with histology slices
of the prostate. The MR ex vivo images and histology slices were 2D registered by visual
inspection.
[Patel et al. (2011)] aimed to register histology slices of the prostate with MR in
vivo T2-W and DCE images in order to deﬁne quantitative MR prostate cancer signatures.
The histology slice is elastically registered to the corresponding MR T2-W image using a
method based on mutual information.
2.3.2 Ensure that the Histolology and Imaging Planes are the Same
A number of methods have been reported that aim to ensure that the same plane is
used for imaging and slicing. [Chen et al. (2010)] provides a comprehensive overview and
comparison of methods and apparatus developed to optimally slice the prostate specimen
to enable correlation of the histology slices with imaged data. Methods of particular
interest are detailed below, in addition to other methods that were not included in the
litterature review of [Chen et al. (2010)].
[Jhavar et al. (2005)] developed an approach whereby the prostate gland is held in
a cradle and the tissue is sliced using a series of evenly spaced blades that can be moved
through the slits, see Figure 2.1. The cradle enables the prostate to be held ﬁrmly during
the dissection permitting even sectioning. However, it is not adaptable for any size of
prostate specimen and the gripping force may distort the specimen. Furthermore, the
orientation of the prostate within the cradle is achieved manually.
Figure 2.1: Approach developed whereby the prostate gland is held in a cradle (b) and the
tissue is sliced using a series of evenly spaced blades (a). Source: [Jhavar et al. (2005)]
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Similar to this method, [Drew et al. (2010)] designed and constructed an adjustable
box that holds the fresh prostate specimen ﬁxed during the sectioning process by applying
a slight pressure on the specimen from every direction. The walls of the device include
4 mm spaced vertical slots that allow the blades of a knife to pass through the speci-
men. Though this method is adaptable for any size of prostate specimen, the positioning
of the orientation of the prostate remains inaccurate. The device was used by [Moradi
et al. (2012)] to generate histology slices that were used as a second validation dataset for
generated multi-parametric MRI maps.
Another method, developed by [Shah et al. (2009)], involved generating a 3D model
of the prostate from segmentations in three orthogonal planes of MR in vivo images.
Patient speciﬁc moulds are then fabricated using 3D printing. The prostate specimen,
after ﬁxation, is held in the mould and equally spaced slots allow the specimen to be
sectioned, see Figure 2.2. The accuracy of the ﬁt of the mould depends on the accuracy of
the MR in vivo segmentations, the change in the gland size between the image acquisition
and surgery and tissue deformation and shrinkage that occurred after surgery and tissue
ﬁxation. Inaccuracy in the ﬁt will introduce a diﬀerence between the orientation of the
MR and histology slices.
Figure 2.2: (a) The individualised mould has parallel cutting slots, (b) fabricated to be
patient speciﬁc using a 3D prostate model generated from MR in vivo images, (c) the
mould is split in two halves to enable the insertion of the prostate specimen (3D model of
the prostate with the urethra in yellow). Source: [Shah et al. (2009)]
[Madabhushi et al. (2005), Chappelow et al. (2007), Zhan et al. (2007), Ou et al.
(2009)] developed a technique whereby the fresh prostate specimen is embedded in 2% agar
at 50◦C in a small plastic box and then cooled to 4◦C to solidify the agar. The embedded
prostate gland is then MR imaged and parallel histology sections of the embedded gland
are cut using a rotary knife, starting at its square face.
[Rouviere et al. (2006)] proposed a method to enable histology specimens to be cut
along the MR imaging plane. First, three ﬁducial markers that are visible in both MR
and macroscopy are injected into the ex vivo tissue to deﬁne the imaging plane. The
‘PlaneFinder device’ (PFD) is then used to rotate the specimen in three dimensions under
MR guidance to ﬁnd the predeﬁned imaging plane for dissection. The MR images are
acquired parallel to the deﬁned plane. After formalin ﬁxation, the specimen is placed
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again in the PFD and MR scanning is used to identify the same orientation for sectioning.
Once the predeﬁned plane is horizontal, the specimen is embedded in wax such that the
top surface is horizontal. The specimen is then sectioned parallel to the top surface, see
Figure 2.3.
Figure 2.3: Fiducial markers are injected in the tissue to deﬁne the imaging plane (a), the
tissue is placed in the PFD (b), which is used to rotate the specimen under MR guidance
to ﬁnd the predeﬁned plane (c). The MR images are acquired parallel to the deﬁned plane.
After ﬁxation, the specimen is again placed in the PFD, the predeﬁned plane is made
horizontal and the specimen is embedded in wax (d). The specimen is sectioned parallel to
the top wax surface (f). Source: [Rouviere et al. (2006)]
The method was applied by [Kimm et al. (2012)] to correlate MR ex vivo images of
the prostate with histology slices. The ﬁrst limitation of this method involves the ﬁducial
markers that are needed to deﬁne the imaging plane. The application of the markers
in vivo is invasive and technically demanding, furthermore their safety for use in vivo is
unclear. Without a suitable marker, the application of the method in vivo is limited.
[Ward et al. (2010),Ward et al. (2012)] developed a method to orient the prostate
specimen such that it is sliced along a plane parallel to the in vivo imaging plane. The
imaging plane of the MR in vivo images deﬁnes the desired cutting plane. The 3D MR in
vivo images are registered to the 3D MR ex vivo images using a manual technique followed
by a reﬁnement, therefore transposing the desired cutting plane into the ex vivo coordinate
system. Prior to ex vivo imaging, internal and surface-mounted strand-shaped ﬁducial
markers, visible in MR and histology, had been attached to the prostate specimen. The
ﬁducial markers visible in the ex vivo images enable a rigid, landmark-based transformation
of the desired cutting plane into a magnetic tracker space, where three points on the
specimen surface lying within the desired cutting plane are located and physically deﬁned
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by inserting three pins. The specimen is then oriented for slicing along the desired plane.
The most signiﬁcant drawback of this method is the 11 hour processing time required.
Similarly, [Langer et al. (2009)] used MR ex vivo images of the ﬁxed prostate specimen
to transpose the desired cutting plane (deﬁned as the in vivo imaging plane) into the ex
vivo coordinate system. This was achieved by acquiring ex vivo images of the gel-embedded
prostate specimen at regular angle intervals and determining by visual inspection the angle
corresponding to the best in vivo agreement. The gel-embedded specimen was sectioned
using a rotary blade, using a wedge to duplicate the angle determined during ex vivo MRI.
[Humm et al. (2003)] developed a method of inserting small (0.71 mm diameter)
hollow Teﬂon rods into tissue samples. The rods can be visualised by MRI and PET as
well as in histology and autoradiography tissue sections. The template used to insert the
rods remains in place during the MR acquisiton, enabling the imaging plane to be aligned
parallel. During histology processing, the template can be mounted in the microtome,
establishing a cutting plane parallel to the template.
[Varghese et al. (2003)] registered elastography images with digitised photographs of
gross pathology liver specimens in order to evaluate the reliability of elastography for delin-
eating thermal lesion boundaries resulting from radiofrequency tumour ablation. Pathol-
ogy photographs were obtained in the same image plane used for elastography by slicing
through the specimen using external markers.
2.4 Two-Step 3D Registration of Histology and Imaged Data
No consensus exists as to an optimum slicing technique [Chen et al. (2010)]. Thus,
in general, it cannot be assumed that the histology slices are cut along the same plane as
the imaged data was acquired and so the registration must often be considered as a 3D
problem. There are two main approaches for achieving the 3D registration of histology
slices with imaged data. We consider in this section the ﬁrst approach, which is a two-step
method. Step 1 involves aligning the histology slices in order to reconstruct a 3D histology
volume and step 2 then consists of 3D registering the histology volume with the imaged
volume.
2.4.1 Step 1: Histology Alignment
Aligning a set of histology slices can more generally be considered as aligning a set of
contiguous thin 2D sections (e.g. histology slices, autoradiography images). The align-
ment involves reconstructing a 3D volume from a stack of 2D images by registering every
pair of consecutive images in the stack to recover their geometrically coherent 3D align-
ment. Signiﬁcant diﬃculties exist and must be considered when aligning histology slices.
These diﬃculties are ﬁrst detailed before a bibliography of the existing histology alignment
techniques is presented.
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Diﬃculties associated with Aligning Histology Slices
There are numerous diﬃculties associated with the alignment of histology slices, fore-
most is that the alignment cannot be considered as a classical image matching problem
because the slices to be aligned are obtained from diﬀerent horizontal planes of the organ,
meaning that though the slices present similar s, no two slices are identical.
Other diﬃculties to be considered are the non-linear 3D deformation as the prostate is
extracted from the body, the non homogeneous 3D shrinkage and distortion introduced by
the ﬁxation, the slice dependent tissue loss and 2D distortion of tissue due to sectioning
(tear, shear, fold, stretch). The staining of the slices can cause a signiﬁcant diﬀerence in
intensity from one slice to another.
When placing the histology slice on the glass slide, the boundary of the tissue may
overlap the edge of the glass slide or the slide label may cover some of the tissue. Also,
when laying the cover-glass over the histology slice, air bubbles can be created, causing
spots to appear and creating artifacts in the slices. Examples of some of these diﬃculties
are shown in Figure 2.4.
Figure 2.4: There are numerous diﬃculties associated with the alignment of histology slices,
including tearing of the histology slices (a), tissue loss at the exterior (b), or interior of
the histology slice (c), intensity diﬀerence between slices, (d) and (e) are two consecutive
slices from the same patient seperated by 2 mm, and overlap of the histology slice with the
label or edge of the glass slide (f).
Histology slice preparation is a skilled, laborious and time-consuming procedure. In
standard clinical practice, the routine must be performed in a reasonable time frame.
Therefore, though it is possible to have histology slices cut with a regular μm inter-slice
spacing, in reality it is not feasible outside of an academic environment. Histology slices
obtained in standard clinical practice have an uneven inter-slice spacing and the spacing
can be signiﬁcant.
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Also to be considered is the ‘shear eﬀect’, that a 3D curved object cannot be recon-
structed from 2D cross-sections without additional information. The eﬀect, referred to as
the ‘banana problem’, is well illustrated by [Malandain et al. (2004)], see Figure 2.5. It
is also referred to as the ‘z-shift eﬀect’ [Yushkevich et al. (2006)] and is further detailed
in [Cifor et al. (2011)].
Furthermore, an interesting study by [Gibson et al. (2012)b] quantitatively evaluated
the assumption that adjacent histology slices are parallel by measuring the average depth
and orientation of histology slices relative to the front face of the paraﬃn-embedded tissue
blocks of prostate specimens. They estimated the mean depth of the slices to be 1.0 ± 0.5
mm and the mean orientation of the slices to be 1.7◦ ± 1.1◦.
Figure 2.5: The ‘banana problem’ refers to the diﬃculty of reconstructing a 3D curved
object from 2D cross-sections. If a 3D curved object, e.g. a banana (a), is cut into slices
(b), the slices are digitised (c), and then mixed (d), the 3D reconstruction results in a
cylindrical banana (e). Source [Malandain et al. (2004)]
Methods of Aligning Histology Slices
Various methods have been proposed in the literature to align histology slices, a review
of the methods is presented in this section. A summary of the diﬀerent histology alignment
techniques can be found in Table 2.1, with the main advantages and disadvantages of each
technique listed, as well as the associated references.
The most common method is manual registration using interactive operator align-
ment. It is a laborious and time-consuming method which is subject to inter- and intra-
operator variability. [Bauer et al. (1999),Loughlin et al. (1998)] both used manual regis-
tration to align prostate histology slices.
Other methods use an intermediate modality as a reference-volume to guide the
alignment. Each 2D histology slice is registered to the corresponding 2D intermediate
modality image. Generally, the 2D images of the intermediate modality are either already
aligned or can be easily aligned.
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Block-face images are often used as the intermediate modality. During the histology
process, the tissue to be examined is generally sectioned into parallel blocks, which are
then embedded in paraﬃn. These paraﬃn blocks are then ﬁnely sliced using a microtome
(see Chapter 3 for a detailed description of the histology process). Block-face images
are photographs or scans of the paraﬃn-embedded tissue. The use of block-face images
is attractive for several reasons; as the histology slices are prepared from the paraﬃn-
embedded tissue, there exist many common features between the two modalities to guide
the registration. Furthermore the 2D slice-independent deformations associated with the
microtome slicing are not present in the block-face photos, the 2D elastic registration of
each histolgy slice to its corresponding block-face photo removes these artifacts from each
slice.
[Kim et al. (1995)] aligned autoradiography images of a rat brain by 2D registering
each image to block-face photos. [Samavati et al. (2011), Park et al. (2008)] both used
block-face photos to align prostate histology slices, guiding the 2D registration by manually
identiﬁed control points. [Bardinet et al. (2002)] aligned histology slices of the human
brain by 2D registering each slice to the corresponding block-face photo. The registration
was achieved using an intensity based method, using the correlation coeﬃcient as the
similarity measure. [Shojaii et al. (2011)] aligned histology slices of a mouse tumour by
2D registering each slice to the corresponding block-face photo. The registration was
achieved using an edge-based registration technique. Holes were drilled into the corners
of the paraﬃn blocks enabling the block-face images to be easily aligned. Block-face
photos were also used by [Gibb et al. (2012)] to align histology slices, tested on animal
heart specimens. Block-face photos were also used by [van Engelen et al. (2011)] to align
histology slices of carotid plaque specimens. Each histology slice was registered to the
corresponding block-face image using manually annotated landmarks. [Seise et al. (2011)]
used micro CT images as the intermediate modality to align histology slices of the liver.
The disadvantage of using an intermediate modality to align the histology slices is that
it requires the acquisition of the intermediate modality images. Block-face images are
acquired during the histology processing, lengthening the processing time of the clinical
routine. This supplemental processing time required may not be possible during standard
clinical routines.
Intensity based methods involve calculating the transformation that maximises the
similarity in intensity between corresponding pixels, the similarity can be measured using
mutual information or the correlation coeﬃcient. These methods are attractive in that
they are non-invasive. However the crucial limitation to intensity based methods is that
there must be information redundancy between slices, i.e. local similarities from one slice
to another. This information redundancy is dependent on both the underlying morphology
of the tissue and the inter-slice spacing between the slices.
Many intensity based methods have been published for the alignment of histology
slices of the brain. Intensity based methods are particularly appropriate for this organ as
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it has rich structural detail, generating signiﬁcant information redundancy between slices.
Ourselin developed a method using the correlation coeﬃcient to quantify the similarity,
tested on histology slices of a human brain (inter-slice spacing 0.7 mm) [Ourselin et al.
(2001)a] and histology slices of a rat brain (inter-slice spacing 0.4 mm) and a monkey
brain (inter-slice spacing 0.1 mm) [Ourselin et al. (2001)b]. The method developed by
[Yushkevich et al. (2006)] used mutual information as the similarity measure, it was tested
on histology slices of a mouse brain, though the inter-slice spacing was not stated, it is
asusmed to be very small as there were 525 histology slices.
[Kiessling et al. (2005)] aligned histology slices of mouse and rat tumours using an
intensity based registration, the inter-slice spacing was 50 μm. [Mathew et al. (2012)]
aligned histology slices of mouse lungs using the correlation coeﬃcient to quantify the
similarity between images, the inter-slice spacing was 10 μm. The similarity measure was
deﬁned as a combination of mutual information and morphological gradient information
by [Tang (2011)] to guide the alignment of histology slices of a gekko spinal chord.
Prostate tissue does not have rich structural detail. Furthermore histology slices ob-
tained in standard clinical routine have in general an inter-slice spacing of 3 - 5 mm. In a
university hospital, prostate histology slices can be prepared with an inter-slice spacing of
1 mm, however spacings of the order of 3 mm or more will still occur (see Section 3.6.2).
Feature-based methods of alignment have the same advantages and disadvantages
as intensity based methods, in that they are also non invasive but limited by information
redundancy. A variety of features can be used to guide the alignment, including points,
contours, anatomical or structural features.
Points were used to guide the alignment of histology slices by both [Park et al. (2008)]
and [Guest et al. (2001)]; [Park et al. (2008)] used manually placed control points to align
prostate histology slices, [Guest et al. (2001)] used automatically generated corresponding
points to align mouse embryo histology slices.
[Cohen et al. (1998),Cifor et al. (2011), Zhao et al. (1993)] used contours to guide
the alignment; [Cohen et al. (1998)] developed a method in which the external contour
of the tissue is modelled using a B-spline, the histology slices of the rat brains are then
aligned by registering the B-splines of consecutive slices, [Zhao et al. (1993)] also used the
external contour of the boundary, aligning autoradiographic images of a rat brain, [Cifor
et al. (2011)] aligned the histology slices of a mouse and rat brain using the contours of
curved anatomical structures that could be extracted.
Though certain structures are visible in prostate histology slices, e.g. the urethra and
ejaculatory ducts, these structures are not visible in all the slices of the prostate specimen
and thus the ensemble of the slices of the specimen could not be registered using this
method. The contour of the prostate, though visible in each slice, is not considered to
be a reliable feature due to the various deformations and tissue losses that occur, both of
which are exacerbated at the edges of the tissue.
[Kay et al. (1998)] automatically segmented micro-vessels in prostate histology slices
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and registered consecutive slices by matching the detected vessels between slices. The
pixel resolution of the slices was 1.37 μm and though the inter-slice spacing is not stated,
it is assumed to be small as there were 87 histology slices obtained from the specimen.
Techniques based on the use of ﬁducial markers involve inserting needles into the
tissue before slicing to create ﬁducial markers that are detectable in the histology slices.
The slices can then be aligned by overlying the corresponding markers. Quite simply,
ﬁducial markers generate information redundancy between the slices.
[Egevad et al. (1998)] developed an apparatus consisting of four parallel needles
(diameter 3 mm) attached to a base in a square pattern. The needles are inserted into the
fresh prostate specimen. After ﬁxation, the needles are removed, leaving small round holes
visible in the histology slices. The device has been used by [Taylor et al. (2004),Bart et al.
(2005)], manually aligning the histology slices by visually aligning the created markers.
[Humm et al. (2003)] developed a similar apparatus that guides the insertion of
three hollow Teﬂon rods (diameter 0.71 mm), creating ﬁdicual markers visible in histology
and autoradiography slices. The created markers are manually identiﬁed enabling the
transformation to be calculated that minimises the root mean square Euclidean distance
betweent the respective markers of two images. The method was tested on histology and
autoradiography slices of mouse tumours.
2.4.2 Step 2: 3D Registration of Aligned Histology and Imaged Data
Once the histology slices have been aligned, the histology volume can be 3D registered
to the imaged volume. Various methods have been proposed in the literature to achieve
this registration.
Often the 3D external surface boundary of the tissue is used to guide the regis-
tration. [Kiessling et al. (2005)] reconstructed the 3D surface volume of mouse and rat
tumours from the aligned histology slices and MR in vivo images and then registered the
two volumes by manually orienting one of the volumes with respect to the other. [Taylor
et al. (2004)] 3D registered prostate histology and ex vivo ultrasound images by calculat-
ing the transformation that maximised the surface voxel overlap of the two reconstructed
surface volumes. [Bart et al. (2005), Reynier et al. (2004)] represented the segmented
boundary in each modality as a 3D point cloud. The two modalities were then regis-
tered by calculating the transformation that minimised the distance between the point
clouds. [Reynier et al. (2004)] registered prostate MR images with ultrasound images
using this method and [Bart et al. (2005)] registered prostate histology with MR images.
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The registration can also be achieved using features that are common to the two
modalities. [Porter et al. (2001)] registered ultrasound and MR images of the liver by
segmenting vessels visible in the two modalities. The vessels are 3D reconstructed and
the transform that maximises the surface voxel overlap of the vessels is calculated. [Kim
et al. (1995)] registered MR and autoradiography images of a rat brain by calculating
the transformation that minimised the distance between control point pairs that has been
manually identiﬁed in each modality.
One or more intermediate imaging modalities can also be used to guide the reg-
istration. In order to achieve the 3D registration of prostate histology slices with MR in
vivo images, [Park et al. (2008)] ﬁrst aligned the histology slices by registering each slice
to its corresponding block-face photo. The block-face photos were then stacked and 3D
registered to MR ex vivo images. The MR ex vivo images were 3D registered to MR in
vivo images. Each intermediate registration step was achieved by calculating the trans-
formation that minimised the distance between manually identiﬁed control point pairs.
Similarly [Samavati et al. (2011)] registered prostate histology slices with MR in vivo
images by ﬁrst registering the histology slices to block-face photos. The block-face photos
were registered to MR ex vivo images of the ﬁxed prostate, which were in turn registered
to MR ex vivo images of the fresh prostate. Finally the MR ex vivo images of the fresh
prostate were registered to the MR in vivo images.
In order to investigate the lesion induced by radio frequency ablation, [Seise et al.
(2011)] registered liver histology slices to in vivo CT images. The registration was achieved
by ﬁrst registering the histology slices to ex vivo micro CT images. The ex vivo CT images
were then registered to the in vivo CT images using segmented vessels visible in both
modalities.
[van Engelen et al. (2011)] registered histology and MR ex vivo images of carotid
plaque specimens using block-face images as an intermediate modality, the intermediate
registrations were achieved using manually annotated landmarks. [Bardinet et al. (2002),
Dauguet et al. (2007)] also used block-face images as an intermediate modality to register
histology slices to MR images of the brain, with the intermediate registrations achieved
using intensity based methods. [Bardinet et al. (2002)] validated his method on a human
brain, with MR ex vivo images and the correlation coeﬃcient as the similarity measure.
[Dauguet et al. (2007)] validated his method on baboon brains, with MR in vivo images
and used mutual information as the similarity measure. [Gibb et al. (2012)] used block-face
images as an intermediate modality to register histology to MR ex vivo images of animal
heart specimens.
Intensity-based methods can be used to guide the registration. [Ourselin et al.
(2001)a] registered the histology slices of a human brain with MR images using an intensity
based method. The correlation coeﬃcient was used as the similarity measure. Note that
the histology inter-slice spacing was 0.7 mm and the MR pixel resolution was 0.9375 mm.
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To investigate the ability of MR imaging to monitor radio-frequency ablation treat-
ments, [Breen et al. (2003),Breen et al. (2005)] registered MR images and histology slices
in order to compare the thermal lesions, tested on rabbit thigh muscle. The registration
was achieved using ﬁducial markers. MR compatible needles were inserted into the tis-
sue, creating ﬁducial markers visible in histology, block-face and MR in vivo images. The
created ﬁducial markers were manually identiﬁed, enabling the histology and MR images
to be registered, using the block-face images as an intermediate modality. The method
was ﬁrst validated by [Lazebnik et al. (2003)] using digital phantoms and sheep brain
tissue.
2.5 Combined 3D Registration of Histology and Imaged Data
The second approach for achieving the 3D registration of histology slices with imaged
data is a single-step method that combines the alignment of the histology slices and the
subsequent 3D registration of the histology volume with the imaged volume into one
algorithm. In this section a bibliography of the methods that have been developed using
this approach are presented.
[Malandain et al. (2004)] developed a method whereby ﬁrst an intial alignment of the
autoradiograph slices is achieved, generating a 3D autoradiograph volume. The autora-
diograph volume is then 3D registered to the MR volume. The MR volume can then be
resampled such that each 2D MR slice corresponds to a 2D autoradiograph slice. Each
autoradiograph slice is 2D registered to the re-sampled MR slice. The autoradiograph
volume is re-generated and the process is iterated to convergence. The method was tested
using a monkey brain specimen. The registrations were achieved by calculating the trans-
formation that maximised the intensity similarity between pixels, with the correlation
coeﬃcient being used as the similarity measure. The histology inter-slice spacing is not
stated, but it is assumed to be small considering that there were 818 slices available.
The same methodology was used by [Goubran et al. (2012),Plank et al. (2009),Man-
soori et al. (2007)]. [Goubran et al. (2012)] used the iterative technique to register his-
tology slices to MR ex vivo images of a human brain sample, similarly using intensity-
based methods with the correlation coeﬃcient to guide the registrations. [Plank et al.
(2009),Mansoori et al. (2007)] used the method to register histology slices and MR ex
vivo images of rabbit heart specimens. Each of the 2D and 3D registrations in the itera-
tive loop were rigid registrations, calculated using an intensity-based method with mutual
information as the metric. When the system reached convergence, a ﬁnal non-rigid trans-
form was calculated to 2D register the histology slices with the last re-sampled MR slices.
A non-rigid transform is able to register any pair of histology-MR slices, even if they do
not correspond to the same anatomical locations. Therefore, the optimal combination of
rigid transforms is ﬁrst calculated and the non-rigid deformation is placed outside of the
iterative loop and is performed only as a last step.
[Xiao et al. (2011)] proposed a similar method to register histology slices and MR
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in vivo images of the prostate. First, the 2D histology - MR slice correspondances are
estimated and each histology slice is 2D registered to the corresponding MR slice. The
registration is achieved using an intensity-based method, with mutual information being
used as the silmilarity measure. With each histology slice mapped into the MR coordinate
space, a 3D histology pseudo-volume is reconstructed using zero-padding. The histology
pseudo-volume is 3D registered to the MR volume, again using a mutual information,
intensity-based method. The 2D MR slices are updated by slicing the MR volume along
the new plane resulting from the 3D registration. The process is iterated to convergence.
The authors noted that the 3D registration caused only a moderate change in the slice
correspondances.
[Gibson et al. (2012)a] registered prostate histology slices with MR ex vivo images by
attaching ten strand-shaped ﬁducial markers (three internal and seven surface-mounted)
to ﬁxed prostate specimens, visible in both histology and MR ex vivo. The markers form
a unique cross-section conﬁguration on each histology slice which enables the plane from
which the slice was cut in the MR ex vivo 3D volume to be identiﬁed for each slice. The
registration is then calculated that minimises the distance between the respective ﬁducial
markers.
2.6 Conclusion
The aim of this thesis is to precisely register the histology slices of prostatectomy
specimens with MR in vivo pre-operative images. The histology slices and MR images are
acquired from standard clinical routines.
During histology processing, the landmarks available on the prostate gland are insuf-
ﬁcient for precise orientation of the specimen. Therefore, it cannot be assumed that the
prostate can be manually orientated such that the histology slicing plane is the same as
the imaging plane. Furthermore, though numerous techniques and apparatus have been
developed in order to ensure the histology slicing plane is oriented parallel to the imaging
plane, no consensus exists as to an optimum slicing technique. In general, it cannot be
assumed that the histology slices are cut along the same plane as the imaged data was ac-
quired. Therefore, for precise prostate histology - MR in vivo registration, a 2D technique
is not considered to be suﬃciently accurate.
Considering therefore the registration as a 3D problem; manual registration is dis-
missed as an option due its laborious and time-consuming nature, which is subject to
inter- and intra-operator variability. The use of one or more intermediate imaging modal-
ities to guide the registration is a popular choice, however it requires the acquisition of
the intermediate modality images. Block-face images are the most commonly used in-
termediate modality. These images are acquired during the histology processing routine,
lengthening the duration of the routine. Our aim is to develop a protocol that can be
included into standard clinical routine, the supplemental processing time required for the
acquisition of the block-face images means that this technique is not a feasible option.
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Several intensity and feature-based registration techniques have been presented in the
bibliography. The crucial limitation to both of these methods is information redundancy,
i.e. there must exist local similarities or features between the slices (either between his-
tology slices or between histology and MR images). Information redundancy is dependent
on both the underlying morphology of the tissue and the inter-slice spacing. The methods
presented in the bibliography were developed for tissue with rich structural detail (e.g.
the brain or heart [Ourselin et al. (2001)a, Ourselin et al. (2001)b, Yushkevich et al.
(2006),Malandain et al. (2004),Goubran et al. (2012),Plank et al. (2009),Mansoori et al.
(2007),Cifor et al. (2011),Kim et al. (1995)]) and/or images with very small and regular
inter-slice spacing (e.g. 10 μm [Mathew et al. (2012)], 50 μm [Kiessling et al. (2005)], 100
μm [Ourselin et al. (2001)b]).
Prostate histology slices present few landmarks. Though certain features exist, e.g. the
urethra and the ejaculatory ducts, these structures are not visible in all the slices of the
prostate specimen and thus the entire specimen could not be registered using this method.
The contour of the prostate, though visible in each slice and image, is not considered to be
a reliable feature due to the deformation and tissue loss caused by the prostatectomy and
histology processing, which is exacerbated at the edges of the tissue. Prostate histology
slices obtained in standard clinical routine have in general an inter-slice spacing of 3 -
5 mm. Though the inter-slice spacing is reduced to 1 mm in a university hospital, the
spacing is irregular and spacings of the order of 3 mm or more regularly occur.
For these reasons, a two-step alignment and registration approach was chosen. The
histology slice alignment is achieved using a ﬁducial marker based method and the sub-
sequent 3D registration between the histology and MR is achieved using a feature-based
method.
In order to create the internal ﬁducial markers in the histology slices, an apparatus was
developed that inserts three ﬁducial needles at three unique angles into the fresh prostate
specimen. The technique enables the markers to be created in a standardised manner and
has been designed to be applicable to standard clinical routine, in terms of time, cost and
material.
Once the histology slices are aligned, the histology and MR volumes are 3D registered
using the ejaculatory ducts. The ejaculatory ducts are paired structures which begin at
the seminal vesicles, pass through the prostate gland along a curved path and enter into
the urethra. They are an anatomical landmark present in every prostate and are visible
in both histology and MR images at standard clinical routine resolution.
The ﬁducial needles are MR compatible, enabling MR ex vivo images to be acquired
of the specimen after insertion of the needles. Applying the developed 3D registration
technique to register the aligned histology slices to the MR ex vivo volume enables an
operator-independent quantiﬁcation of the accuracy of the technique via the needles which
are visible in both histology and MR ex vivo.
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3.1 Introduction
Patients that had undergone a MR in vivo prostate examination and for whom a rad-
ical prostatectomy was planned were eligible to be included in our database. Following
the prostatectomy, ﬁducial markers are created in the fresh prostate specimen. A MR ex
vivo acquisition of the specimen is then performed. The prostate is subsequently histology
processed according to standard clinical routine and the resulting histology slices are digi-
tised. This chapter details each of the various diﬀerent techniques, protocols and routines
involved in the overall image acquisition process.
3.2 MR in vivo Protocol
Each patient included in our database had undergone an MR in vivo prostate exami-
nation using a 3T clinical MR scanner (Discovery MR750, GE Healthcare, USA) with a
32-channel pelvic phased array (PPA) coil. T2-W, DWI and DCE images were acquired
for each patient. The MR image acquisition parameters are detailed in Table 3.1. DWI
and DCE images were acquired in the axial plane and T2-W images were acquired in both
the axial and sagittal planes. The axial images were oriented such as to be perpendicular
to the rectal surface of the prostate. For DCE imaging, an intravenous injection of 0.2
mL/kg of gadoterate meglumine (DotaremTM, Guerbet, Roissy, France) was performed
at 3 mL/sec. The axial T2-W, DWI and DCE images were acquired with the same slice
thickness and position to enable a direct comparison between the modalities.
Sequence T2-W DWI DCE
Repetition time (TR) (ms) 5000 5000 3.9
Echo time (TE) (ms) 104 90 1.7
Field of view (FOV) (mm2) 220x220 380x380 240x192
Acquisition matrix 384x256 128x128 180x160
Flip angle (degrees) 90/180 90 12
b values (s/mm2) - 0-2000 -
Slice thickness (mm) 3 3 3
Number of temporal acquisitions - - 32
Temporal resolution (s) - - 7
Table 3.1: MR in vivo image acquisition parameters for the T2-W, DWI and DCE se-
quences.
3.3 Fiducial Marker Creation
The 3D histology - MR in vivo registration requires the prior alignment of the histology
slices. The method we have developed to achieve the histology slice alignment is based on
the use of ﬁducial markers. In this section, we detail the apparatus that was developed to
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create the ﬁducial markers and explain the reasoning behind the design choices that were
made. We describe the protocol for creating the ﬁducial markers using the apparatus and
the characteristics of the created markers.
3.3.1 Apparatus
The objective was to design and fabricate an apparatus that would enable ﬁducial
needles to be inserted, in a standardised manner, into fresh prostate specimens following
a radical prostatectomy, such that internal ﬁducial markers are created and visible in each
histology slice. The protocol for creating the ﬁducial markers was developed such that the
following criteria were respected,
• the histological examination and diagnosis of the histology slices would not be im-
paired,
• the protocol could be easily integrated into the existing histology processing routine,
• the supplemental time required for the ﬁducial marker creation would be minimised,
• one apparatus could be used for all prostate specimens.
The apparatus developed, see Figure 3.1a, consists of a support that holds horizontal
and rigid, a guide to insert three ﬁducial needles at three distinct angles into the prostate.
The guide is made of plexi-glass and is of dimension 50x50x20 mm. The support enables
the vertical position of the guide to be adjusted (5 - 70 mm) so that the guide is positioned
exactly at the height of each prostate specimen.
3.3.2 Prostate Orientation
The orientation of the prostate in the apparatus is standardised; the apex on the
top, the base on the bottom with the seminal vesicules behind. During the subsequent
histology processing routine (see Section 3.5) the specimen will be sectioned along a plane
approximately perpendicular to the rectal surface of the prostate (imitating the MR in
vivo imaging plane), the ﬁducial needles must therefore be inserted perpendicular to that
sectioning plane.
The needles are inserted from the apex to the base of the prostate because the apex is
of a smaller dimension than the base (see Figure 1.2), meaning that,
(i) positioned on the base, the prostate is in a more stable position and
(ii) by progressing from the ‘smaller end’ to the ‘larger end’, we minimise the risk that
a needle exits the prostate before passing through the entire length of the prostate,
which would result in the absence of ﬁducial markers in histology slices cut from after
the needle has exited the tissue.
To ensure that the needles completely exit the prostate, thus ensuring the proper creation
of the ﬁducial markers at the base, the prostate is placed on a layer of polystyrene when
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Figure 3.1: (a) Apparatus designed to create ﬁducial markers in the histology slices, the
guide enables three ﬁducial needles to be inserted at three distinct angles from the apex to
the base of the prostate, (b) as the needles are inserted at three diﬀerent angles, a diﬀerent
triangle is formed by the three created ﬁducial markers at each horizontal plane a distance
h from the guide.
positioned in the appartus. The needles are then inserted until they have entered the
polystyrene.
3.3.3 Fiducial Needles
The needles used are 16 G IV catheters (BD Angiocath), of radius 0.82 mm. They
were chosen as they have a rigid plastic sheath. Once the three catheters have been
inserted into the prostate, the needles are removed, leaving the sheaths in place within
the prostate. The guide can then be slightly raised, the sheaths cut with a scissors and
the prostate (with the inserted sheaths within) can be removed from the apparatus, see
Figure 3.2. It is necessary that the plastic sheaths remain within the prostate to ensure
that the ﬁducial markers created are maintained, in particular during the ﬁxation step of
the histology processing routine, see Section 3.5, as the ﬁxation induces a shrinkage of the
prostate tissue which, if the sheaths were not present, would cause the created markers to
close.
It was decided to insert three ﬁducial needles into the prostate as a compromise between
minimising the pertubation to the histology examination and the fact that a minimum of
two ﬁducial markers are required in order to align a slice. Three needles would create
55 3.3. FIDUCIAL MARKER CREATION
enough markers to align the slices, while allowing for some to be lost, either because the
tissue was torn during the histology processing routine or the marker falls within, for
example, the urethra.
The creation of the ﬁducial markers is an invasive technique. The primary design
constraint was that the histological examination and diagnosis of the specimen would not
be impaired by the creation of the markers. Upon examination of the histology slices of
a specimen in which ﬁducial markers had been created, the anatomo-pathologists judged
that the insertion of three needles of radius 0.82 mm did not compromise the histology
examination.
Figure 3.2: Sample prostate specimen after removal from the apparatus, the plastic sheaths
remain within the prostate to ensure that the ﬁducial markers created are maintained, in
particular during the ﬁxation of the specimen.
3.3.4 Needle Insertion Angle
The needles are inserted at three distinct angles and in a twist style such that the
needles do not intersect. This means that at each horizontal plane a distance h from the
needle insertion guide (i.e. the apex of the prostate), a diﬀerent triangle is formed by
the three created ﬁducial markers, see Figure 3.1b. We denote the three ﬁducial markers
created at any height h, i.e. the vertices of the triangle formed, as n1, n2 and n3. If
a circumcircle is ﬁtted to the formed triangle, see Figure 3.3, the clockwise order of the
ﬁducial markers around the circumcircle is constant for each histology slice obtained from
the specimen. That is, if the clockwise order at the apex is (n1, n2, n3), then for every
other histology slice, if a circumcircle is ﬁtted to the triangle formed in that slice, the
clockwise order of the markers will be (n1, n2, n3), see Figure 3.3.
That the clockwise order of the markers is the same for each histology slice is particu-
larly interesting for the later classiﬁcation of the ﬁducial markers. If care is taken to orient
the histology slices before digitisation, the permutations that result in the markers being
in a non clockwise order can be eliminated, as they correspond to a ﬂip orientation, see
Figure 4.8.
The fact that a diﬀerent triangle is formed by the three ﬁducial markers in each histol-
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Figure 3.3: If a circumcircle is ﬁtted to the triangle formed by the three ﬁducial markers,
denoted n1, n2 and n3, the clockwise order of the markers (following a path around the
circumcircle) is constant for each histology slice obtained from the specimen. The inter-
slice spacing between: image (a) and (b) is 4 cm, and between image (b) and (c) is 14
cm.
ogy slice means that the label attached to each histology slice by the anatomo-pathologists,
detailing the distance of each slice from the apex, can be veriﬁed and, if necessary, cor-
rected. For example, if during the histology processing routine, a 6 mm section was
embedded in the paraﬃn facing the wrong direction (see Section 3.5), the slices obtained
from that speciﬁc section would be in the reverse order and a discontinuity in the pro-
gressively changing shape of the triangle would appear. Inserting the needles each at a
diﬀerent angle enables the detection and correction of such an error.
A further advantage concerns the histology - MR ex vivo registration. The ﬁducial
needles are used to quantify the accuracy of the registration technique, the fact that
the needles are inserted at angles enables the registration quality along the z-axis to be
evaluated.
Another advantage of inserting the needles at an angle, is that if a needle falls within,
for example, the urethra, the needle will exit the urethra after a few slices because the
needle progression is at an angle, meaning that the ﬁducial markers of that needle are lost
for only a few slices. If the needles were inserted vertically, and a needle falls within the
urethra, the ﬁducial markers of that needle would be lost for the majority of the histology
slices of the specimen.
In conclusion, the main advantages of inserting the needles at an angle rather than
vertically are that,
(i) the relative order of the histology slices from the apex can be veriﬁed and, if necessary,
corrected,
(ii) the accuracy of the histology - MR ex vivo registration can be quantiﬁed along the
z-axis and
(iii) if one of the needles falls within, for example, the urethra, the ﬁducial markers will
be lost in a fewer number of histology slices.
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3.3.5 Model Geometry
We deﬁne the model geometry as the three theoretical polar angles with respect to
the vertical axis at which the apparatus guides the insertion of the ﬁducial needles. In
order to measure the model geometry, a rectangular sample of 3% agar was prepared and
three ﬁducial needles were inserted using the apparatus. MR axial images of the agar were
acquired, with the axial image plane oriented parallel to the surface of the agar which
had been positioned beneath the guide of the apparatus. Images were acquired with an
inter-slice spacing of 1 mm. The polar angles were measured as: θn1 = 12.8◦, θn2 = 13.8◦
and θn3 = 16.6◦.
Ideally, the polar angles of the ﬁducial needles created in each prostate specimen would
be equal to this model geometry. However, unlike the agar, into which the needles are
easily inserted, for a fresh prostate, due to its semi-solid consistency, a certain force is
required to puncture the surface. Once punctured, the tissue expands due to the high
pressure of any hypertrophic nodules. This causes a slight yet unavoidable displacement
of the prostate, repeated by the insertion of each proceeding needle. The result is that the
angle geometry created in each prostate specimen is slightly diﬀerent.
We assume that the insertion of the needles creates ﬁducial markers in straight 3D lines,
though we cannot assume the exact polar angle at which the line is positioned. In order
to quantify this assumption, MR ex vivo axial images were acquired of 7 fresh prostate
specimens after insertion of the ﬁducial needles, see Section 3.4. A point was placed at
the location of each ﬁducial marker visible in the axial images, and 3D least-squares lines
passing through the points were calculated. The average distance of each point from the
line was 0.15 ± 0.11 mm. As the radius of the ﬁducial needle is 0.82 mm, we consider the
assumption that the needles create ﬁducial markers in straight 3D lines to be justiﬁed.
3.3.6 Fiducial Marker Geometry
The internal ﬁducial markers created and visible in the histology slices are approxi-
mately circular holes, see Figure 3.4 for a sample histology slice, with the created ﬁducial
markers indicated with arrows. However, as the ﬁducial needles are not inserted vertically,
the ﬁducial markers created are not exactly circles but ellipses. If we quantify the diﬀer-
ence of the ellipses created from circles of radius r in terms of area a and circular quality
c deﬁned as
c = 4πa
p2
(3.1)
where p is the perimeter, with the ideal values for a circle of radius r being πr2 and 1
respectively, the percentage diﬀerence of the area Δa and circular quality Δc for the three
needles is thus
• θn1 = 12.8◦ : Δa = +2.55%,Δc = −0.02%,
• θn2 = 13.8◦ : Δa = +2.97%,Δc = −0.03%,
• θn3 = 16.6◦ : Δa = +4.35%,Δc = −0.07%.
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Figure 3.4: Sample histology slice; the created ﬁducial markers are approximately circular
holes, and are indicated with arrows.
3.4 MR ex vivo Protocol
The aim of this thesis is to precisely register prostate histology slices with MR in vivo
pre-operative images. MR ex vivo images of the fresh prostate specimen are acquired fol-
lowing the creation of the ﬁducial markers. Before applying the developed 3D registration
technique to register the histology and MR in vivo images, the registration technique is
applied to register the histology and MR ex vivo images. As the needles used to create
the ﬁducial markers are MR compatible and visible in MR ex vivo images, they enable
an operator-independent quantiﬁcation of the accuracy of the registration technique to be
achieved, before applying the technique to register histology and MR in vivo images. The
MR ex vivo acquisition of the prostate specimen is therefore a step that is only included in
the ‘development phase’, in order to quantify and evaluate the accuracy of the developed
algorithm before it is applied to register histology and MR in vivo images.
Concerning the MR ex vivo protocol, the MR ex vivo images of the prostate specimen
are acquired following the creation of the ﬁducial markers (the evening of the day on
which the radical prostatectomy occurred). The fresh prostate is placed in a plastic box,
dimension 10x10x7 cm, which is then ﬁlled with saline solution, see Figure 3.5. The
polystyrene block, to which the prostate is attached by the plastic sheaths, causes the
prostate to ﬂoat. This enables the MR ex vivo axial imaging plane to be oriented parallel
to the polystyrene block, i.e. parallel to the needle insertion guide of the apparatus.
The MR images were acquired using the same 3T clinical MR scanner as previously
described. For each prostate, axial T1-W and T2-W images were acquired. The T1-W im-
ages enable the ﬁducial markers to be visualised and the anatomical detail of the specimen
can be seen in the T2-W images. The acquisition parameters were for T1-W: TE/TR = 7.1
ms/2197 ms, and for T2-W: TE/TR = 120 ms/4158 ms, for both T1-W and T2-W: FOV
50x50 mm2, acquisition matrix 320x320, ﬂip angle 90◦, slice thickness 2 mm.
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Figure 3.5: Set-up for the MR ex vivo image acquisition: the prostate, after creation of
the ﬁducial markers, is placed in a plastic box ﬁlled with saline solution. The polystyrene
block causes the prostate to ﬂoat, enabling the axial imaging plane to be oriented parallel
to the polystyrene block, i.e. parallel to the apparatus needle insertion guide.
3.5 Histology Processing
The morning following the day on which the radical prostatectomy occurred, the
polystyrene block is removed and the prostate specimen is ﬁxed in 10% formaldehyde
for a minimum of 24 hours. After ﬁxation, the sheaths are removed and the prostate is
dissected following the Stanford method [Bostwick and Cheng (2008)]; the seminal vesi-
cles, the bladder neck and a 3 - 5 mm portion of the apex are removed and studied apart.
The remainder of the prostate is sectioned, from the apex to the base, into 6 mm sections,
see Figure 3.6. The sections are cut such as to be perpendicular to the rectal surface of
the prostate, i.e. along the same plane as the MR in vivo axial imaging plane.
The 6 mm sections are re-ﬁxed for at least 48 hours, then de-hydrated in formaldehyde
and methyl and embedded in paraﬃn. The paraﬃn blocks are sliced using a microtome.
The ﬁrst few slices of the microtome cut away the block until a complete slice of the
prostate is achieved. Slices are then cut every 500 - 1000 μm, thickness 4 μm. The whole-
mount slices (50 x 75 mm) are stained using hematoxylin eosin safran (HES) and sealed.
A paper label is attached to each slice, detailing the patient reference and the relative
position of the slice from the apex.
3.6 Digitisation of the Histology Slices
3.6.1 JPEG Digitisation
The histology slices of each prostate specimen are colour digitised using an illuminated
workbench, equipped with a support that enables the camera (FujiFilm ﬁnePix S8000 fd)
to be ﬁxed at a certain height. This ensures a constant pixel resolution for each histology
slice of the prostate specimen. A ruler is included in each image to enable the resolution to
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Figure 3.6: The prostate is dissected following the Stanford method; the seminal vesicles,
bladder neck and a portion of the apex are removed and studied apart, the remainder of the
prostate is sectioned into 6 mm sections. Figure adapted from [Vieillefond et al. (2004)].
be later calculated. The histology slices are positioned such that the normal vector of each
slice is oriented in the same direction (see Figure 3.7), i.e. that no ‘ﬂip orientation’ need
be subsequently taken into account. In order to have a constant illumination intensity
for each histology slice, inter- and intra- prostate specimen, the shutter speed must be
deﬁned such that the exposure duration is a multiple of the light source period. As this
results in a long exposure duration (100 ms), ﬁlters are placed between the light source
and the slices to avoid over-exposure. The digitised images are of dimension 3264x2448
pixels, pixel resolution 0.03 mm. See Figure 3.8 for a sample digitised histology slice. The
ﬁle name of each digitised histology slice is the patient reference followed by the relative
position of the slice from the apex, this information is detailed on the paper label attached
to each histology slice by the anatomo-pathologists.
Figure 3.7: The histology slices are positioned such that the normal vector n of each slice is
oriented in the same direction. This ensures that no ‘ﬂip orientation’ need be subsequently
taken into account.
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Figure 3.8: Sample digitised histology slice. A ruler is included in each image to enable
the pixel resolution to be later calculated. The paper label attached to each slice by the
anatomo-pathologists, detailing the patient reference and the relative position of the slice
from the apex, can be seen on the right-hand side of the histology slice.
3.6.2 Histology Slice Inclusion Criteria
Not every histology slice is digitised. Even though the 6 mm sections are sliced every
0.5 - 1.0 mm, on average 3 - 4 slices per section are digitised and included for further
study. This creates a certain clustering of the slices, evident in Figure 3.9, which shows
the stack of digitised histology slices for a particular prostate specimen with the relative
inter-slice spacing indicated on the z-axis. There are a few diﬀerent reasons for this,
(i) though the sections were cut 6 mm thick, the following ﬁxation and dehydration steps
cause a volume reduction of the section, such that when inlcuded in the paraﬃn, the
section is less than 6 mm thick,
(ii) if the section was embedded in the paraﬃn at an angle to the horizontal, when sliced
with the microtome, the ﬁrst and last few slices will not contain a full cross-section of
the specimen and will be discarded, reducing the number of complete slices achieved
for that section,
(iii) as a minimum of two ﬁducial markers is necessary to align a slice, slices with signif-
icant tissue loss such that less than two markers remain, are not digitised.
3.7 Conclusion
MR in vivo, MR ex vivo and histology images have been acquired during this thesis.
This chapter ﬁrst detailed the MR in vivo protocol and acquisition parameters. Following
radical prostatectomy, internal ﬁducial markers are created in the fresh prostate specimen.
The apparatus that was designed to create the ﬁducial markers, as well as the reasoning
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Figure 3.9: Stack of digitised histology slices of a prostate specimen, the relative inter-slice
spacing is indicated on the z-axis. On average 3-4 slices per section are included for further
study, creating a clustering eﬀect of the slices.
behind the various design choices made, have been explained. The ﬁducial marker creation
protocol is detailed and the characteristics of the created markers are described.
Once the ﬁducial markers have been created, MR ex vivo images of the prostate spec-
imen are acquired. The MR ex vivo protocol and acquisition parameters are detailed.
As it was not an initial design criterion to fabricate the apparatus to be MR compati-
ble, the prostate is removed from the apparatus before the MR ex vivo acquisition. The
polystyrene block, attached to the prostate by the plastic sheaths, causes the prostate to
ﬂoat, therefore enabling the imaging plane to be oriented parallel to the needle insertion
guide of the apparatus. A future perspective is to fabricate the apparatus such that it
is MR compatible so that MR ex vivo images could be acquired of the prostate within
the guide. This would ensure that the imaging plane is oriented parallel to the needle
insertion guide and futhermore that the prostate remains absolutely stationary during the
MR acquisition.
The histology processing routine is then described in order to better understand the
deformations and uncertainties associated with the histology images. Finally, which his-
tology slices are included for further study and how they are digitised was discussed. The
following chapter will detail the method developed to achieve the alignment of the digitised
histology slices using the created ﬁducial markers.
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4.1 Introduction
The creation of the internal ﬁducial markers in the histology slices creates information
redundancy between the slices, enabling each 2D prostate slice to be aligned in order to
recreate the 3D prostate volume. This chapter details the method employed to segment the
2D prostate slice in each histology slice, the method that has been developed to detect the
potential ﬁducial markers within each segmented prostate. The algorithm that has been
developed to detect which of the potential markers are true ﬁducial markers and to identify
by which needle each marker was created is also detailed. Once the true ﬁducial markers
have been detected and it has been identiﬁed by which needle each marker was created,
three ‘synthetic needles’, 3D least-squares lines passing through the detected markers for
each needle, can be calculated, enabling a 2D transform to be calculated for each image
that aligns the dataset of images. The images are then shear corrected.
The proposed method has been tested using simulated images (Section 4.8.1), images
acquired from a beef liver sample (Section 4.8.2) and experimentally using 10 prostate
specimens (Section 4.8.3). The results are presented in Section 4.9.
4.2 Glossary
The digitised histology slices are referred to as images. The set of images of a prostate
specimen is called a dataset, with N the number of images in the dataset. Objects in the
image that could be ﬁducial markers are referred to as potential ﬁducial markers and as
true ﬁducial markers when it has been established that they are ﬁducial markers. The
three needles are referred to as needle 1 (n1), needle 2 (n2) and needle 3 (n3).
4.3 Pre-processing
The ﬁle name of each digitised histology slice includes the relative position of the slice
from the apex. This enables the images of the dataset to be automatically ordered with
respect to their relative position from the apex and the inter-slice spacing between each
image to be calculated.
The user is asked to manually identify on the ﬁrst image of the dataset: two grada-
tions on the ruler (enabling the pixel resolution to be calculated), a sample region of the
background, a sample region of the prostate and the location of the three ﬁducial markers
(in any order), see Figure 4.1.
The manually detected markers are identiﬁed as having been created by the three
needles and labelled as n1, n2, n3 in any order provided that if a circumcircle is ﬁtted to
the triangle formed by the three markers, the sequence of the markers (n1, n2, n3) is in
a clockwise order. As previously explained in Section 3.3.4 ‘Needle Insertion Angle’, as
the needles are inserted in a twist style, a diﬀerent triangle is formed by the three ﬁducial
markers in each histology slice. If a circumcircle is ﬁtted to the formed triangle, see
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Figure 4.1: The ﬁrst image of a pa-
tient dataset, the user is asked to
manually identify a sample region of
the background and prostate (dashed
rectangles) and the location of the
three ﬁducial markers (marked with
a x). The markers are labelled such
that, if a circumcircle (dashed circle)
is ﬁtted to the three markers, the se-
quence (n1, n2, n3) is in a clockwise
order.
Figure 3.3, the clockwise order of the ﬁducial markers around the circumcircle is constant
for each histology slice obtained from the specimen.
The mean values of the RGB component intensities, for the background and prostate,
are calculated from the deﬁned sample regions. For each image, each pixel is classiﬁed as
background or prostate according to the sum of the least-squares diﬀerence of its RGB
component intensity from that of the mean values, see Figure 4.2(b). The noise (objects
of less than 100 pixels) is removed from the image and closed boundary objects are ﬁlled.
The objects are then eroded (disk-shaped structuring element of radius 3 pixels), see
Figure 4.2(c). The three objects with the largest areas are detected. For the ﬁrst image of
each dataset, the user manually identiﬁes which of the three largest objects is the prostate.
For each other image in the dataset, the prostate is detected by comparing the overlap of
each of the three objects with the ﬁrst prostate segmented and the previously segmented
prostate. The resultant segmentation is shown for a sample image in Figure 4.2(d).
Each image in the dataset is translated such that the centre of gravity of each seg-
mented prostate is at the centre of each image. The images are then cropped about the
segmented prostate and padded such that each image in the dataset is the same size, see
Figure 4.3(a). An ellipse is least-squares ﬁtted [Fitzgibbon et al. (1996)] to each detected
prostate contour, the orientation of which is deﬁned as the angle between the horizontal
axis and the major axis of the ellipse, Figure 4.3(b). Each image is rotated such that
the orientation of the dataset is uniform, Figure 4.3(c). This ﬁrst coarse alignment of the
images (2D translation and rotation, Tinit) enables the regions of interest (ROI), in which
the ﬁducial markers will be searched, to be reduced thus reducing the risk of erroneously
detecting markers.
4.4 Potential Fiducial Marker Detection, Scoring and Clas-
siﬁcation
For each dataset of images, the potential ﬁducial markers in the images are detected.
For each potential ﬁducial marker detected, a geometric score is calculated which quantiﬁes
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Figure 4.2: The prostate in each image is segmented by classifying each pixel as background
or prostate by comparing to the deﬁned sample regions (b), the noise is removed and closed
boundary objects are ﬁlled and eroded (c). The resultant segmentation is shown in (d).
the similarity of the potential marker to the ideal shape, i.e. the cross section of the needle
used to create the markers. The potential markers are classiﬁed according to their relative
geometric score, into high, medium or low probability of being true markers.
4.4.1 Potential Fiducial Marker Detection
The ﬁducial markers are (approximately circular) holes in the prostate tissue; their
pixel intensity is thus that of the background. Potential ﬁducial markers are deﬁned as
objects of background intensity, positioned within the segmented prostate contour, whose
area, a respects 0.5πr2 < a < 1.5πr2 (heuristic choice), where r is the radius of the needle
used to create the ﬁducial markers. For each image, a binary mask is calculated, referred
to as the ﬁducial mask of the image, where the pixels of potential ﬁducial markers have a
value of 1 and all other pixels have a value of 0.
In order to calculate the ﬁducial mask, each pixel in the RGB image is classiﬁed as
background or prostate according to the sum of the least-squares diﬀerence of its RGB
component intensity from that of the mean values. The closed boundary objects are then
ﬁlled, Figure 4.4(b), and a morphological open is applied using a disk-shaped structuring
element of radius 10 pixels, Figure 4.4(c). Objects of area a < 0.5πr2 and objects of area
a > 1.5πr2 are removed, Figure 4.4(d).
4.4.2 Potential Fiducial Marker Scoring
For each object i returned in the N ﬁducial masks of the dataset, a geometric score
si, 0 ≤ si ≤ 1 , is calculated in order to quantify its similarity to a circle of radius r,
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Figure 4.3: The images are translated such that the centre of the segmented prostate is at
the centre of each image, cropped about the segmented prostate and padded such that each
image in the dataset is the same size (a). An ellipse is then ﬁtted to each detected prostate
contour (b) in order to estimate the orientation of the image. Each image is then rotated
(c) such that the orientation of the dataset is uniform.
si = 1 indicates a perfect geometrical match. For each object i, the circular quality ci
(deﬁned as ci = 4πai/pi2, with pi the perimeter) and area ai is calculated, compared to the
ideal values for a circle of radius r (1 and πr2 respectively) and divided by the maximum
diﬀerence values measured across all the objects under test in that dataset (respectively
max |ci − 1| ∀i and max |ai − πr2| ∀i) in order to calibrate each parameter between 0 and
1.
si = 1 −
(
w
|ci − 1|
max |ci − 1| ∀i + (1 − w)
|ai − πr2|
max |ai − πr2| ∀i
)
(4.1)
w is a weight coeﬃcient, 0 ≤ w ≤ 1, of practical value set to 2/3. The geometric score
is weighted in favour of the circular quality as we have observed that there are more non
marker objects that approach the ideal area than non marker objects that approach a
circular form. Figure 4.5 indicates the geometric score calculated for each object returned
in the ﬁducial mask of a particular image.
It has been previously discussed in Section 3.3.6 ‘Fiducial Marker Geometry’, that
as the needles are not inserted vertically, the ﬁducial markers created are not in fact
circles but ellipses. However due to the small angles at which the needles are inserted
(θn1 = 12.8◦, θn2 = 13.8◦, θn3 = 16.6◦), the diﬀerence of the ellipses from circles (quantiﬁed
in terms of the percentage diﬀerence of the area Δa and circular quality Δc) is considered
negligible, θn1: Δa = +2.55%,Δc = −0.02%; θn2: Δa = +2.97%,Δc = −0.03%; θn3:
Δa = +4.35%,Δc = −0.07%. The markers are thus considered to be circles.
4.4.3 Potential Fiducial Marker Classiﬁcation
For a dataset of N images, there are theoretically 3N ﬁducial markers to detect in the
dataset (three markers per image). The potential ﬁducial markers detected across the N
ﬁducial masks of the dataset are ordered from the highest to the lowest geometric score,
i.e. from the highest to the lowest relative probability of being true markers. The potential
markers are then classiﬁed into 3 sets: the ﬁrst set S1, includes the potential markers with
the top 3N scores in the dataset, the second set S2, includes the potential markers with
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Figure 4.4: For each image (a),the potential ﬁducial markers are detected by ﬁrst classifying
each pixel as background or prostate (b), then following a morphological open (c), objects
of area a < 0.5πr2 and objects of area a > 1.5πr2 are removed (d) resulting in the ﬁducial
mask for the image.
the next best N scores. The third set, containing the remaining potential markers, is
discarded. Figure 4.6 shows the classiﬁcation of the potential ﬁducial markers detected for
that particular image into S1 (pink) and S2 (blue) according to their relative geometric
score with respect to all the other potential markers detected in the N ﬁducial masks. The
ﬁducial markers that are not included in either S1 or S2 are no longer considered.
We deﬁne as NS1E and NS2E the number of potential markers in an image classiﬁed
in, respectively, S1 and S2, with NE the total number of potential markers, i.e. NE =
NS1E +NS2E . Only the ﬁve potential markers with the highest scores are retained per image,
i.e. NE ≤ 5.
At the end of the classiﬁcation, there is for each image in the dataset, a list of the
coordinates of the centre of each potential ﬁducial marker in that image, as well as whether
each marker was classiﬁed in S1 or S2.
4.5 True Fiducial Marker Detection and Identiﬁcation
The insertion of the three ﬁducial needles into the prostate specimen creates three
ﬁducial markers in each histology slice. As discussed in Section 3.3.5 ‘Model Geometry’,
due to the semi-solid consistency of the fresh prostate, the needle angle geometry created
in each specimen is slightly diﬀerent and cannot be assumed to be that of the model
geometry measured from the agar sample. However we do assume that each needle creates
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Figure 4.5: For each object returned in the ﬁducial mask, a geometric score si, 0 ≤ si ≤ 1,
is calculated in order to quantify its similarity to a circle of radius r.
Figure 4.6: The potential ﬁducial markers are classiﬁed into 3 sets; S1 (pink) includes the
potential markers with the top 3N scores in the dataset, S2 (blue) includes the next best
N scores, the remaining markers are discarded. Only the ﬁve potential markers with the
highest scores are retained per image.
ﬁducial markers in a straight 3D line.
The insertion of the three needles, at three diﬀerent angles in a twist style, creates a
diﬀerent triangle, formed by the three created ﬁducial markers, in each histology slice. The
shape of the created triangle progressively changes from the apex to the base. Further-
more, if a circumcircle is ﬁtted to the formed triangle, the clockwise order of the ﬁducial
markers around the circumcircle is constant for each histology slice in the dataset. Fig-
ure 4.7 shows the three needles inserted, from the apex to the base using the developed
apparatus, into a rectangular sample of agar. Circles denote the ﬁducial markers created
at sequential axial planes. These axial planes are displayed on the right, in which the
diﬀerent and progressively changing shape of the triangle formed in each image can be
visually appreciated. It can also be noted that the clockwise order of the markers on each
slice remains constant for each axial plane.
The shape of the triangle at the apex is initialised by the manually identiﬁed markers
in the ﬁrst image, Section 4.3 ‘Pre-processing’. Using this initialisation, we study the
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Figure 4.7: The three needles inserted, from the apex to the base using the developed appa-
ratus, create ﬁducial markers (denoted by circles) in each axial plane. The diﬀerent and
progressively changing shape of the triangle formed in each plane can be visually appreci-
ated in the axial planes on the right. It can also be noted that the clockwise order of the
markers remains constant for each axial plane.
images, iterating from the apex to the base and then re-looping through the images,
searching the gradually changing shape of the triangle amongst the detected potential
ﬁducial markers. We search ﬁrst amongst the potential markers classiﬁed as having a high
probability of being true markers (set S1), and then amongst those classiﬁed as having a
medium probability of being true markers (set S2). Each time true ﬁducial markers are
detected amongst the potential ﬁducial markers, the shape of the triangle we are searching
in that locality is further deﬁned.
The algorithm developed to detect the true markers from the potential markers clas-
siﬁed in S1 and S2 and to identify by which needle each marker was created, consists of
four sequential steps. The pseudocode of the overall algorithm is shown in Algorithm 1,
with each of the four processing steps detailed in the sections below.
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Algorithm 1: Detection and identiﬁcation of the true ﬁducial markers from the po-
tential markers.
for step i = 1 to 4 do
while # markers detected > 0 do
# markers detected = 0;
for image 2 to N do
if # true markers detected for image < 3 then
Processing step i;
Update # markers detected;
end
end
end
end
Processing step 1
Step 1 only considers potential ﬁducial markers classiﬁed in S1, those with the highest
probability of being true markers. This enables the algorithm to initialise with a minimal
risk of an error being included.
We consider an image if three true markers have not yet been detected for the image
and if there are at least three potential ﬁducial markers classiﬁed in S1 for that image, i.e.
NS1E ≥ 3. Each possible ﬁducial maker (combinatoric) arrangement of the NS1E potential
markers is generated, AN
S1
E
3 = C
NS1E
3 × P 33 . For each arrangement, the ﬁrst position in
the arrangement corresponds to needle 1, the second position to needle 2 and the third
position to needle 3, that is, each arrangement is of the form (n1, n2, n3).
The permutations of each combination that correspond to a ﬂip orientation are elimi-
nated as when the histology slices were digitised, they were positioned such that the normal
vector of each slice is oriented in the same direction, see Section 3.6 ‘Digitisation of the
Histology Slices’. The permutations that correspond to a ﬂip orientation are those that
when a circumcircle is ﬁtted to the potential markers in the arrangement, the sequence
(n1, n2, n3) is no longer in a clockwise order.
Figure 4.8 shows an example of an image i in which four potential ﬁducial markers
classiﬁed in S1 have been detected. The four possible combinations of these potential
markers are detailed. Studying the permutations of one of these possble combinations,
by referring to the clockwise order deﬁned by the ﬁducial markers in the ﬁrst image, the
permutations that correspond to a ﬂip orientation can be eliminated.
Each possible arrangement is tested by calculating the 2D least-squares rigid aﬃne
transform [Arun et al. (1987)] that best registers the arrangement under test to a target
set deﬁned for that image. The target set is deﬁned as the 2D coordinates of the closest
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Figure 4.8: Sample image i in which four potential ﬁducial markers classiﬁed in S1 have
been detected. For each combination, the permutations that correspond to a ﬂip orientation
can be eliminated by referring to the clockwise order deﬁned by the ﬁducial markers in the
ﬁrst image.
(in terms of inter-slice spacing) previously detected set of true ﬁducial markers. If, for
example, we were considering image i in Figure 4.8 and we were testing the arrangement
(a,b,d) and the closest previously detected set of true markers were those detected in
image 1, the transform is calculated to best register a to n1 , b to n2 and d to n3, that is
we calculate the 2D rotation matrix R and the translation vector T to minimise
Σ2 =‖ n1 − (Ra + T ) ‖2 + ‖ n2 − (Rb + T ) ‖2 + ‖ n3 − (Rd + T ) ‖2 (4.2)
The error of each arrangement is deﬁned as the maximum 2D distance (in mm) between
the respective elements of the transformed arrangement under test and the target set,
normalised with respect to the number of elements in the arrangement. That is, for the
previous example,
e = max (‖ n1 − (Ra + T ) ‖, ‖ n2 − (Rb + T ) ‖, ‖ n3 − (Rd + T ) ‖)3 (4.3)
The arrangement with the minimum error, emin, is compared to an error limit deﬁned
for step 1, denoted L1, see Section 4.9.3 for the numerical value. If emin ≤ L1, the potential
markers in the arrangement under test are considered the true markers for that image and
identiﬁed as having been created by needle 1, 2 or 3 according to their position in the
arrangement.
If emin > L1 the potential markers in the arrangement are temporarily considered the
true markers and conﬁrmed if in two following images, arrangements with errors emin ≤ L1
are detected. The temporarily considered arrangement will be used as the target set
(closest previously detected set of true ﬁducial markers) for the following images. As the
location of non true markers is considered to be random, an arrangement of non true
markers will probably not be reproduced in the following images. So if the temporarily
considered arrangement contains non true markers, arrangements with errors emin ≤ L1
will not be found in the following images.
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Each image in the patient dataset is considered, from image 2 to N , in this manner. We
then reiterate through the images until no further markers are detected, see Algorithm 1.
Images for which three ﬁducial markers have been detected are not re-studied.
Processing step 2
The centres of the detected ﬁducial markers are 2D coordinates. However, as it is known
from which image each marker was detected, and the height of each image from the apex is
known, the detected ﬁducial markers can be represented in a 3D-space. From the detected
ﬁducial markers, three ‘synthetic needles’ can be calculated. The synthetic needles are
3D least-squares lines passing through the previously detected ﬁducial markers. For any
image, a distance z from the apex, the points of intersection of the three synthetic needles
with the image plane can be calculated. The points of intersection indicate the expected
locations of the markers and thus the expected shape of the triangle formed by the three
markers. The three points of intersection thus deﬁne the centres of three circular regions
of interest (ROIs), radius rROI, for that image, see Figure 4.9. The synthetic needles (and
thus the positions of the ROIs) are updated each time a new marker is detected.
As in step 1, step 2 only considers potential ﬁducial markers classiﬁed in S1. Further-
more, if a potential marker is to be considered, it must be positioned within one of the
three ROIs. Therefore, an image is considered if three true markers have not yet been
detected for the image and if, for that image, there are at least two potential ﬁducial
markers classiﬁed in S1 ( NS1E ≥ 2) and they are positioned within at least two diﬀerent
ROIs.
Figure 4.9: The points at which
the synthetic needles intersect an
image deﬁne the centres of the
three ROIs (radius rROI) for that
image. Step 2 and 3 only con-
sider elements positioned within
the ROIs. When deﬁning the
possible arrangements, potential
markers are placed in arrange-
ment positions according to the
ROI(s) in which they are located.
Each possible ﬁducial maker arrangement of the potential markers is generated. As
before, each arrangement is of the form (n1, n2, n3). The ROIs in which the potential
markers are positioned are taken into account when deﬁning the arrangements, that is, if
a potential marker is positioned within ROI 1, it can only be placed in the n1 position
of arrangements. However ROIs may overlap and so a potential marker may be placed in
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more than one arrangement position. For example, in Figure 4.9, the potential marker c
could be identiﬁed as having been created by needle 2 or 3 and thus can be placed in either
the second or third position of arrangements. On the other hand, the potential marker a
could only be placed in the ﬁrst position of any arrangement.
Arrangements formed by ‘leaving out’ one of the elements are also generated. How-
ever each arrangement must contain a minimum of two potential markers. As in step 1,
arrangements that correspond to a ﬂip orientation are eliminated. Considering again the
example in Figure 4.9, the possible arrangements for the potential markers (created by
needle 1, 2, 3 respectively) are (a,b,c), (a,-,c), (a,b,-), (a,c,-), (-,b,c), where the symbol -
denotes that no element is tested for that position.
Each possible arrangement is tested by calculating the 2D least-squares rigid aﬃne
transform that best registers the arrangement under test to a target set deﬁned for that
image. The target set is deﬁned as the 2D coordinates of the centres of the three ROIs
of that image. The error, deﬁned as in step 1, is the maximum 2D distance (in mm)
between the respective elements of the transformed arrangement under test and the target
set, normalised with respect to the number of elements in the arrangement. The potential
markers in the arrangement are considered to be the true markers for that image if emin ≤
L2.
Each image in the patient dataset is considered, from image 2 to N , in this manner.
We then reiterate through the images until no further markers are detected. Images for
which three ﬁducial markers have been detected are not re-studied, however if only two
markers have been detected for an image, the image is re-studied to see if there exists an
arrangement with a lower associated error than that already detected, in which case the
detected ﬁducial markers for that image are updated.
Processing step 3
Step 3 considers potential ﬁducial markers classiﬁed in both S1 and S2, provided that
they are positioned within one of the three circular ROIs. Therefore, an image is considered
if three true markers have not yet been detected for the image and if, for that image, there
are at least two potential ﬁducial markers classiﬁed in S1 or S2 (NE ≥ 2) and they are
positioned within at least two diﬀererent ROIs.
The possible ﬁducial maker arrangements of the potential markers are generated and
tested as in step 2, with the target set deﬁned as the 2D coordinates of the centres of
the three ROIs of that image. The error of each arrangement under test is as previously
deﬁned in step 1 and 2. The potential markers in the arrangement are considered to be
the true markers for that image if emin ≤ L3.
Each image in the patient dataset is considered, from image 2 to N , in this manner.
We then reiterate through the images until no further markers are detected. Images for
which three ﬁducial markers have been detected are not re-studied, however if only two
markers have been detected for an image, the image is re-studied to see if there exists an
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arrangement with a lower associated error than that already detected, in which case the
detected ﬁducial markers for that image are updated.
Processing step 4
For step 4, no ROIs are taken into account. This enables markers to be detected
in images where the pre-processing coarse alignment (Section 4.3 ‘Pre-processing’) was
insuﬃcient and the potential markers thus do not fall within the ROIs.
Step 4 considers potential ﬁducial markers classiﬁed in both S1 and S2. An image is
considered if three true markers have not yet been detected for the image and if, for that
image, there are at least two potential ﬁducial markers classiﬁed in S1 or S2 (NE ≥ 2).
The possible ﬁducial maker arrangements of the potential markers are generated (min-
imum two potential markers per arrangement) and tested, with the target set deﬁned as
the 2D coordinates of the closest (in terms of inter-slice spacing) previously detected set
of ﬁducial markers. The error of each arrangement under test is as previously deﬁned in
step 1-3. The potential markers in the arrangement are considered to be the true markers
for that image if emin ≤ L4.
Each image in the patient dataset is considered, from image 2 to N , in this manner.
We then reiterate through the images until no further markers are detected. Images for
which three ﬁducial markers have been detected are not re-studied. Images for which two
ﬁducial markers have been detected are not changed but potential markers that could
complete the arrangement are considered.
4.6 Alignment and Shear Correction of the Histology Slices
4.6.1 Alignment
The ﬁducial marker detection and identiﬁcation process completed, we proceed to align-
ing the histology slices using the detected markers. First, images for which less than two
ﬁducial markers have been detected are discarded as the alignment cannot be calculated.
The three synthetic needles, 3D least-squares lines passing through the detected markers,
are calculated. For each image a distance z from the apex, the points at which the syn-
thetic needles intersect the image plane are calculated, the 2D coordinates are denoted as
s1, s2 and s3. For each image, a 2D least-squares rigid aﬃne transform is calculated that
best registers the detected ﬁducial markers for that image (denoted as n1, n2 and n3) to
the points at which the synthetic needles intersect the image. That is, for each image, we
re-calculate R and T such as to minimise
Σ2 =‖ s1 − (Rn1 + T ) ‖2 + ‖ s2 − (Rn2 + T ) ‖2 + ‖ s3 − (Rn3 + T ) ‖2 (4.4)
The transformation is applied to the image for which it was calculated. A transformation
is calculated for, and applied to, each image in the patient dataset, from image 1 to N .
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Once each image in the dataset has been individually 2D transformed, the sum of the
2D distances of each detected marker from its respective synthetic needle is calculated,
d =
N∑
image=1
(‖ s1 − (Rn1 + T ) ‖ + ‖ s2 − (Rn2 + T ) ‖ + ‖ s3 − (Rn3 + T ) ‖) (4.5)
The synthetic needles are then re-calculated and the 2D transformation for each image is
re-calculated and re-applied. The process is iterated until the diﬀerence of sums between
two iterations is less than 0.001 mm, that is di − di+1 < 0.001 mm.
4.6.2 Shear Correction
Two ﬁnal parameters to ﬁx arises from the ‘shear eﬀect’ phenomenon, that the distance
between any two points on a horizontal plane is unchanged by the application of a shear
matrix, Tshear,
Tshear =
⎡
⎢⎢⎢⎣
1 0 λ1
0 1 λ2
0 0 1
⎤
⎥⎥⎥⎦ (4.6)
where λ1 and λ2 are the shear parameters. The eﬀect can be visually appreciated in
Figure 5.5. The shear eﬀect means that, though the histology slices were aligned by
registering the detected markers for each slice to the synthetic needles, the ensemble of
slices may need to be ‘un-sheared’.
Figure 4.10: The ‘shear eﬀect’ is due to the fact that the distance between any two points
on a horizontal plane is unchanged by the application of a shear matrix, Tshear.
From the model geometry, the direction vectors, from the apex to the base, of the three
needles were measured, denoted AB1, AB2 and AB3, describing the direction at which
the apparatus guides the insertion of each needle, see Figure 4.7. The three model needles
were arbitrarily labelled as needle 1, 2 and 3.
It is undetermined at this point the correspondence between the three synthetic needles
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in the patient dataset and the three model needles. Though care was taken when the
histology slices were digitised that the normal vector of each slice was oriented in the
same direction, that is, that no ‘ﬂip orientation’ exists between the slices, the ensemble of
histology slices in the dataset may need to be ﬂipped.
In order to determine the correspondence between the three needles in the patient
dataset and the three model needles, the 3! possible permutations are generated and each
is tested with and without a ﬂip applied to all the slices in the patient dataset, thus a
total of 12 permutations, p ∈ {1, 2, ..., 12}.
To test each permutation, the synthetic needles in the patient dataset are labelled (as
needle 1, 2 and 3) according to the permutation under test and the least-squares rigid
aﬃne transform (rotation R and translation T ) is calculated in order to align the three
markers at the apex of the patient dataset with the three markers at the apex of the
model. The transformation is applied to all the slices in the patient dataset. The error of
the alignment, E1(p), is deﬁned as the mean distance between the corresponding markers
at the apex of the model and the apex of the patient dataset after the transformation has
been applied.
The direction vector of each of the three needles in the transformed patient dataset is
calculated, denoted as ABp,1, ABp,2 and ABp,3, and the parameters λ1 and λ1 of the shear
matrix are calculated such as to minimise the angular diﬀerence between the corresponding
direction vectors of the model and the transformed patient dataset. That is, we minimise
the function E2(p),
E2(p) = cos−1
(
AB1 · ABp,1
‖ AB1‖‖ ABp,1‖
)
+ cos−1
(
AB2 · ABp,2
‖ AB2‖‖ ABp,2‖
)
+ cos−1
(
AB3 · ABp,3
‖ AB3‖‖ ABp,3‖
)
(4.7)
where f · g indicates the dot product of vector f and g.
The error of each permutation is deﬁned as the average of E1(p) and E2(p). The
permutation with the minimum error indicates if the ensemble of patient histology slices
need to be ﬂipped and the parameters λ1 and λ2 of the optimal shear matrix Tshear to be
applied to the histology slices of the patient dataset to correct for the shear eﬀect.
This shear correction method assumes that the plane along which the histology slices
were cut was exactly parallel to the needle insertion guide of the apparatus. It can be
noted that, though the histology slices have undergone a shrinkage with respect to the
model geometry, as the shear eﬀect is corrected for using angles, it is not necessary to take
the shrinkage into account.
4.7 Transformation Summary
In summary, the following geometric transformations are calculated for each image:
(i) a coarse alignment which consists of a 2D rotation and translation, Tinit,
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(ii) a 2D rotation and translation to align the ﬁducial markers detected for the image
with the three points at which the synthetic needles intersect the image, recalculated
and applied each iteration until convergence, Tk, k = (1, 2, ...,K), with K the number
of iterations to convergence and
(iii) a 3D shear to correct for the shear eﬀect, Tshear.
Thus for each slice, the total matrix transformation is Tshear × TK × ... × T2 × T1 × Tinit.
4.8 Validation
The accuracy of the alignment achieved with the proposed protocol and algorithm was
quantiﬁed in simulated images (Section 4.8.1), in a beef liver sample (Section 4.8.2) and in
10 prostate specimens (Section 4.8.3). The quality of the shear correction was estimated
using the simulated images and the beef liver sample.
4.8.1 Validation in Simulated Images
A dataset of simulated images was created for each prostate specimen studied. The
parameters of the simulated images were set identical to those of the prostate specimen
dataset, i.e. the same number of images N with the same inter-slice spacing, the same
pixel resolution and the same number and distribution of ﬁducial markers detected. The
diﬀerence between the datasets is thus the absence of tissue deformation in the simulated
images. A comparison of the accuracy of the alignment achieved with the histology images
and that achieved with the simulated images of each specimen will thus indicate if there
is a residual error associated with the algorithm.
The simulated images are binary images, background = 0, markers = 1, see Figure 4.12.
The position of the ﬁducial markers in each of the N images is deﬁned by intersecting the
model geometry with an axial plane at an appropriate height h from the apex, as illustrated
in Figure 4.7.
A ‘validation marker’ is also included in each simulated image. The validation marker
is a pentagon, formed from a symmetric hexagon, side length l = 4.62 mm, of which
one point had been shaved ﬂat, see Figure 4.11, the removed point is represented by the
dashed lines. We deﬁne the direction vector of the validation marker as the vector from
the centre of the base of the pentagon to the tip of the pentagon, indicated by an arrow
in Figure 4.11. The validation marker is included at the same position in each image.
Once each of the N images of the simulated dataset has been deﬁned, a random rigid
transformation is applied to each image in the dataset, see Figure 4.12. The transformation
consists of a random rotation R(ϕ), −45◦ ≤ ϕ ≤ 45◦, and a random translation T (γ),
|T (γ)| ≤ 12 mm, in any direction.
The ﬁducial markers were detected in each image and the images were aligned and
shear corrected using the method described in Section 4.6. The accuracy of the alignment
was quantiﬁed at the ﬁducial markers by calculating the minimum, mean, maximum and
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Figure 4.11: The validation marker is formed
from a symmetric hexagon, side length l = 4.62
mm, of which one point had been shaved ﬂat
(dashed section), resulting in a pentagon. The
direction vector of the validation marker, indi-
cated by the arrow, is deﬁned as the vector from
the centre of the base of the pentagon to the tip
of the pentagon.
standard deviation of the distances of each ﬁducial marker from its respective synthetic
needle after alignment of the slices. The accuracy of the alignment was also quantiﬁed at
the validation markers; a 3D least-squares line passing through the centres of the validation
markers after alignment of the slices was calculated. The minimum, mean, maximum and
standard deviation of the distances from the centre of each validation marker to the least-
squares line was calculated.
The validation markers were, before application of the random rotation and translation,
each located at the same position of the simulated images and each at the same orientation
(deﬁned by the direction vector of the validation marker). Therefore, after alignment of
the images, the validation markers should each be at the same position and orientation,
and a line passing through the centres of the validation markers should be vertical. The
angular precision of the alignment was quantiﬁed by calculating the standard deviation of
the orientations of the direction vectors after the alignment of the images. The quality of
the shear correction was measured by calculating the angular diﬀerence from the vertical
of the 3D least-squares line passing through the centres of the validation markers after
alignment of the images.
Figure 4.12: For each prostate specimen studied, a dataset of simulated images was created
with a validation marker included at the same position before a random rotation R(ϕ) and
translation T (γ) is applied to each image.
Note that the validation marker was situated approximately 20 mm from the ﬁducial
markers. It can be seen from the prostate dimensions in Figure 3.4 that 20 mm represents
a position at the periphery of the prostate. Therefore, the quantiﬁcation of the accuracy
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of the alignment at the validation markers enables an estimation of how well a peripheral
cyst or tumour would be aligned after alignment of prostate histology slices using the
method described in Section 4.6.
4.8.2 Validation in Beef Liver
A dataset of validation images was prepared using a sample of beef liver. Three nee-
dles were inserted into the fresh beef liver sample using the apparatus, creating ﬁducial
markers in the same manner as they are created in the prostate specimens. Parallel and
approximately 20 mm from the needles, was inserted a pointed metal bar with a cross
section as previously described (a pentagon formed from a symmetric hexagon, side length
l = 4.62 mm), creating a validation marker at the same position and orientation in each
image. The needles and metal bar were left in place during the tissue ﬁxation. The liver
was then sectioned, embedded in paraﬃn and sliced to obtain whole mount histology slices
using the same protocol as that used for a prostate specimen, described in Section 3.5. A
sample beef liver histology slice is shown in Figure 4.13. The slices were digitised using
the standardised method described in Section 3.6.
Figure 4.13: Sample beef liver histology
slice, the three ﬁducial markers and the
validation marker are indicated by arrows.
The ﬁducial markers were detected in each image and the ideal pentagonal cross-section
was least-squares ﬁtted to the validation marker detected in each image. The images were
aligned and shear corrected using the method described in Section 4.6. The performance
of the alignment was tested under three scenarios;
(i) using 3 ﬁducial markers per image to align the dataset,
(ii) using 2.71 markers per image to align the dataset (the average number visible and
detected per image for a prostate specimen) and
(iii) using 2.47 markers per image to align the dataset (the worst case number of markers
visible and detected per image for a prostate specimen).
Note that for both (ii) and (iii), the ﬁducial markers to be eliminated were randomly
selected, the random selection was carried out 30 times and the results reported are the
average of the 30 iterations.
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The accuracy of the alignment was quantiﬁed, for each of the three scenarios, at the
ﬁducial markers by calculating the minimum, mean, maximum and standard deviation of
the distances of each ﬁducial marker from its respective synthetic needle after alignment of
the slices. The accuracy of the alignment was also quantiﬁed at the validation markers by
calculating the minimum, mean, maximum and standard deviation of the distances from
the centre of each validation marker to a 3D least-squares line passing through the centres
of the validation markers after alignment of the slices.
For each of the three scenarios, the angular precision of the alignment was quantiﬁed
by calculating the standard deviation of the orientations of the direction vectors of the
validation markers after alignment of the images. The quality of the shear correction was
measured by calculating the angular diﬀerence from the vertical of the 3D least-squares line
passing through the centres of the validation markers after alignment and shear correction
of the images.
4.8.3 Experimental Validation in 10 Prostate Specimens
Fiducial markers were created using the apparatus in 10 fresh prostate specimens. The
histology slices were prepared following the protocol described in Section 3.5. The images
were aligned and shear corrected using the method detailed in Section 4.6. The accu-
racy of the alignment was quantiﬁed at the ﬁducial markers by calculating the minimum,
mean, maximum and standard deviation of the distances of each ﬁducial marker from its
respective synthetic needle after alignment of the slices. The robustness of the algorithm
was investigated. For three prostate datasets,the algorithm was iterated 5 times, from the
pre-processing step (redeﬁnition each iteration of the sample regions of the background
and prostate) to the ﬁne alignment and shear correction of each slice. For each dataset,
the standard deviation of the alignment accuracy results of the 5 iterations was calculated.
4.9 Results
4.9.1 Results in Simulated Images
A dataset of simulated images was created for each prostate specimen studied. The
parameters of the simulated images were set identical to those of the prostate dataset.
After alignment and shear correction of the simulated images, the minimum, mean, maxi-
mum and standard deviation of the distances of the ﬁducial markers from their respective
synthetic needles were limited only by the computing precision for each dataset studied.
The accuracy of the alignment was also evaluated at the validation markers, positioned
approximately 20 mm from the ﬁducial markers. After alignment and shear correction of
the slices, a 3D least-squares line passing through the centres of the validation markers was
calculated. The minimum, mean, maximum and standard deviation of the distances from
the centre of each validation marker to the least-squares line was, for each dataset, limited
only by the computing precision. Furthermore, the angular precision of the alignment,
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deﬁned as the standard deviation of the direction vector of the validation markers, was
limited only by the computing precision.
The validation marker was located at the same position in each simulated image,
therefore after alignment and shear correction of the slices, the 3D least-squares line passing
through the centres of the validation markers should be exactly vertical. After alignment,
but before shear correction, the average angle with respect to the vertical of the least-
squares validation line was 12.30◦ ± 4.36◦ (minimum = 7.58◦, maximum = 19.88◦). After
shear correction, the angle with respect to the vertical of the least-squares validation line
was on average 0.06◦ ± 0.00◦ (minimum = 0.06◦, maximum = 0.06◦).
Figure 4.14 shows the stack of simulated images for a sample dataset, the ﬁducial mark-
ers and their respective synthetic needles are shown in red, green and blue, the validation
marker and the 3D least-squares line passing through the centres of the validation markers
are in yellow, (top) before alignment of the simulated images, (middle) after alignment
of the images using the ﬁducial markers, the 3D least-squares line passing through the
validation markers is at an angle of 13.47◦ to the vertical, (bottom) after shear correction
of the simulated images, the validation markers line is now at an angle of 0.06◦ to the
vertical. Note that the ensemble of slices have been ﬂipped.
Figure 4.14: A sample
dataset of simulated im-
ages, the ﬁducial markers
are shown in red, green
and blue, the validation
marker is outlined in yel-
low, (top) before alignment
of the simulated images,
(middle) after alignment
of the images using the
ﬁducial markers, red, green
and blue lines indicate
the synthetic needles and
the least squares 3D line
passing through the centres
of the validation markers
is in yellow, the line is
at an angle of 13.47◦ to
the vertical, (bottom) after
shear correction of the
simulated images, the least
squares line passing through
the validation markers is
now at an angle of 0.06◦ to
the vertical. Note that the
ensemble of slices have been
ﬂipped.
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4.9.2 Results in Beef Liver
The beef liver dataset consisted of 20 images, on average 3 images per 6 mm section, see
Figure 4.15 which shows the stack of beef liver images, (top) before alignment of the beef
liver images, (middle) after alignment of the images using 2.71 ﬁducial markers per image,
(bottom) after shear correction of the aligned images. The ﬁducial markers and their
respective synthetic needles are shown in red, green and blue and the validation markers
and the 3D least-squares line passing through the centres of the validation markers are
shown in yellow.
Figure 4.15: The beef
liver dataset consisted of
20 images, the ﬁducial
markers and their re-
spective synthetic needles
are shown in red, green
and blue and the valida-
tion markers and the 3D
least-squares line passing
through the centres of
the validation markers is
shown in yellow, (top) be-
fore alignment of the beef
liver images, (middle) af-
ter alignment of the im-
ages using 2.71 ﬁducial
markers per image, (bot-
tom) after shear correc-
tion of the aligned im-
ages.
The accuracy of the alignment, using 2.71 markers per image, was on average 0.11 ±
0.09 mm at the ﬁducial markers (see Table 4.1) and 0.58 ± 0.43 mm at the validation
markers positioned approximately 20 mm from the ﬁducial markers (see Table 4.2). The
angular precision, deﬁned as the standard deviation of the orientations of the validation
markers after alignment, using 2.71 markers per image, was on average 2.67◦ ± 0.51◦, see
Table 4.3. After alignment of the slices using 2.71 markers per image, but before shear
correction, the average angle with respect to the vertical of the least-squares validation
line was 8.17◦ ± 1.45◦. After shear correction, the angle with respect to the vertical of the
least-squares validation line was on average 7.54◦ ± 1.46◦.
CHAPTER 4. HISTOLOGY SLICE ALIGNMENT 84
Nb. ﬁducial markers
per image min mean max variance
3 0.01 0.12 0.45 0.09
2.71 0.01 0.11 0.41 0.09
2.47 0.01 0.11 0.36 0.08
Table 4.1: Experimental validation in beef liver: performance of the alignment quantiﬁed
(in mm) at the ﬁducial markers after alignment using 3, 2.71 and 2.47 ﬁducial markers
per image.
Nb. ﬁducial markers
per image min mean max variance
3 0.14 0.52 1.34 0.35
2.71 0.10 0.58 1.65 0.43
2.47 0.12 0.66 1.79 0.46
Table 4.2: Experimental validation in beef liver: performance of the alignment quantiﬁed
(in mm) at the validation markers after alignment using 3, 2.71 and 2.47 ﬁducial markers
per image.
Nb. ﬁducial markers
per image min mean max variance
3 - 2.35 - -
2.71 1.89 2.67 4.04 0.51
2.47 1.81 2.92 4.14 0.69
Table 4.3: Experimental validation in beef liver: angular precision of the alignment, quant-
ﬁed (in ◦) as the standard deviation of the orientation of the validation markers after
alignment using 3, 2.71 and 2.47 ﬁducial markers per image. The results presented are
the average of 30 iterations.
Nb. ﬁducial markers
per image
average angle before
shear correction
average angle after
shear correction
3 7.66 7.27
2.71 8.17 ± 1.45 7.54 ± 1.46
2.47 7.58 ± 2.11 6.96 ± 2.20
Table 4.4: Experimental validation in beef liver: the quality of the shear correction was
measured by calculating the angular diﬀerence from the vertical of the 3D least-squares line
passing through the centres of the validation markers after alignment and before and after
shear correction of the images. The results presented are the average of 30 iterations.
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4.9.3 Results in 10 Prostate Specimens
Fiducial markers were created in 10 fresh prostate specimens, resulting in an average
of 19.2 histology slices digitised per specimen (minimum 17, maximum 22).
Values used in the algorithm were experimentally deﬁned using a training dataset of
5 prostate specimens and were as follows: the weight coeﬃcient in the geometric score,
w = 23 , the classiﬁcation of the detected objects according to their relative geometric score,
S1 contained the top 3N scores and S2 the next best N scores, the radius of the ROIs,
rROI = 5 mm , the error limit for each of the steps, L1 = 0.3 mm, L2 = L3 = L4 = 0.5 mm.
The segmentation of the prostate was achieved using a RGB threshold-based tech-
nique. This method was adequate as, irrespective of the slice dependent staining intensity,
there was always a sharp gradient between the prostate tissue and the uniform intensity
background for each R, G and B component of the image. Furthermore, the distinct
diﬀerence between the tissue and background meant that a prior intensity normalisation
of the images was unnecessary. Furthermore, we have veriﬁed that the proposed RGB
threshold-based technique was more eﬀective than a luminance-based thresholding of the
monochrome image. The dashed line in Figure 4.2 and Figure 4.3 shows a sample segmen-
tation result. This segmentation quality was achieved in each of the 192 images across the
10 prostate specimens, indicating that the RGB threshold-based segmentation technique
was both adequate and robust.
Theoretically three ﬁducial markers are created in each histology slice, considering the
digitised histology slices of the prostate specimen dataset, on average 93.7% of the markers
created are visible to the eye (worst case 87.7%, best case 100%). Of those markers visible,
on average 98.7% were returned as objects in the ﬁducial masks (worst case 96.2%, best
case 100%).
By ordering the objects according to their relative geometric score, on average 88.4%
of the objects included in S1 and 9.2% of the objects included in S2 are true markers.
The overall result being that, on average, 99.0% (worst case 97.8%, best case 100%) of
the true markers returned as objects in the masks had a geometric score suﬃcient to be
considered, i.e. were included in S1 or S2.
Of the objects included in (S1, S2), on average 98.5% were automatically correctly
detected and identiﬁed (worst case 95.8%, best case 100%), excluding the three markers
per dataset that are manually detected. This equates to, on average, the correct automatic
detection and identiﬁcation of 96.1% of the markers visible to the eye (worst case 93.6%,
best case 100%). Overall, this results in an average of 2.71 markers per image to align the
dataset (worst case 2.47, best case 2.89). Excluding the ﬁrst image of each dataset, for
which the three markers are manually detected, three markers were detected in 75.2% of
the images and two markers were detected in 23.7% of the images. Images for which less
than two markers were detected are discarded as the alignment cannot be calculated, less
that two markers were detected in 1.1% of images.
Recall for processing step 2, Section 4.5 ‘True Fiducial Marker Detection and Identiﬁ-
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cation’, that a minimum of two ﬁducial markers detected per needle is required to calculate
the synthetic needles that deﬁne the ROIs. On average 11.6 markers (worst case 8, best
case 15) are detected per needle by step 1.
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There are two types of errors that can occur;
• type (i) an object that is not a true marker is determined to be a marker,
• type (ii) a marker is erroneously identiﬁed i.e. a marker created by needle 1 is
identiﬁed as having been created by needle 2 or needle 3.
The error is ﬁrst quantiﬁed as the distance between the erroneously detected object and the
position of the marker it was determined as, referred to as the direct error measurement.
However, as for a slice to be aligned, there must be at least 2 ﬁducial markers detected in
the image, the eﬀect of the error is reduced by the inﬂuence of the other markers detected.
Thus the error is also quantiﬁed as the alignment accuracy of the image, i.e. the average
distance after alignment of each of the detected ﬁducial markers from their respective
synthetic needles. A total of 4 errors occurred, the details are as follows (format: patient,
error type, direct error measurement, alignment accuracy of the image):
• patient 2, type (i), 2.54 mm, 0.04 mm;
• patient 6, type (i), 4.04 mm, 0.87 mm;
• patient 10, type (ii), 4.08 mm, 0.09 mm;
• patient 10, type (ii), 4.52 mm, 0.06 mm.
After ﬁne alignment of each image, the distance of each detected ﬁducial marker from
its respective synthetic needle is calculated for each prostate specimen. The mean distance
(i.e. the mean accuracy) is 0.18 ± 0.13 mm. Presented in Table 4.5 is the minimum,
maximum, mean and standard deviation of the distances (in mm) for the worst case
dataset (patient 3), the average of the 10 datasets, and the best case dataset (patient
5). In 98.6% of the cases, the distance of the detected ﬁducial marker from its respective
synthetic needle is less than the radius of the needles used to create the markers.
min mean max variance
Worst case 0.01 0.30 0.97 0.23
Average 0.01 0.18 0.61 0.13
Best Case 0.01 0.10 0.30 0.07
Table 4.5: Experimental validation in 10 prostate specimens: the accuracy of the alignment
quantiﬁed (in mm) at the ﬁducial markers for the worst case dataset (patient 3), the average
of the 10 datasets, and the best case dataset (patient 5).
Figure 4.16 presents for a sample prostate specimen, (left) the stack of digitised his-
tology slices with the relative inter-slice spacing respected along the z-axis, (right-upper
row) the segmented and coarsely aligned prostate slices with the detected ﬁducial mark-
ers in red, green and blue, and (right-lower row) the segmented prostate slices after ﬁne
alignment, with the ﬁnal synthetic needles.
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Figure 4.16: Patient 1 (left) stack of digitised histology images (relative inter-slice spacing
respected), (right-upper row) images segmented and coarsely aligned with the detected ﬁdu-
cial markers displayed in red (needle 1), green (needle 2), and blue (needle 3), 3D view,
x-z view and y-z view, (right-lower row) as above after ﬁne alignment of the slices.
The robustness of the algorithm was investigated using the datasets of patient 3, patient
9 and patient 5 as they represented respectively the worst case, average case and best case
in terms of alignment accuracy across the 10 patient datasets. For each dataset, the
standard deviation of the alignment accuracy results (minimum, maximum and mean) of
the 5 iterations was on average 0.01 mm (worst case 0.02 mm).
For an average of 19.2 images per prostate specimen, the algorithm takes approximately
5.5 minutes, with 30-60 s for the interactive initialisation.
4.10 Conclusion
The developed apparatus enables internal ﬁducial markers to be created in a rapid and
standardised manner in fresh prostate specimens. The created ﬁducial markers are then
automatically detected and identiﬁed enabling the alignment and shear correction of the
stack of histology slices.
The quality of the alignment achieved using the proposed apparatus and method was
ﬁrst validated using simulated images which diﬀered from the prostate datasets solely by
the absence of tissue deformation. The accuracy of the alignment was limited only by the
computing precision, both at the ﬁducial markers and at a point 20 mm away. Furthermore
the angular precision of the alignment of each simulated dataset was limited only by the
computing precision. This demonstrates that
(i) there is no residual error associated with the algorithm for a situation where there is
no deformation and
(ii) a certain number of markers can be missed without aﬀecting the performance of the
alignment.
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This indicates that the non-perfect alignment measured for each prostate dataset (average
accuracy 0.18 mm) is thus due to the various tissue deformations and distortions previously
discussed in Section 2.4.1. A limit of our method is that these deformations and distortions
cannot be quantiﬁed. However, as a prostate cancer of volume < 0.5 cm3 is classiﬁed as
clinically insigniﬁcant [Stamey et al. (1993),Bastian et al. (2009)], we consider that the
accuracy achieved justiﬁes our choice to rigidly register the slices.
The algorithm was tested experimentally using a sample of beef liver. The slices were
aligned using the ﬁducial markers, the average accuracy of the alignment was 0.11 ±
0.09 mm at the ﬁducial markers, and 0.58 ± 0.43 mm at the validation marker, using 2.71
ﬁducial markers per image. As the validation marker was positioned approximately 20
mm from the ﬁducial markers, it enabled an estimation of the quality of the alignment of
a peripheral tumour. The angular precision, using 2.71 ﬁducial markers per image, was
on average 2.67◦ ± 0.51◦.
The protocol was tested on 10 prostate specimens, with 19.2 histology slices per spec-
imen on average. The accuracy of the alignment at the ﬁducial markers was on average
0.18 ± 0.13 mm.
The quality of the shear correction was evaluated ﬁrst using simulated images. The
average angle, with respect to the vertical, of the 3D least squares line passing through the
validation markers after alignment of the simulated images but before shear correction was
12.30◦ ±4.36◦ and after shear correction was 0.06◦ ±0.00◦. This result demonstrates ﬁrstly
the necessity of including a shear correction calculation after alignment of the histology
slices and secondly the quality of the proposed shear correction method.
The shear correction was also evaluated using the beef liver sample. After alignment
of the slices using 2.71 markers per image, but before shear correction, the average angle
with respect to the vertical of the least-squares validation line was 8.17◦ ± 1.45◦. After
shear correction, the angle with respect to the vertical of the least-squares validation line
was on average 7.54◦ ± 1.46◦.
The shear correction is achieved by comparing the dataset under test with the model
geometry. The shear correction transformation is calculated such as to minimise the
angular diﬀerence between the direction vectors of the respective synthetic needles in the
model geometry and the dataset under test. The method assumes that the images of the
dataset under test were cut along a plane parallel to the needle insertion guide of the
apparatus. If the sectioning plane is at a tilt angle θ to the needle insertion guide, the
direction vectors of the synthetic needles in the dataset under test will not be the same
as those in the model geometry. For the simulated images, θ = 0◦. However, for the beef
liver images, the tilt angle could not be ensured to be zero nor the diﬀerence from zero, if
it existed, quantiﬁed. This is a partial explanation of the average shear correction result
of 7.54◦ ± 1.46◦ in the beef liver sample.
Furthermore, the shear correction quality is measured as the angle, with respect to the
vertical, of the 3D least squares line passing through the validation markers after alignment
and shear correction of the slices. This assumes that the validation marker is vertical. As
CHAPTER 4. HISTOLOGY SLICE ALIGNMENT 90
before, this was assured for the simulated images but the angular diﬀerence, if it existed,
was not measured for the beef liver sample. If an angular diﬀerence from the vertical
existed, it would inﬂuence (improve or worsen) the accuracy of the reported quality of the
shear correction in the beef liver sample. An interesting perspective, would thus be to
repeat the beef liver validation experiment, creating the validation marker with an MR
compatible material. A MR acquisition of the beef liver sample before sectioning would
enable the exact angle with respect to the vertical of the validation marker to be measured
thus rendering more accurate the shear correction quality reported. This perspective is
further discussed in Chapter 6 ‘Perspectives and Conclusion’.
The tilt angle uncertainty equally exists for the prostate specimens. It is assumed that
when the prostate is sliced into 6 mm sections, the plane along which the sections are cut
is parallel to the needle insertion guide of the apparatus. The tilt angle is studied in detail
in the next chapter, Chapter 5 ‘Histology - MR Registration’.
As previously discussed in Section 3.3.5, the angle geometry of the ﬁducial needles cre-
ated in each prostate specimen is slightly diﬀerent from the theoretical model geometry.
Each inserted needle creates ﬁducial markers in straight 3D lines, however no assumption
is made concerning the polar angle at which the line is positioned. The model geometry,
that is the three theoretical polar angles with respect to the vertical axis at which the
apparatus guides the insertion of the ﬁducial needles, is therefore not utilised in the devel-
oped algorithm. It remains advantageous however to insert the needles at an angle rather
than vertically, for the reasons detailed in Section 3.3.4.
It could be imagined that the vertical position of each histology slice could be calculated
from the model geometry, i.e. an optimisation of the ﬁt of the three ﬁducial markers in
each histology slice to the three ﬁducial needles. The vertical position of the histology
slices was not calculated using this method because,
(i) it had been noted that the ﬁducial marker angle geometry created in each prostate
specimen is slightly diﬀerent from the theoretical model geometry and
(ii) the deformations due to the histology processing, in particular the shrinkage caused
by the ﬁxation, would have to be prior quantiﬁed and corrected for.
The vertical position of the histology slices, deﬁned as the relative distance of each slice
from the apex, was therefore calculated from the information written on the label attached
to each histology slice by the anatomo-pathologists. The assumption was therefore made
that the histology slices are parallel and that the information written on the label by the
anatomo-pathologists is accurate. These assumptions are further discussed and examined
in Section 6.3 of the ﬁnal chapter, ‘Perspectives and Conclusion’.
As no optimum protocol yet exists to dissect prostatectomy specimens [Chen et al.
(2010)], a perspective is the conception of an apparatus which would enable the position
of the prostate specimen to be held rigid during the guided insertion of the ﬁducial needles
and ﬁxation. Slits at 6 mm intervals along the walls of the apparatus would ensure that the
prostate is sectioned along planes parallel to the needle insertion guide of the apparatus.
91 4.10. CONCLUSION
Inspiration should be taken from the comprehensive overview of existing apparatus in
[Chen et al. (2010)]. This perspective is further explored in Chapter 6 ‘Perspectives and
Conclusion’.
The developed protocol has now been implemented as part of the standard clinical
routine at our institution, less than 5 minutes is required for the creation of the ﬁducial
markers. On average, 93.7% of the created ﬁducial markers are visible to the eye, those
‘lost’ are because the marker fell within for example the urethra or a portion of the slice
was missing.
The algorithm presented for the detection and identiﬁcation of the ﬁducial markers
is, after an interactive initialisation (approximate duration 30-60 s), entirely automatic
(average duration less than 6 minutes per dataset). On average, 96.1% of the visible
markers are correctly detected and identiﬁed.
It was assumed that each ﬁducial needle created markers in a straight 3D line. In order
to quantify this assumption, MR ex vivo images were acquired of 7 fresh prostate specimens
after insertion of the ﬁducial needles. A point was placed at the location of each ﬁducial
marker visible in the axial images, and 3D least-squares lines passing through the points
were calculated. The average distance of each point from the line was 0.15± 0.11 mm. As
the radius of the ﬁducial needle is 0.82 mm, we consider our assumption justiﬁed.
The protocol and algorithm developed to achieve the alignment of the histology slices
are ad hoc. The values used in the algorithm were experimentally deﬁned using a training
dataset in order to run this preliminary study. The results of the preliminary study are
encouraging; the study has shown that it is feasible to create ﬁducial markers in the fresh
prostate specimen, simply, quickly and in a standardised manner in order to integrate
the protocol into the clinical routine. The study has also shown that the created ﬁducial
markers are visible in the histology slices, and that they can be automatically detected and
identiﬁed. Furthermore, the study has enabled a quantiﬁcation of the alignment accuracy
obtainable. Possible future work includes an automatic optimisation of the values used
in the algorithm and an estimation of the inﬂuence of each parameter on the alignment
precision achieved. A simpler, more structured algorithm, with fewer parameters could
also be envisaged.
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5.1 Introduction
The previous chapter detailed the method developed to align a stack of 2D prostate
histology slices. This chapter details the 3D registration of the aligned histology slices with
the MR images. The 3D registration technique that has been developed is a feature-based
technique, using the ejaculatory ducts to guide the registration.
The ejaculatory ducts are an anatomical landmark that are present in every prostate
specimen and are visible in both histology slices and MR images acquired at standard
clinical routine resolution. The anatomy and characteristics of the ejaculatory ducts are
detailed and also the method by which they are identiﬁed in both MR and histology.
The ejaculatory ducts are curved structures, we represent the ducts using 3D 2nd order
parametric curves, ﬁtted to the identifed coordinates in the images. The 3D histology -
MR registration is thus reduced to the registration of two histology curves with two MR
curves.
Three signiﬁcant phenomena, described using ﬁve parameters, need to be taken into
account in order to achieve the histology - MR registration. The ﬁrst is the shrinkage of
the prostate specimen caused by the ﬁxation and histology processing. The second is the
‘shear eﬀect’ previously discussed in Section 4.6. The ﬁnal phenomenon we refer to as the
‘tilt’, it describes the angular diﬀerence between the histology sectioning plane and the
MR imaging plane.
The registration algorithm designed to register the histology and MR data can be
guided by either the ejaculatory ducts (i.e. curves) or the ﬁducial needles (i.e. lines). The
overall algorithm and each step is fully detailed.
The developed algorithm has been tested with two diﬀerent studies. First, the algo-
rithm is used to register the histology and MR ex vivo data, with the registration guided
by the ﬁducial needles. This ﬁrst study enables an initial approximation of the previously
mentioned phenomena (shrinkage, shear, tilt), as well as an estimation of the importance
of including each of the parameters used to describe the phenomena in the algorithm. It is
also an important feasibility study, evaluating the proposed idea of using the ejaculatory
ducts to guide the registration.
The second application of the algorithm is to register the histology and MR ex vivo
data, with the registration guided by the ejaculatory ducts. The registration accuracy
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achieved can be objectively quantiﬁed using the ﬁducial needles, enabling an evaluation of
the algorithm before application to MR in vivo images. The details and results of each of
these studies are presented in Section 5.6 and Section 5.7 respectively.
5.2 Features Description
A feature-based technique has been developed to guide the 3D registration of the
aligned histology slices with the MR images. It was initially intended to use both the
ejaculatory ducts and urethra as features to guide the registration. Both are anatomical
landmarks present in every prostate specimen and are visible in both histology slices and
MR images acquired at standard clinical routine resolution. In this section, the anatomy,
visual aspect and characteristics of the ejaculatory ducts and urethra are detailed.
5.2.1 Ejaculatory Ducts
Anatomy
The ejaculatory ducts are paired structures, referred to as the left and right ejaculatory
duct, and are a direct continuation of the seminal vesicles. The ducts course superﬁcially
on the posterior surface of the prostate for 10 to 15 mm and then angle 75◦ anteriorly
and penetrate the substance of the prostate for the ﬁnal 5 to 8 mm of their length,
see Figure 5.1. Within the prostate the ducts course obliquely towards each other as
they progress from the proximal to distal region (regions labelled A and C respectively in
Figure 5.1). The ejaculatory duct diameter varies along its course, and is larger proximally
than distally; the average luminal diameter is 1.7±0.3 mm in the proximal region, 0.6±0.1
mm in the middle region and 0.3±0.1 mm in the distal region [Nguyen et al. (1996)]. The
ejaculatory ducts terminate at the verumontanum, where they enter into the urethra.
Figure 5.1: The ejaculatory ducts are a direct continuation of the seminal vesicles. Within
the prostate the ducts course obliquely towards each other as they progress from the proximal
(A), through the middle (B) to the distal (C) region, at which point they enter into the
urethra. Source: The Turek Clinic.
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From the study carried out by [Nguyen et al. (1996)], it would appear that ejaculatory
duct dimensions are remarkably uniform among normal men. However it should be noted
that the measurements were obtained from formalin ﬁxed specimens and may therefore
underestimate the dimensions in vivo. Furthermore, the specimens studied were derived
from older patients (54 - 72 years old) and it is unknown whether patient age has an
inﬂuence on ejaculatory duct dimensions.
Identiﬁcation
The ejaculatory ducts are an anatomical landmark present in every prostate and are
visible in both histology slices and MR images acquired at standard clinical routine reso-
lution.
In order to identify the ejaculatory ducts in the histology slices, the aligned histology
images are visualised using MATLAB. The boundaries of the left and right ejaculatory
ducts are outlined in the images in which they are visible. The centre of gravity of each
outline is calculated and saved. The histology right and left ejaculatory ducts are thus
each represented by a list of 3D coordinates, denoted respectively VH,R and VH,L, where
V = [Vx,Vy,Vz], |V| = N × 3, with N the number of coordinates in the list, i.e. the
number of images on which the duct was outlined. The ejaculatory ducts are visible in 7.6
histology slices on average (average of the ﬁve prostate specimens studied), (minimum 5,
maximum 9). Figure 5.2 shows the subset of histology slices of a sample prostate specimen
in which the ejaculatory ducts are visible, with the images ordered from the base to the
apex. The position of the ejaculatory ducts is localised by a black-outlined rectangle in
each image, a zoom of each rectangle (magniﬁcation ×2) can be found at the bottom right
of each image. Pixel resolution 0.03 mm.
The ejaculatory ducts are identiﬁed in the MR ex vivo images by visualising the T2-W
axial images of the dataset using the OsiriX software (OsiriX Foundation, Switzerland).
The ejaculatory ducts are characterised by a hypointense signal and a point is placed
at the centre of each location that the left or right ejaculatory duct is visible. A list
of 3D coordinates are exported and read into MATLAB. The MR ex vivo right and left
ejaculatory ducts are denoted respectively VM,R and VM,L.
Five prostate specimens were studied, MR ex vivo images were acquired of four spec-
imens at a pixel resolution of 0.31 mm, and one specimen at a pixel resolution of 0.16
mm. There were 15.6 axial images on average per prostate specimen (minimum 14, max-
imum 17). The ejaculatory ducts are visible in 4.2 MR ex vivo axial images on average,
(minimum 4, maximum 5). Figure 5.3 shows the subset of MR ex vivo axial images of a
sample prostate specimen (the same specimen as in Figure 5.2) in which the ejaculatory
ducts are visible, with the images ordered from the base to the apex. The position of the
ejaculatory ducts is localised by a white-outlined rectangle in each image, a zoom of each
rectangle (magniﬁcation ×2) can be found at the bottom right of each image.
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Figure 5.2: Subset of the histology slices of a prostate specimen in which the ejaculatory
ducts are visible, ordered from the base to the apex. The ejaculatory ducts are located
within the black-outlined rectangle in each image, the rectangle is zoomed (magniﬁcation
×2) in the bottom right of each image. Inter-slice spacing between images (a-b) 1 mm, (b-
c) 5 mm, (c-d) 1 mm, (d-e) 1 mm, (e-f) 5 mm, (f-g) 3 mm, (g-h) 4 mm. Pixel resolution
0.03 mm. The scale in image (e) is the same for each of the images. See Figure 5.3 for
the MR ex vivo images of the same prostate specimen.
5.2.2 Urethra
It was initially intended to use both the urethra and the ejaculatory ducts as features
to guide the registration. Similarly to the ejaculatory ducts, the urethra is an antomical
feature present in every prostate specimen and is visible in both histology slices and MR
images acquired at standard clinical routine resolution. As can be seen in Figure 5.1, the
urethra enters the prostate at the base, passes through the prostate along a curved path
and exits the gland at the apex.
The advantage of the urethra as an anatomical feature is therefore that it is present
and visible in a far greater number of images of the prostate than the ejaculatory ducts.
However, the axial length of the urethra is a signiﬁcant disadvantage. Figure 5.4 shows a
histology slice of a sample prostate specimen, with the approximately corresponding MR
T1-W ex vivo axial image. In order to improve the visualisation of the urethra in the
MR ex vivo images, a ﬂexible, hollow plastic tube, diameter 2 mm, was inserted into the
urethra of the fresh prostate specimens before MR imaging. In Figure 5.4, the created
ﬁducial markers are indicated with arrows in both the histology and MR image. In the
MR image, the tube inserted into the urethra is visible as the slighter larger, hollow circle
centred within the ﬁducial markers. For comparative purposes, the approximate position
of the tube has been indicated in the histology slice. It can be seen that the axial length of
the urethra, in this particular histology slice measures 18.5 mm. There is thus signiﬁcant
uncertainty as to the position of the 2 mm diameter ﬂexible tube within the urethra.
For this reason, the urethra is not considered to be an accurate feature to guide the 3D
histology - MR registration and is no further considered.
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Figure 5.3: Subset of the MR ex vivo images of a prostate specimen in which the ejaculatory
ducts are visible, ordered from the base to the apex. The ejaculatory ducts are located within
the white-outlined rectangle in each image, the rectangle is zoomed (magniﬁcation ×2) in
the bottom right of each image. Inter-slice spacing between images (a-b), (b-c) and (c-d)
is 2 mm. Pixel resolution 0.16 mm. The scale is the same for each of the images. See
Figure 5.2 for the histology images of the same prostate specimen.
5.3 3D Parametric Curve Fit
A 3D 2nd order parametric curve is least-squares ﬁtted to the 3D coordinates of the
centres of gravity of the manually identiﬁed ejaculatory ducts in the histology and MR
images. The parametric curve f(t) is given by
f(t) =
[
x(t) y(t) z(t) 1
]
, 0 ≤ t ≤ 1
where
⎧⎪⎪⎪⎨
⎪⎪⎪⎩
x(t) = cx,1t2 + cx,2t + cx,3
y(t) = cy,1t2 + cy,2t + cy,3
z(t) = cz,1t2 + cz,2t + cz,3
(5.1)
From the identiﬁcation step, each ejaculatory duct has an associated N × 3 matrix,
containing the 3D coordinates of the centres of gravity of the ejaculatory duct from each
image in which it was identiﬁed. The general matrix is denoted V = [Vx,Vy,Vz].
For each dimension d ∈ {x, y, z}, the polynomial coeﬃcients (cd,1, cd,2, cd,3) are calcu-
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Figure 5.4: A histology slice of a sample prostate specimen (left), with the approximately
corresponding MR T1-W ex vivo axial image (right). The ﬁducial markers are indicated
with arrows in both images. The ﬂexible, hollow plastic tube inserted into the urethra
of the fresh prostate before MR imaging can be seen in the MR image as the slighter
larger, hollow circle centred within the ﬁducial markers. For comparative purposes, the
approximate position of the tube has been indicated in the histology slice. Due to the
signiﬁcantly larger axial length of the urethra (18.5 mm) compared to the diameter of the
inserted tube (2 mm), there is signiﬁcant uncertainty as to the position of the tube within
the urethra. Note that the scale is the same for both images.
lated as the least-squares solution of the system of equations
[
t2 t1 t0
]
⎡
⎢⎢⎢⎣
cd,1
cd,2
cd,3
⎤
⎥⎥⎥⎦ = Vd (5.2)
where tk, k ∈ {0, 1, 2} is the N × 1 vector given by
{
tk
}
i
=
(
i
N − 1
)k
, 0 ≤ i ≤ N − 1 (5.3)
and Vd is the N × 1 matrix of coordinates of the identiﬁed duct in the dimension d ∈
{x, y, z}. The resulting 4 × 4 polynomial coeﬃcient matrix is denoted c
c =
⎡
⎢⎢⎢⎢⎢⎢⎢⎣
cx,1 cx,2 cx,3 0
cy,1 cy,2 cy,3 0
cz,1 cz,2 cz,3 0
0 0 0 1
⎤
⎥⎥⎥⎥⎥⎥⎥⎦
(5.4)
Using the polynomial coeﬃcient matrix and Equation 5.1, f(t) is evaluated for M points
such that there is one point every Δ distance along the curve (see Section 5.6 and Sec-
tion 5.7 for the numerical values used). Each curve is thus represented by a M × 4 matrix
of points denoted p where ‖pi, pi+1‖ = Δ.
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5.4 Registration Parameters
Three signiﬁcant phenomena, described using ﬁve parameters, need to be taken into
account when calculating the transformation to register the histology and MR data, they
are (i) shrinkage, (ii) shear and (iii) tilt. Each phenomenon and its associated parameter(s)
is explained and detailed in this section.
5.4.1 Shrinkage (s)
The ﬁxation and histology processing of the prostate specimen causes a shrinkage of
the tissue. Published histology linear correction factors to compensate for tissue shrink-
age vary considerably; 1.14 [Schned et al. (1996),Haider et al. (2007)], 1.22 [Bart et al.
(2005), Egevad et al. (1998)], 1.33 [Egawa et al. (2000)], 1.5 [Noguchi et al. (2000)]. A
single tissue shrinkage correction factor may not be applicable for all laboratories because
of inter-laboratory variations in tissue processing procedures and diﬀerences in measuring
shrinkage [Schned et al. (1996)]. Furthermore, to our knowledge, no study has yet exam-
ined whether the shrinkage is, as assumed, homogenous. We denote the histology linear
correction factor as s, in theory s > 1.
5.4.2 Shear (α, β)
The ‘shear eﬀect’ has been previously discussed in Section 4.6. It arises due to the
fact that the distance between any two points on a horizontal plane is unchanged by the
application of a shear matrix, Tshear,
Tshear =
⎡
⎢⎢⎢⎢⎢⎢⎢⎣
1 0 α 0
0 1 β 0
0 0 1 0
0 0 0 1
⎤
⎥⎥⎥⎥⎥⎥⎥⎦
(5.5)
where α and β are the shear parameters. The eﬀect can be visually appreciated in Fig-
ure 5.5. In order to accurately register the aligned histology slices with the MR images,
shear correction parameters, α and β, must be included in the registration calculation.
5.4.3 Tilt (θ, φ)
The ﬁducial needles are inserted into the fresh prostate specimen using the developed
apparatus, that holds horizontal and rigid the needle insertion guide, see Figure 3.1. It is
then assumed that during histology processing, the prostate specimen is sectioned along
a plane parallel to the needle insertion guide. The MR ex vivo axial imaging plane is
oriented parallel to the polystyrene block, which is attached to the base of the prostate by
the needle sheaths, see Figure 3.5. The MR ex vivo imaging plane is therefore parallel to
the needle insertion guide. The MR in vivo axial imaging plane is oriented such as to be
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Figure 5.5: The ‘shear eﬀect’ is due to the fact that the distance between any two points
on a horizontal plane is unchanged by the application of a shear matrix, Tshear.
perpendicular to the rectal surface of the prostate, roughly parallel to the needle insertion
guide.
The ‘tilt’ is deﬁned as the angular diﬀerence between the histology sectioning plane and
the MR (in vivo or ex vivo) imaging plane and is described using the elevation and azimuth
angles of the polar coordinate system, denoted respectively as θ and φ, see Figure 5.6.
Figure 5.6: The ‘tilt’, deﬁned as the angular diﬀerence between the histology sectioning
plane and the MR imaging plane, is described using the elevation and azimuth angles
of the polar coordinate system, denoted respectively as θ and φ. Note that usually θ is
measured with respect to the z axis, i.e. 90◦ −θ, however for quantifying the tilt, it is more
intuitive to measure θ with respect to the x-y plane.
The tilt causes signiﬁcant deformation to the geometry of both lines and curves. A
simpliﬁed 2D example is considered in Figure 5.7 which represents three lines, intersected
by equally spaced planes. The planes are tilted at an angle θ to the horizontal, Fig-
ure 5.7(a). The points of intersection of the lines and the planes are indicated by circles,
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Figure 5.7(b). If it assumed that the images were acquired along horizontal planes and
the imaging planes and points of intersection are therefore made horizontal, Figure 5.7(c),
it can be seen that the vectors of the reconstructed lines passing through the points of
intersection are diﬀerent from those of the original three lines Figure 5.7(a).
In order to accurately register the aligned histology slices with the MR images, the tilt
parameters, θ and φ, must be included in the registration calculation.
Figure 5.7: A simpliﬁed 2D example to demonstrate the eﬀect of a tilt on the geometry
of lines. Three lines are intersected by equally spaced planes, tilted at an angle θ to the
horizontal (a). The points of intersection of the lines and the planes are indicated by circles
(b). If it assumed that the images were acquired along horizontal planes and the imaging
planes and points of intersection are therefore made horizontal (c), it can be seen that the
vectors of the reconstructed lines passing through the points of intersection are diﬀerent
from those of the original three lines (a).
5.5 3D Histology - MR Registration Algorithm
5.5.1 Algorithm Overview
The registration algorithm is designed to register the histology and MR (in vivo or ex
vivo) data. The registration can be guided by either the ejaculatory ducts (i.e. curves) or
the ﬁducial needles (i.e. lines). For either case, ﬁrst one of the MR needles or ejaculatory
ducts is chosen as a reference. For each iteration, the rotation points are deﬁned along this
reference line or curve and each rotation point is tested. Figure 5.8 illustrates an example,
the rotation points (∗) are deﬁned along the reference line, the rotation point being tested
is denoted ().
The rotation point deﬁnes the height at which the horizontal plane is positioned and
is also the point of rotation about which the tilt is applied to the horizontal plane. The
points of intersection of the tilted plane with the MR lines or curves deﬁne the starting
points of the MR lines or curves. The starting points deﬁne the initial distances between
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the lines or cuves. Furthermore, the section of the MR line or curve to be included in
the registration is measured from the starting points. Therefore the rotation point deﬁnes
what section of each MR line or curve is to be registered to the histology line or curve.
Figure 5.8: Each iteration, rotation points (∗) are deﬁned along a reference line or curve
and each rotation point is then tested (). The rotation point deﬁnes the height at which
the horizontal plane is positioned and is the point of rotation about which the tilt is applied
to the horizontal plane. The points of intersection of the tilted plane with the MR lines or
curves deﬁne the starting points of the MR lines or curves. The starting points deﬁne the
initial distances between the lines or cuves and what section of the MR line or curve is to
be included in the registration.
For each rotation point tested, a range of tilt values are tested (0 ≤ θ ≤ θmax,
0 ≤ φ ≤ 359). The tilt changes the MR line vectors or curve coeﬃcients and also the
starting points of the lines or curves. For each tilt value tested, the optimum values of
the shrinkage correction coeﬃcient and shear paramaters are calculated such that the
registration accuracy between the histology and MR is maximised, i.e. minimise the per-
pendicular distance bewteen the respective histology and MR points. The algorithm is
run until convergence.
5.5.2 Preliminary Calculations
If the registration is guided by the ejaculatory ducts, the following preliminary
calculations are required,
• the curve coeﬃcients of the left and right ejaculartory ducts in the histology data,
denoted respectively cH,L and cH,R, or in general cH ,
• the curve coeﬃcients of the left and right ejaculartory ducts in the MR data, denoted
respectively cM,L and cM,R, or in general cM ,
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• the initial coordinates of the left and right ejaculartory ducts in the histology data,
i.e. the highest (with respect to the z-axs) coordinate, denoted respectively pH,R
and pH,L, or in general pH ,
• the initial coordinates of the left and right ejaculartory ducts in the MR data, denoted
respectively pM,R and pM,L, or in general pM .
If the registration is guided by the ﬁducial needles (only possible with the MR ex
vivo data), the following preliminary calculations are required,
• the normalised vectors (‖v‖ = 1), from the apex to the base, of the three ﬁducial
needles in the histology data, denoted respectively vH,1, vH,2 and vH,3, or in general
vH ,
• the normalised vectors (‖v‖ = 1), from the apex to the base, of the three ﬁducial
needles in the MR data, denoted respectively vM,1, vM,2 and vM,3, or in general vM ,
• the initial coordinates of the three ﬁducial needles in the histology data, denoted
respectively pH,1, pH,2 and pH,3, or in general pH ,
• the initial coordinates of the three ﬁducial needles in the MR data, denoted respec-
tively pM,1, pM,2 and pM,3, or in general pM .
5.5.3 Algorithm Pseudo-code
The pseudo-code of the registration algorithm is as follows. Each calculation step is
detailed below.
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Algorithm 2: 3D Histology - MR Registration Algorithm.
ﬂag = 0 ;
iteration = 0 ;
deﬁne the initial rotation point spacing Δrinitial ;
while ﬂag = 0 do
iteration = iteration + 1 ;
Δriteration = Δrinitial10iteration−1 ;
calculate the points of rotation ;
for each rotation point calculated ri,j do
for θ = 0 to θmax do
for φ = 0 to 359 do
calculate the tilted MR vectors vM (θ, φ) or curve coeﬃcients
cM (θ, φ) ;
calculate the tilted MR initial line or curve coordinates with respect
to the rotation point pM (ri,j , θ, φ) ;
calculate the optimum values of α, β and s ;
calculate the error measure ;
end
end
end
calculate the optimum rotation point ri,opt;
test for convergence ;
if convergence = 1 then
ﬂag = 1 ;
end
end
5.5.4 Calculation of the Points of Rotation for Iteration i
Iteration i = 1
We choose arbitrarily one of the MR needles or ejaculatory ducts as a reference to
deﬁne the points of rotation. The ﬁrst point of rotation is deﬁned as the highest (along
the z axis) coordinate of the chosen reference line or curve. For the ﬁrst iteration (i = 1),
the remaining rotation points are then deﬁned as equally spaced points from that initial
rotation point along the reference line or curve, with the restriction that at least 50% of the
reference line or curve is included from the rotation point to the end of the line or curve.
For iteration 1, the spacing between the rotation points is deﬁned as Δr1 = Δrinitial mm.
The rotation points are denoted ri,j , where i is the iteration and 1 ≤ j ≤ the number of
rotation points calculated for iteration i. Figure 5.9 shows the rotation points (indicated
by an asterix (∗) symbol) calculated for both a reference line and curve, the ﬁrst rotation
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point is diﬀerentiated by an encircled asterix (). The spacing between two successive
rotation points is equal to Δr1 mm.
Figure 5.9: For the ﬁrst iteration, i = 1, one of the MR needles (left) or ejaculatory ducts
(right) is chosen arbitrarily as the reference. The ﬁrst point of rotation is the highest
coordinate of the chosen reference line or curve (). The remaining rotation points (∗)
are equally spaced points along the reference line or curve, with spacing Δr1 mm.
Iteration i > 1
For each iteration i > 1, the rotation points are calculated with respect to the optimum
rotation point calculated from the previous iteration i−1. If for an iteration i the optimum
rotation point is denoted ri,opt, then the rotation points for an iteration i > 1 are deﬁned
in the range
ri−1,opt−1 : ri−1,opt+1 (5.6)
with the spacing bewteen successive points Δri deﬁned as
Δri =
Δrinitial
10i−1 (5.7)
Figure 5.10 shows on the left the rotation points tested for iteration i = 1, with spacing
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Δr1. The optimum rotation point calculated at the conclusion of iteration i = 1, r1,opt
is indicated with a  symbol. The area around this optimum point is zoomed on the
right hand side of the image. For the next iteration, i = 2, the rotation points (denoted
•) are calculated as equally spaced points in the range r1,opt−1 : r1,opt+1 with spacing
Δr2 = 0.1Δr1.
Figure 5.10: For each iteration i > 1, the rotation points are calculated with respect to
the optimum rotation point calculated from the previous iteration, ri−1,opt (denoted ).
For iteration i, the rotation points are calculated in the range ri−1,opt−1 : ri−1,opt+1 with
spacing bewteen successive points Δri = 0.1Δri−1.
5.5.5 Calculation of MR Vectors vM(θ, φ) and Curve Coeﬃcients cM(θ, φ)
For a given tilt, deﬁned by the angles θ and φ, the corresponding matrices of rotation
are
R(θ) =
⎡
⎢⎢⎢⎢⎢⎢⎣
1 0 0 0
0 cos(θ) − sin(θ) 0
0 sin(θ) cos(θ) 0
0 0 0 1
⎤
⎥⎥⎥⎥⎥⎥⎦
(5.8)
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and
R(φ) =
⎡
⎢⎢⎢⎢⎢⎢⎣
cos(φ) − sin(φ) 0 0
sin(φ) cos(φ) 0 0
0 0 1 0
0 0 0 1
⎤
⎥⎥⎥⎥⎥⎥⎦
(5.9)
The eﬀect of the tilt on the MR vectors is calculated according to
vM (θ, φ)T = R(φ)T × R(θ)T × R(φ) × (vM )T (5.10)
where vM is the normalised (‖vM‖ = 1) MR vector vM = [vx, vy, vz, 1].
Similarly the eﬀect of the tilt on the MR curves can be calculated from the polynomial
coeﬃcient matrix of the curve cM ,
cM (θ, φ)T = R(φ)T × R(θ)T × R(φ) ×
⎡
⎢⎢⎢⎢⎢⎢⎣
cx,1 cx,2 cx,3 0
cy,1 cy,2 cy,3 0
cz,1 cz,2 cz,3 0
0 0 0 1
⎤
⎥⎥⎥⎥⎥⎥⎦
T
(5.11)
5.5.6 Calculation of MR Initial Line and Curve Coordinates pM(ri,j, θ, φ)
For a tilt, deﬁned by the angles θ and φ, the normal of the tilted plane is deﬁned by
nTtilt = R(φ)T × R(θ) × R(φ) ×
[
0 0 1 0
]T
(5.12)
The point of intersection, pintersection, of each MR line with the plane tilted about the
rotation point ri,j is calculated by
pintersection = pl + vM
(ri,j − pl) · ntilt
vM · ntilt (5.13)
Where f · g denotes the dot product of the two vectors f and g, pl denotes a point on the
MR line, vM the normalised (‖vM‖ = 1) MR line vector (from the apex to the base) and
ntilt the normal of the tilted plane. The points of intersection then need to be inverse
transformed (with respect to the tilted plane) such that they lie along a horizontal plane,
pM (ri,j , θ, φ)T = R(φ)T × R(θ)T × R(φ) × (pintersection)T (5.14)
These deﬁne the initial coordinates of the three MR lines after a tilt deﬁned by θ and φ,
applied about the rotation point ri,j .
Figure 5.11 illustrates this idea. The rotation points (∗) are deﬁned along the reference
line, the rotation point being studied is indicated (). A horizontal plane, passing through
the studied rotation point, is deﬁned. The points of intersection of the three lines with
the horizontal plane are indicated (•), solid lines between the points enable the distance
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between the points of intersection to be appreciated. A tilt is applied to the plane (θ =
−10◦, φ = 45◦) about the point of rotation. The points of intersection of the three lines
with the tilted plane are indicated (•), with dashed lines showing the distance (diﬀerent
from the solid line distances) between them.
Figure 5.11: A horizontal plane is deﬁned with respect to a rotation point (). A tilt
is applied to the plane (θ = −10◦, φ = 45◦) about the point of rotation. The distances
between the points of intersection (•) of the lines with the horizontal plane diﬀers from
the distances between the points of intersection of the lines with the tilted plane
5.5.7 Calculation of the Optimum Values of α, β and s
For a tilt, deﬁned by the angles θ and φ and applied about the point of rotation ri,j , the
eﬀect on the MR lines or curves has been calculated as respectively the vectors vM (θ, φ)
or curve coeﬃcients cM (θ, φ), with initial line or curve coordinates pM (ri,j , θ, φ).
An unconstrained nonlinear optimisation is used to determine the shrinkage and shear
parameters (s, α and β), using a quasi-Newton line-search method [Fletcher (1987), Al-
Baali and Fletcher (1986)]. The aim is to determine the minimum of the multivariable
function speciﬁed by
min
x
f(x) (5.15)
where x is the vector [s, α, β] and f(x) is a function that returns a scalar. An initial
estimate is supplied to deﬁne the starting point.
The shrinkage correction factor s is applied to the initial coordinates of the histology
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data pH . The shear is applied to the tilted MR vectors vM (θ, φ) according to
vM (θ, φ, α, β)T =
⎡
⎢⎢⎢⎢⎢⎢⎣
1 0 α 0
0 1 β 0
0 0 1 0
0 0 0 1
⎤
⎥⎥⎥⎥⎥⎥⎦
× vM (θ, φ)T (5.16)
The shear is similarly applied to the tilted MR curve coeﬃcients cM (θ, φ) resulting in the
coeﬃcients cM (θ, φ, α, β).
The initial lengths of the histology lines or curves is known. Similarly the initial length
of the MR lines or curves, from the starting points pM (ri,j , θ, φ), is known. The length
of each line or curve to be used, measured from the initial coordinates, is deﬁned as the
minimum of either the MR or histology lengths.
The histology shrink adjusted lines or curves are reconstructed using vH or cH and the
initial coordinates pH(s), with spacing between consecutive points along the line or curve
deﬁned as Δ mm. Similarly, the MR tilted, sheared lines or curves are reconstructed using
the vectors vM (θ, φ, α, β) or curve coeﬃcients cM (θ, φ, α, β) and the starting coordinates
pM (θ, φ), with spacing between consecutive points along the line or curve deﬁned as Δ
mm.
Therefore for each unique set of (θ, φ, s, α, β) values to be tested, there are three MR
lines to be registered with three histology lines or two MR curves to be registered with
two histology curves. For both situations, the respective lines or curves are of equal length
and deﬁned with equally spaced points.
The registration is therefore reduced to the registration of two point clouds, with the
association of the points between the two clouds known. The registration is achieved
using Procrustes Analysis (see Appendix 1), which determines a linear transformation
(translation, orthogonal rotation) of the points in one dataset to best conform them to
the points in the second dataset. The error measure e is the average distance between the
respective points in the two point clouds after the linear transformation has been applied.
This error measure is the returned scalar value of the function f(x) (Equation 5.15)
that is being minimised, i.e. s, α and β are determined such that e is a minimum for a
given θ and φ.
5.5.8 Calculation of the Optimum Rotation Point
For each iteration, each deﬁned rotation point for that iteration is tested. For each
rotation point, a range of tilt values are tested, 0 ≤ θ ≤ θmax and 0 ≤ φ ≤ 359. For each
tilt value tested, the optimum values of s, α and β are determined, with an associated
error measure e. Therefore for each rotation point, a result as in Figure 5.12 is obtained.
That is, for each value of θ and φ, the parameters s, α and β are determined such that
the error measure e is minimised. The minimum error of each rotation point is calculated.
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The optimum rotation point for iteration i, ri,opt, is deﬁned as the rotation point with the
minimum error.
Figure 5.12: For each iteration, each deﬁned rotation point for that iteration is tested. The
ﬁgure shows a sample result for a rotation point being tested. That is, for each value of θ
and φ, s, α and β determined such that the error measure e is minimised.
5.5.9 Convergence Deﬁnition
At the end of each iteration i, the optimum rotation point has been calculated ri,opt
with the associated optimum values θi,opt, φi,opt, αi,opt, βi,opt, si,opt and the minimum error
ei,opt.
A convergence test is performed at the end of each iteration. The deﬁnition that
convergence has been reached is that,
Δθ < 0.5◦ & Δφ < 0.5◦ & Δα < 0.001 & Δβ < 0.001 & Δs < 0.001 & Δe < 0.001
(5.17)
where
• Δθ = |θi,opt − θi−1,opt|,
• Δφ = |φi,opt − φi−1,opt|,
• Δα = |αi,opt − αi−1,opt|,
• Δβ = |βi,opt − βi−1,opt|,
• Δs = |si,opt − si−1,opt| and
• Δe = |ei,opt − ei−1,opt|.
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5.5.10 Registration Evaluation
The accuracy of the developed 3D registration algorithm is quantiﬁed according to
the metrics described by [Fitzpatrick (2010)]; in particular the ﬁducial registration error
(FRE) and the target localisation error (TLE).
The registration algorithm is ﬁrst applied to register the histology and MR ex vivo
data, with the registration guided by the ﬁducial needles. For this ﬁrst study, the FRE
is therefore deﬁned as the average perpendicular distance between the respective ﬁducial
needles in the histology and MR data (measured in mm) after convergence of the algo-
rithm. The TLE is deﬁned as the average perpendicular distance between the respective
ejaculatory ducts in the histology and MR data (measured in mm) after convergence of
the algorithm.
The second application of the algorithm is to register the histology and MR ex vivo
data, with the registration guided by the ejaculatory ducts. For the second study, the
FRE is therefore deﬁned as the average perpendicular distance between the respective
ejaculatory ducts in the histology and MR data (measured in mm) after convergence
of the algorithm. The TLE is deﬁned as the average perpendicular distance between
the respective ﬁducial needles in the histology and MR data (measured in mm) after
convergence of the algorithm.
5.6 Registration via Fiducial Needles
5.6.1 Objectives and Details
The algorithm is ﬁrst used to register the histology and MR ex vivo data, with the
registration guided by the ﬁducial needles. This preliminary study is important for several
reasons. Firstly, it enables an initial approximation of the parameters θ, φ, s, α and
β to be achieved. Furthermore, it enables an estimation of the importance of including
each of these parameters in the registration algorithm. Secondly, it enables the developed
registration algorithm to be tested and moreover it enables the capabilities of the algorithm
to be explored. Do further parameters need to be considered and integrated? Finally, the
registration of the histology with the MR ex vivo data constitutes an important feasibility
study. After registration of the two modalities using the ﬁducial needles, the average
distance between the ejaculatory ducts will indicate the feasibility of using the ejaculatory
ducts to register the MR and histology data.
Five prostate specimens were included in this preliminary study. The image acquisition
parameters are detailed in Chapter 3. The histology slices were aligned as described in
Chapter 4. Note that the shear correction of the histology slices was not included in the
alignment protocol. The ﬁducial needles were identiﬁed in the MR images and the ejacu-
latory ducts were manually identiﬁed in both the histology and MR images (Section 5.2.1)
and 3D parametric curves were ﬁtted to each duct (Section 5.3).
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The registration was achieved using the ﬁducial needles. For each prostate specimen,
four diﬀerent registration scenarios were tested,
(i) f(s): the registration was achieved taking the histology shrinkage correction factor
into account as a variable parameter,
(ii) f(s, α, β): the registration was achieved taking the histology shrinkage correction
factor, as well as the shear parameters into account as variable parameters,
(iii) f(s, θ, φ): the registration was achieved taking the histology shrinkage correction
factor, as well as the tilt parameters into account as variable parameters and ﬁnally,
(iv) f(s, α, β, θ, φ): the registration was achieved taking the histology shrinkage correc-
tion factor, the shear parameters and the tilt parameters into account as variable
parameters.
For this study, θ was deﬁned in the range 0◦ ≤ θ ≤ 30◦, φ was deﬁned in the range
0◦ ≤ φ ≤ 359◦. The histology shrinkage correction factor s and the shear factors α and
β are unconstrained variables. The spacing between the points of the ﬁducial needles,
Δ = 1.0 mm. The initial rotation point spacing along the reference ﬁducial needle is
deﬁned as Δrinitial = 2.0 mm.
5.6.2 Results and Discussion
Table 5.1 to Table 5.5 detail, for each prostate specimen studied, the results of each reg-
istration scenario at the convergence of the algorithm. That is, the optimum values of the
parameters included in the registration (s, α, β, θ, φ), the FRE - the average perpendicular
distance between the respective ﬁducial needles in the histology and MR data (measured in
mm) and the TLE - the average perpendicular distance between the respective ejaculatory
ducts in the histology and MR data (measured in mm).
The ﬁrst interest of this preliminary study was to enable an initial approximation of
the parameters θ, φ, α, β and s to be achieved. From the ﬁve prostate specimens studied,
the average value of θ is 13.6◦ ± 9.61◦ (minimum 3◦, maximum 24◦), measured from the
most accurate registration f(s, α, β, θ, φ). Among the ﬁve prostate specimens studied,
there is a signiﬁcant variance in the values of θ calculated. Furthermore, it is interesting
to note that for two of the ﬁve prostate specimens, θ > 20◦. As the MR ex vivo imaging
plane was oriented parallel to the needle insertion guide of the apparatus, θ corresponds
to the angle at which the prostate specimen was sectioned during histology processing. θ
exhibits far greater variance and reaches a greater magnitude than had been expected. To
our knowledge, θ has not been previously estimated and thus a comparison with published
values in the litterature is not possible.
Considering the histology linear correction factor, from the ﬁve prostate specimens
studied, the average value of s is 1.07 ± 0.03 (minimum 1.03, maximum 1.11), measured
from the most accurate registration f(s, α, β, θ, φ). This value is diﬃcult to compare
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to published values in the litterature due to the signiﬁcant variation of the published
values, 1.14 [Schned et al. (1996),Haider et al. (2007)], 1.22 [Bart et al. (2005),Egevad
et al. (1998)], 1.33 [Egawa et al. (2000)], 1.5 [Noguchi et al. (2000)]. Furthermore the
assumption that this value is linear must be investigated.
The second interest of this preliminary study was to enable an estimation of the impor-
tance of including each of the parameters in the registration algorithm. The registration
accuracy of the ﬁducial needles and ejaculatory ducts improves as more parameters are
included in the algorithm. Considering ﬁrst the registration f(s), that is taking only the
histology shrinkage correction factor into account as a variable parameter, the average
perpendicular distance between the ﬁducial needles (FRE) is 0.94±0.42 mm, and between
the ejaculatory ducts (TLE) is 4.03 ± 0.37 mm, averaged over the ﬁve prostate specimens
studied.
For the registration f(s, α, β), averaged over the ﬁve prostate specimens studied, the
average perpendicular distance between the ﬁducial needles (FRE) is 0.58± 0.32 mm, and
between the ejaculatory ducts (TLE) is 1.98 ± 0.45 mm.
For the registration f(s, θ, φ), averaged over the ﬁve prostate specimens studied, the
average perpendicular distance between the ﬁducial needles (FRE) is 0.54± 0.30 mm, and
between the ejaculatory ducts (TLE) is 1.17 ± 0.23 mm.
These preliminary results indicate that a signiﬁcant registration improvement is achieved
by taking into account either the tilt or the shear, with the tilt appearing to have a greater
inﬂuence on the accuracy of the registration. The registration accuracy is further im-
proved by taking into account both the tilt and the shear. The results for the registration
f(s, α, β, θ, φ), averaged over the ﬁve prostate specimens studied, are an average perpen-
dicular distance between the ﬁducial needles (FRE) of 0.45 ± 0.25 mm, and 1.04 ± 0.21
mm between the ejaculatory ducts (TLE).
The preliminary study also enabled the developed registration algorithm to be tested
and its capabilities to be explored. Considering the registration technique f(s, α, β, θ, φ),
the average perpendicular distance between the ﬁducial needles (FRE) is < 0.45 mm,
averaged over the ﬁve prostate specimens studied. The average angular diﬀerence between
the respective ﬁducial needles after convergence of the registration algorithm is 3.15◦ ±
1.35◦ (minimum 0.25◦, maximum 5.19◦). The average perpendicular distance between the
ejaculatory ducts (TLE) is approximately 1 mm.
Furthermore, for patients that a large tilt angle θ was detected, there is a greater
improvement in the registration accuracy by taking the tilt into account in the registration
algorithm, than for patients for whom a small tilt angle was detected. For example,
for patient 2, a tilt angle of 24◦ was detected. The average registration accuracy of
the ejaculatory ducts (TLE) improved from 9.88 ± 0.10 mm (f(s)) to 0.97 ± 0.30 mm
(f(s, α, β, θ, φ)). Whereas for patient 3, for whom a tilt angle of only 6◦ was detected, the
average registration accuracy of the ejaculatory ducts (TLE) changed far less signiﬁcantly
from 0.62 ± 0.25 mm (f(s)) to 0.63 ± 0.17 mm (f(s, α, β, θ, φ)).
Lastly, this preliminary study was an important feasibility study as to whether the
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histology and MR data could be registered using the ejaculatory ducts. After registration
of the two modalities using the ﬁducial needles, the average perpendicular distance between
the ejaculatory ducts (TLE) was 1.04 ± 0.21 mm (worst case 1.70 ± 0.28 mm, best case
0.39 ± 0.23 mm). It would therefore appear that MR - histology registration via the
ejaculatory ducts is worth considering.
Concerning the average number of iterations to convergence, the details for each regis-
tration technique are as follows; f(s) 3.8 (minimum 3, maximum 4), f(s, α, β) 3.6 (mini-
mum 3, maximum 4), f(s, θ, φ) 3.6 (minimum 3, maximum 4), f(s, α, β, θ, φ) 4.2 (minimum
4, maximum 5).
The absolute variation of the parameters from one iteration to the next was small. The
average values (excluding the last iteration before convergence) are, |Δs| = 0.01 ± 0.01
(minimum 0.00, maximum 0.03), |Δα| = 0.01 ± 0.01 (minimum 0.00, maximum 0.04),
|Δβ| = 0.01 ± 0.01 (minimum 0.00, maximum 0.04), |Δθ| = 0.55◦ ± 0.82◦ (minimum
0.00◦, maximum 2.00◦), |Δφ| = 3.55◦ ± 5.75◦ (minimum 0.00◦, maximum 20.00◦), where
|Δparameter| = |parameteri,opt − parameteri−1,opt|.
The average processing time to arrive at convergence for each registration technique
was as follows; f(s) 1.6 s (minimum 1.1 s, maximum 2.1 s), f(s, α, β) 3.5 s (minimum 2.6
s, maximum 4.7 s), f(s, θ, φ) 1749 s (minimum 1602 s, maximum 1844 s), f(s, α, β, θ, φ)
3960 s (minimum 3444 s, maximum 4549 s).
The registration result for a sample prostate specimen is shown in Figure 5.13. The
histology ﬁducial needles and ejaculatory duct curves are plotted in red, while the MR
ﬁducial needles and ejaculatory duct curves are in blue. The registration is guided by
the ﬁducial needles, using the registration technique f(s, α, β, θ, φ). The location of the
manually identiﬁed ejaculatory ducts, in both histology and MR, are indicated by circles.
Figure 5.14 shows for a sample patient, the shape of the error measure obtained at the
optimum rotation point for each of the four iterations to convergence.
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Figure 5.13: Histology (red) and MR ex vivo (blue) ﬁducial needles and ejaculatory ducts
showing the registration result for a sample prostate specimen. The registration is guided
by the ﬁducial needles, using the registration technique f(s, α, β, θ, φ). The location of the
manually identiﬁed ejaculatory ducts are indicated by circles.
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5.7 Registration via Ejaculatory Ducts
5.7.1 Objectives and Details
The second application of the algorithm is to register the histology and MR ex vivo
data, with the registration guided by the ejaculatory ducts. This study constitutes a
second important feasibility study. The accuracy of the histology - MR ex vivo registra-
tion, achieved using the ejaculatory ducts, can be objectively quantiﬁed using the ﬁducial
needles. This enables an evaluation of the MR - histology registration algorithm to be
evaluated before application to MR in vivo images.
Four of the previous prostate specimens were included in this second study, patient
1, 3, 4 and 5. Patient 2 was excluded as the MR - histology registration, guided by the
ﬁducial needles, showed that only a very small section of the identiﬁed histology and MR
ejaculatory ducts overlapped.
As described in the previous section, the histology slices were aligned but not shear
corrected, 3D parametric curves were ﬁtted to each detected ejaculatory duct. The regis-
tration was guided by the ejaculatory ducts, using all possible variable parameters, that
is f(s, α, β, θ, φ).
For this study, θ was deﬁned in the range 0◦ ≤ θ ≤ 45◦, φ was deﬁned as for the
previous study, in the range 0◦ ≤ φ ≤ 359◦. The histology shrinkage correction factor was
constrained in the range 1.00 ≤ s ≤ 1.11. The shear factors, α and β, remain unconstrained
variables as for the previous study. The spacing between the points of the curves, Δ = 0.5
mm. The initial rotation point spacing along the reference ejaculatory duct is deﬁned as
Δrinitial = 0.5 mm.
5.7.2 Results and Discussion
Table 5.6 details, for each of the four prostate specimens studied, the results after one
iteration of the algorithm - the optimum values of s, α, β, θ and φ as well as the FRE - the
average perpendicular distance between the respective ejaculatory ducts in the histology
and MR data (measured in mm) and the TLE - the average perpendicular distance between
the respective ﬁducial needles in the histology and MR data (measured in mm).
Only one iteration was run for each prostate specimen for the following reasons,
(i) considering the small absolute variation of the parameters from one iteration to the
next measured from the previous study (|Δs|max = 0.03, |Δα|max = 0.04, |Δβ|max =
0.04, |Δθ|max = 2.00◦, |Δφ|max = 20.00◦), it was assumed that an approximation of
the accuracy of the algorithm could be taken from the results obtained after the ﬁrst
iteration,
(ii) the average processing time for one iteration of the algorithm is approximately 7-8
hrs,
(iii) and ﬁnally, the results obtained after the ﬁrst iteration were so poor that it was not
judged to be time-worthy to continue the algorithm to convergence.
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From the four prostate specimens studied, the average value of s is 1.04 ± 0.03, α is
−0.05±0.56, β is 0.58±0.46, θ is 40.0◦±5.4◦, φ is 161.5◦±101.1◦. There is a very signiﬁcant
variation between the parameter values measured by the two studies, in particular with
respect to θ and φ. The average absolute variations between the two studies for each
parameter are, |Δs| = 0.04 ± 0.03 (minimum 0.00, maximum 0.08), |Δα| = 0.49 ± 0.44
(minimum 0.01, maximum 0.08), |Δβ| = 0.68 ± 0.37 (minimum 0.15, maximum 0.94),
|Δθ| = 29.0◦ ± 7.8◦ (minimum 19.0◦, maximum 38.0◦), |Δφ| = 84.0◦ ± 58.7◦ (minimum
12.0◦, maximum 152.0◦), where |Δparameter| = | average value of the parameter in study
1 - average value of the parameter in study 2 |.
The average perpendicular distance between the ejaculatory ducts (FRE), averaged
over the four studied prostates, is 0.16 ± 0.05 mm (worst case 0.22 ± 0.22 mm, best case
0.11 ± 0.05 mm). This represents a signiﬁcant improvement compared to the ﬁrst study,
where the average distance between the ejaculatory ducts was 1.04 ± 0.21 mm.
However, the registration accuracy of the ﬁducial needles (TLE) is signiﬁcantly poorer.
The average perpendicular distance between the needles, averaged over the four studied
prostates, is 2.82 ± 0.41 mm (worst case 5.25 ± 1.08 mm, best case 1.55 ± 0.93 mm),
compared to the average result obtained in the ﬁrst study of 0.45 ± 0.25 mm).
In conclusion, further work must be undertaken before the histology and MR data can
be registered using the ejaculatory ducts. An investigation into possible problems that
must be prior resolved is presented in the ﬁnal chapter, ‘Conclusions and Perspectives’.
Patient 1 Patient 3 Patient 4 Patient 5
s 1.07 1.03 1.06 1.00
α -0.79 0.56 0.07 -0.03
β 0.73 -0.10 0.80 0.88
θ 42◦ 44◦ 42◦ 32◦
φ 262◦ 22◦ 194◦ 168◦
needle 1 (mm) 4.19 ± 0.08 1.55 ± 0.93 4.75 ± 0.24 2.35 ± 1.42
needle 2 (mm) 1.86 ± 0.98 2.13 ± 0.92 1.58 ± 0.29 1.81 ± 1.14
needle 3 (mm) 5.25 ± 1.08 2.49 ± 1.04 3.78 ± 0.55 2.14 ± 0.72
ejac. duct R (mm) 0.14 ± 0.08 0.17 ± 0.07 0.11 ± 0.05 0.22 ± 0.22
ejac. duct L (mm) 0.17 ± 0.09 0.17 ± 0.06 0.16 ± 0.07 0.12 ± 0.07
Table 5.6: Registration results after one iteration of the algorithm for the four prostate
specimens studied. The registration is guided by the ejaculatory ducts, using the registration
technique f(s, α, β, θ, φ). The results include the optimum values calculated for s, α, β,
θ and φ as well as the average perpendicular distance (mm) between the ﬁducial needles
(TLE) in the histology and MR data and the average perpendicular distance (mm) between
the ejaculatory ducts (FLE) in the histology and MR data.
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5.8 Conclusion
The ejaculatory ducts are an anatomical landmark present in every prostate specimen
and visible in both histology slices and MR images acquired at standard clinical routine
resolution. They thus provide a means to guide the 3D histology - MR registration. The
ejaculatory ducts are curved structures, therefore after manual identiﬁcation of the ducts
on the axial images and slices, a 3D 2nd order parametric curve can be least-squares ﬁtted
to the detected coordinates. The histology - MR registration is then simpliﬁed to the
registration of two histology curves with two MR curves.
The algorithm developed was ﬁrst tested by using the ﬁducial needles to guide the
registration. This enabled a ﬁrst approximation of the histology linear shrinkage correction
factor and the tilt angle. The average value of s was 1.07±0.03 (minimum 1.03, maximum
1.11), which appears to be somewhat less than the published values in the litterature
which are in the range 1.14 - 1.5. The average value of θ was 13.6◦ ± 9.61◦ (minimum
3◦, maximum 24◦). Interesting to note was the signiﬁcant variance in the values of θ
calculated. Furthermore, for this study, θ corresponds to the angle at which the prostate
specimen was sectioned during histology processing. The magnitude of the value was
greater than had been expected. This value has, to our knowledge, not been previously
estimated and thus a comparison is not possible.
The registration accuracy of the algorithm was tested with respect to the variable
parameters included in the algorithm. The accuracy of the registration was improved
by including either the shear or the tilt, and was further improved by including both
the shear and the tilt. The average perpendicular distance between the ﬁducial needles
(FRE) was 0.45 ± 0.25 mm, and 1.04 ± 0.21 mm between the ejaculatory ducts (TLE) for
the registration technique f(s, α, β, θ, φ). It is therefore necessary to include each of the
parmeters, shrinkage, shear and tilt, in the registration algorithm.
Finally, the registration guided by the ﬁducial needles enabled an estimation of whether
the histology and MR data could be registered using the ejaculatory ducts. The average
perpendicular distance between the ejaculatory ducts (TLE) was 1.04±0.21 mm, indicating
that the registration guided by the ejaculatory ducts is worth considering.
The second application of the algorithm was therefore to register the histology and
MR ex vivo data, with the registration guided by the ejaculatory ducts. There was a
signiﬁcant variation in the values of the parameters caclulated between the two studies.
Though the average perpendicular distance between the ejaculatory ducts (FRE) was
improved, 0.16 ± 0.05 mm, the registration accuracy of the ﬁducial needles (TLE) was
signiﬁcantly reduced, 2.82 ± 0.41 mm.
The algorithm developed to 3D register the aligned histology slices with the MR images
of the prostate is ad hoc. The algorithm was developed as such in order to carry out two
important feasibility studies. The ﬁrst study - the registration of the histology and MR ex
vivo data, with the registration guided by the ﬁducial needles - enabled an examination of
the diﬀerent phenomena that must be included in the algorithm as well as a ﬁrst approx-
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imation of the magnitude of the parameters used to describe the phenomena. The results
of the ﬁrst study are interesting. The shrinkage factor shows signiﬁcant variance between
prostate specimens and also appears to be consistently less than the values published in
the litterature. A detailed study of the shrinkage is required in order to determine if the
phenomena is homogeneous within the specimen and constant between specimens. This
perspective is further explored in Chapter 6 ‘Perspectives and Conclusion’. If a better
understanding and quantiﬁcation of the shrinkage factor could be achieved, it could be
envisaged that the shrinkage factor is ﬁrst applied to the histology data before register-
ing the histology and MR images, therefore removing the shrinkage parameter from the
variables to be optimised in the algorithm. The shear parameters could also be removed
as variables to be optimised within the registration algorithm. A method to calculate the
shear parameters within the histology alignment algorithm was presented in Chapter 4.
However, as discussed in the Conclusion of that chapter, a more complete and accurate
validation of the shear correction method must ﬁrst be achieved. The removal of the
shrinkage and shear parameters as variables of the registration algorithm would mean
that the only variables to optimise in the registration algorithm are the tilt parameters.
This would enable the developed algorithm to be simpliﬁed and the processing time re-
duced. It would also remove the requirement to evaluate whether the order in which the
parameters (s, α, β, θ, φ) are optimised has an eﬀect on the registration accuracy. When
the algorithm has been simpliﬁed, it should be compared to, if not replaced by, more es-
tablished existing algorithms, e.g. Iterative Closest Point (ICP) [Besl and McKay (1992)],
Thin-Plate Spline (TPS) [Duchon (1977)], chamfer matching [Borgefors (1988)]. The ﬁrst
study was an important feasibility study to evaluate using the ejaculatory ducts to guide
the registration. After registering the histology and MR data, using the ﬁducial needles to
guide the registration, the average perpendicular distance between the ejaculatory ducts
(TLE) was 1.04 ± 0.21 mm. The results indicate that it is feasible to use the ejaculatory
ducts as landmarks to guide the histology - MR registration.
The second study was therefore the registration of the histology and MR ex vivo data,
with the registration guided by the ejaculatory ducts. The results of this second study -
registration accuracy of the ﬁducial needles (TLE) 2.82 ± 0.41 mm on average - showed
that further work is required before the histology - MR registration can be achieved using
the ejaculatory ducts. As previously mentioned, a detailed study of the shrinkage is
required, as well as a more complete and accurate validation of the shear correction method.
Furthermore, signiﬁcant assumptions were made concerning the histology slices: that the
inter-section spacing is 6 mm, that the sections are parallel, that the inter-slice spacing
could be deduced from the slice labels and that the slices cut from a section are parallel.
A comprehensive evaluation of these assumptions is required. This perspective is further
explored in Chapter 6 ‘Perspectives and Conclusion’. The uncertainty associated with the
inter-section and inter-slice spacing and the angular diﬀerence between the sections and
slices could be reduced by the development of an apparatus which ensures the prostate
is held rigid during the insertion of the ﬁducial needles and ﬁxation. Slits incorporated
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along the walls of the apparatus would ensure that the sections are parallel to each other
and that the sections are parallel to the needle insertion guide. This perspective has been
previously discussed in Chapter 4 and is further explored in Chapter 6.
The application of the developed registration algorithm to histology and MR in vivo
data is direct. Though the MR in vivo resolution is lower than the MR ex vivo resolution,
the ejaculatory ducts are visible in vivo due to the liquid present within the structures
in vivo. The quality of the histology - MR ex vivo registration accuracy achieved can be
accurately quantiﬁed using the ﬁducial needles, this is not possible for the histology - MR in
vivo registration. The quality of the histology - MR in vivo registration can be estimated by
manually identifying common landmarks visible in both modalities, e.g. cysts. However,
the size of the detected landmarks as well as the uncertainty as to whether the same
landmark has been identiﬁed in each modality, mean that the quantiﬁcation of the quality
of the histology - MR in vivo registration is less accurate. Therefore, as further work
is required before the histology - MR registration can be achieved using the ejaculatory
ducts and as the quality of the histology - MR in vivo registration can be less accurately
quantiﬁed than the histology - MR ex vivo registration, the developed algorithm was not
applied to MR in vivo data. Neither was a study carried out to quantify the registration
quality achieved when using both the ﬁducial needles and the ejaculatory ducts to guide
the registration. The overarching aim remains the 3D registration of histology slices and
MR in vivo images, for which ﬁducial needles and ejaculatory ducts will never both be
available to guide the registration.
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6.1 Introduction
The aim of this thesis was to develop a method to 3D register the histology slices
of radical prostatectomy specimens with MR in vivo images. The problem is two-fold,
requiring ﬁrst the alignment of the histology slices and then the 3D registration of the
aligned histology slices with the MR images.
Considering ﬁrst the histology slice alignment, an apparatus has been designed and
fabricated that enables internal ﬁducial markers to be created in a rapid and standardised
manner in fresh prostate specimens. An algorithm was then developed that automati-
cally detects and identiﬁes the created ﬁducial markers, enabling the alignment and shear
correction of the stack of histology slices.
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The developed protocol has been implemented as part of the standard clinical routine
at our institution, less than 5 minutes is required for the creation of the ﬁducial markers.
On average, 93.7% of the created ﬁducial markers are visible to the eye. The algorithm to
detect and identify the ﬁducial markers is, after an interactive initialisation (approximate
duration 30 - 60 s), entirely automatic (average duration less than 6 minutes per dataset).
On average, 96.1% of the visible markers are correctly detected and identiﬁed.
The quality of the alignment achieved using the proposed apparatus and method was
ﬁrst validated using simulated images, whose sole diﬀerence from histology slices was
the absence of tissue deformation. The resulting accuracy and angular precision of the
alignment was limited only by the computing precision, demonstrating that there is no
residual error associated with the algorithm for a situation where there is no deformation
and that a certain number of markers can be missed without aﬀecting the performance of
the alignment.
The algorithm was tested experimentally using a sample of beef liver. The average
accuracy of the alignment, using an average of 2.71 ﬁducial markers per image, was 0.11±
0.09 mm at the ﬁducial markers, and 0.58 ± 0.43 mm at a point 20 mm away from the
ﬁducial markers, with an average angular precision of 2.67◦ ± 0.51◦.
The protocol was tested on 10 prostate specimens, with 19.2 histology slices per spec-
imen on average. The accuracy of the alignment at the ﬁducial markers was on average
0.18 ± 0.13 mm.
The aligned histology slices require a shear correction. This shear correction can either
be applied to the aligned histology slices, or included in the 3D histology - MR registration
algorithm. If applied to the aligned histology slices, the quality of the shear correction was
estimated as the angular diﬀerence from the vertical of the 3D least squares line passing
through the validation markers. The average angular diﬀerence, evaluated ﬁrst using the
simulated images, was 0.06◦ ± 0.00◦ and using the beef liver sample was 7.54◦ ± 1.46◦.
The second aspect of this thesis is the 3D registration of the aligned histology slices
with the MR images. An algorithm was developed that guides the registration using the
ejaculatory ducts, an anatomical landmark present in every prostate specimen and visible
in both histology slices and MR images acquired at standard clinical routine resolution.
The algorithm developed was ﬁrst tested by using the ﬁducial needles to guide the
registration. This enabled a ﬁrst approximation of the parameters that must be included
in the registration algorithm, that is shrinkage (s), shear (α, β) and tilt (θ, φ). The average
value of the histology linear shrinkage correction factor was 1.07 ± 0.03 and the average
value of the tilt angle was 13.6◦ ±9.61◦. There was signiﬁcant variance in the values of the
shrinkage and tilt calculated. Furthermore, for this study, the tilt angle corresponds to
the angle at which the prostate specimen was sectioned during histology processing. The
magnitude of the value was greater than had been expected.
The registration accuracy of the algorithm was tested with respect to the variable
parameters included in the algorithm. The accuracy of the registration was improved by
including either the shear or the tilt, and was further improved by including both the shear
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and the tilt, indicating that it is necessary to include each of the parmeters (shrinkage,
shear and tilt) in the registration algorithm.
For the registration technique f(s, α, β, θ, φ), the average perpendicular distance be-
tween the ﬁducial needles was 0.45 ± 0.25 mm, and 1.04 ± 0.21 mm between the ejacu-
latory ducts. The registration accuracy of the ejaculatory ducts achieved indicated that
the registration of the histology and MR data, guided by the ejaculatory ducts, is worth
considering.
The second application of the algorithm was therefore to register the histology and MR
ex vivo data, with the registration guided by the ejaculatory ducts. The accuracy of the
registration was quantiﬁed using the ﬁducial needles, enabling an evaluation of the MR -
histology registration algorithm to be evaluated before application to MR in vivo images.
There was a signiﬁcant variation in the values of the parameters caclulated between the
two studies. Though the average perpendicular distance between the ejaculatory ducts was
improved, 0.16±0.05 mm, the registration accuracy of the ﬁducial needles was signiﬁcantly
reduced, 2.82 ± 0.41 mm.
In order to improve the histology - MR registration, certain deformations and assump-
tions must be studied in detail, quantiﬁed and incorporated into the algorithm. The work
to be done, the perspectives of this thesis, are detailed in the sections below.
6.2 Histology Shrinkage Correction Factor
The ﬁxation and histology processing of the prostate specimen cause a shrinkage of
the tissue. Published histology linear correction factors to compensate for tissue shrinkage
vary considerably; 1.14 [Schned et al. (1996), Haider et al. (2007)], 1.22 [Bart et al.
(2005),Egevad et al. (1998)], 1.33 [Egawa et al. (2000)], 1.5 [Noguchi et al. (2000)]. In
order to proceed with the histology - MR registration, it is of absolute importance that
the histology shrinkage is examined and quantiﬁed.
An apparatus has been designed and fabricated to enable the histology shrinkage study
to be achieved. It is a plexi-glass guide, of dimension 50x50x20 mm, that can be attached
to the previously made support in place of the needle insertion guide. Equally spaced
holes, (spacing dx, dy) have been vertically drilled through the guide, see Figure 6.1.
The idea is to vertically insert approximately ﬁve of the previously used catheter needles
into the tissue, using various holes such that there are needles inserted at the centre, middle
region and extremity of the tissue. The needles are removed and the rigid plastic sheaths
are left in place. Thread, which has been soaked in gadolinium and coloured dye, should
be passed through the plastic sheaths and the sheaths can be removed. The gadolinium
will ensure than the threads are visible in MR images and the dye will stain the tissue such
that the position of the threads can be detected in the histology slices. An MR ex vivo
acquisition will show the intial spacing between the threads. The tissue specimen is then
ﬁxed. The threads will not aﬀect the shrinkage induced by the ﬁxation. After resoaking
the threads in gadolinium, a second MR ex vivo acquisition of the specimen should be
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Figure 6.1: The ﬁxation and histology processing of the prostate causes a shrinkage of
the tissue. The nature and magnitude of the shrinkage must be estimated. This plexi-
glass guide, dimension 50x50x20 mm, can be attached to the previously made support and
enables catheters to be vertically inserted into the tissue at deﬁnite distances from each
other. Thread soaked in gadolinium and coloured dye can be passed through the catheters,
enabling the shrinkage to be estimated after ﬁxation and after histology processing.
acquired. The shrinkage due to the ﬁxation can thus be deduced. The threads can then
be removed and the specimen histology processed. The dye will have stained the histology
slices, enabling the slices to be aligned and the shrinkage and deformation associated with
the histology processing routine to be estimated.
The experiment should ﬁrst be tested on a beef liver sample to ensure the feasibility of
the study, and then on 5 - 10 prostate specimens. The study protocol has been validated
by the anatomo-pathologists at our institution. The study should enable the following
questions to be answered,
(i) Is the shrinkage homogeneous? If not, can it be modelled as a function of the distance
from the centre of the prostate?
(ii) Is the shrinkage factor constant between prostate specimens? If not, does it depend
on the size of the prostate specimen, the ﬁxation time, the formaldehyde concentra-
tion?
6.3 Distances and Angles between Histology Sections and
Slices
During histology processing, the prostate specimen is ﬁrst cut into 6 mm sections.
These sections, ordered from the apex to the base, are labelled using roman numerals, e.g.
X, XI, XII, etc. Each 6 mm section is embedded in paraﬃn and the paraﬃn-embedded
tissue blocks are sliced using the microtome, approximately every 1 mm. The slices are
then labelled with the roman numeral indicating which section it was cut from, and then
a ﬁgure indicating the depth at which the slice is cut, i.e. for the section XII, the ﬁrst
slice from the section is labelled XII_0, a slice 2 mm deeper is labelled XII_2.
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When aligning the histology slices, it was assumed that
(i) the inter-section spacing is 6 mm,
(ii) the sections are parallel,
(iii) the inter-slice spacing could be deduced from the slice labels and
(iv) the slices cut from a section are parallel.
These assumptions are diﬃcult to quantify, however a ﬁrst eﬀort has been made using
prostate specimen 1. The coordinates of the ﬁducial markers, for the subset of histology
slices in which the three ﬁducial markers are visible (15 of the 21 slices), are saved for each
slice. From the MR ex vivo acquisition of the prostate specimen, the coordinates of the
three ﬁducial markers is calculated for horizontal planes spaced every 0.02 mm along the
z-axis. For each histology slice, the optimum registration of the three histology markers
with three MR markers is calculated. The optimum registration is deﬁned as that which
minimises the distance between the respective markers. The tilt is allowed to vary in the
range, 0◦ ≤ θ ≤ 30◦, 0◦ ≤ φ ≤ 359◦. Various linear histology shrinkage correction factors
are ﬁrst applied to the histology data, 1.03 ≤ s ≤ 1.11.
The result is presented in Figure 6.2. It would appear that histology slices cut from
the same section are approximately parallel. This was expected as the tissue is held
rigid within the paraﬃn block and the paraﬃn block, once mounted, is held rigid by the
microtome during slicing. The assumption that the sections are parallel should be further
examined. However, it is in particular, the assumptions regarding the inter-section and
inter-slice spacing that appears to be ﬂawed.
A more accurate understanding of the shrinkage due to ﬁxation and histology pro-
cessing is ﬁrst required. Then, a more complete study of the inter-section and inter-slice
spacing should be carried out. The histology - MR registration cannot be considered before
the histology slices are ﬁrst accurately aligned.
A further perspective (previously mentioned in Chapter 4 ‘Histology Slice Alignment’)
concerns the development of an apparatus that would enable the position of the prostate
specimen to be held rigid during the guided insertion of the ﬁducial needles and ﬁxation.
If the apparatus could be designed such as to incorporate slits at 6 mm intervals along the
walls of the apparatus, it would enable the prostate to be sectioned along planes parallel to
the needle insertion guide of the apparatus. An advantage would be that the apparatus is
MR compatible to enable the preliminary tests and trials to be carried out. Inspiration for
such an apparatus should be taken from the comprehensive overview of existing apparatus
in [Chen et al. (2010)].
6.4 Complete Evaluation
Once a detailed study of the shrinkage, inter-section spacing, inter-slice spacing, and
the angles between the sections has been carried out and the results incorportated into
the algorithm, a complete validation of the algorithm should be undertaken.
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Figure 6.2: For prostate specimen 1, the coordinates of the histology ﬁducial markers (for
histology slices in which three ﬁducial markers are visible) are registered to the MR ex vivo
ﬁducial marker coordinates (data every 0.2 mm), varying the tilt in the range, 0◦ ≤ θ ≤ 30◦
and 0◦ ≤ φ ≤ 359◦. The result shows that the assumptions regarding the inter-section and
inter-slice spacing appear to be ﬂawed. The assumption that the sections are parallel should
also be further examined.
Similarly to the validation protocol for the alignment of the histology slices, a beef
liver sample could be used. The ﬁducial markers should be inserted using the developed
apparatus, as well as an MR compatible validation marker. Furthermore, curved needles
could be used to insert thread, previously soaked in gadolinium and coloured dye, creating
simulated ejaculatory ducts visible in MR and histology. An MR ex vivo acquisition of
the fresh sample should be acquired. After ﬁxation and histology processing, the histology
slices can be aligned using the ﬁducial markers. The aligned histology slices can then be
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3D registered to the MR images using the simulated ejaculatory ducts. The quality of
the histology slice alignment can be quantiﬁed using the validation marker. The angle
with respect to the vertical of the validation marker can be measured from the MR ex
vivo images. As previously mentioned in Chapter 4 ‘Histology Slice Alignment’, this
information was lacking from the previous validation study. The 3D histology - MR
registration can be quantiﬁed using the ﬁducial needles.
6.5 Registration Algorithm Extension
The ﬁrst requirement is a detailed study of the shrinkage, inter-section spacing, inter-
slice spacing, and the angles between the sections. If the incorporation into the algorithm
of the results of the study does not improve the registration accuracy, the addition of a
cyst, visible in both the histology and MR data, to complement the ejaculatory ducts in
guiding the registration could be tested.
6.6 Virtual Microscopy
This thesis was funded by the company Centre Compétence International en Télé-
Image (CCITI). CCITI develop and sell scanners that enable histology slices to be digitised
at very high resolution. The histology slices can be viewed at ten diﬀerent levels. For each
level, the image is composed of a number of JPEG tiles and an associated pixel resolution.
For example, at level 9, the histology image is composed of one JPEG tile of dimension
600 × 600 pixels, with a pixel resolution of 863 μm. At level 0, the histology image is
composed of 1554 JPEG tiles, each of dimension 600 × 600 pixels, with a pixel resolution
of 1.7 μm. Figure 6.3 shows one JPEG tile (600 × 600 pixels) of a sample histology slice
viewed at (a) level 5 (resolution 53.9 μm), (b) level 4 (resolution 27.0 μm), (c) level 3
(resolution 13.5 μm), (d) level 2 (resolution 6.7 μm), (e) level 1 (resolution 3.4 μm) and
(f) level 0 (resolution 1.7 μm).
The process of high resolution histology slice digitisation is referred to as virtual mi-
croscopy. The advantages of virtual microscopy are numerous; the access, archiving, anno-
tation and sharing of the slices is simpliﬁed. The inherent risk of damaging or breaking the
glass histology slices is eliminated. An unlimited number of users can examine the slices at
the same time, independent of access time or location. This renders the slices available to
a broader audience, meaning that a second opinion can be more easily obtained. Multiple
slides can be opened, analysed and compared at the same time and on the same screen.
Furthermore the use of virtual microscopes can transform traditional teaching methods
by removing the reliance on physical space, equipment and specimens to a model that is
solely dependent upon computer-internet access.
Virtual microscopy enables the integration of image processsing algorithms into the
standard anatomo-pathology routine, for example, automatic identiﬁcation of malignant
regions, calculation of the area and volume of detected malignant regions, identiﬁcation
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Figure 6.3: Virtual microscopy refers to the high resolution digitisation of histology slices.
One JPEG tile (600 × 600 pixels) of a sample prostate histology slice viewed at (a) level
5, resolution 53.9 μm, total number of tiles = 4, (b) level 4, resolution 27.0 μm, total
number of tiles = 9, (c) level 3, resolution 13.5 μm, total number of tiles = 30, (d) level 2,
resolution 6.7 μm, total number of tiles = 110 (e) level 1, resolution 3.4 μm, total number
of tiles = 399 and (f) level 0, resolution 1.7 μm, total number of tiles = 1554. The scale
of each image is indicated in the top right hand corner. The histology slice was digitised
using a CCITI scanner and viewed using CCITI developed software.
of the Gleason grade of a designated area. Furthermore the positive surgical margins can
be delineated and incorporated into the reconstructed prostate histology volume, enabling
an accurate evaluation and visual appreciation of the surgery performed.
6.7 Conclusion
In conclusion, an apparatus has been designed and tested that enables internal ﬁducial
markers to be created in a rapid and standardised manner in fresh prostate specimens
and an algorithm has been developed and tested that automatically detects and identiﬁes
the created ﬁducial markers, enabling the alignment and shear correction of a stack of
histology slices. Though the alignment accuracy was quantiﬁed using simulated images, a
beef liver sample and 10 prostate specimens, further issues must be studied before it can
be conﬁdently asserted that the histology slices are accurately aligned. In particular, the
histology inter-slice spacing and the angle between the slices must be further examined.
A second algorithm has been developed that 3D registers the aligned histology slices
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with the MR images, using the ejaculatory ducts to guide the registration. Three signif-
icant phenomena, described using ﬁve parameters, that need to be included in the regis-
tration algorithm have been identiﬁed and studied. However, in particular, the shrinkage
that the histology undergoes due to the ﬁxation and histology processing must be better
understood and quantiﬁed before the histology and MR data can be registered.
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A
Appendix
A.1 Procrustes Analysis
Procrustes analysis [Kendall (1989), Bookstein (1991), Seber (1984)] determines the
linear transformation (translation T and orthogonal rotation R) of the points in matrix
B to best register them to the points in matrix A. The goodness-of-ﬁt criterion is the
average distance between the respective points after the transformation has been applied.
A and B are n × m matrices, that is they both have the same number of 3D points.
Procrustes analysis matches B(i) to A(i).
Centre at the origin
The two matrices of coordinates are ﬁrst centred at the origin;
A0 = A − A (A.1)
B0 = B − B (A.2)
where A and B represent the mean of matrix A and B respectively.
Centred Frobenius norm
The centred Frobenius norm is calculated for each matrix as;
‖AF ‖ =
√√√√ n∑
i=1
m∑
j=1
|ai,j |2 (A.3)
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‖BF ‖ =
√√√√ n∑
i=1
m∑
j=1
|bi,j |2 (A.4)
Scale
The matrices are scaled to the same unit norm,
A0,1 =
A0
‖AF ‖ (A.5)
B0,1 =
B0
‖BF ‖ (A.6)
Calculation R
The matrix H is calculated,
H = AT0,1 × B0,1 (A.7)
The singular value decomposition (SVD) of this matrix,
H = U × S × V T (A.8)
enables the matrix X to be calculated
X = V × UT (A.9)
R is deﬁned depending on the value of the determinant of X;
• if det(X) = 1, then R = X,
• if det(X) = −1, then RT = V T × UT [Arun et al. (1987)].
Calculation T
The translation component is calculated as,
T = A − (B × R) (A.10)
Error measure
The normalised error measure, the goodness-of-ﬁt criterion, is calculated as
e = 1
n
n∑
i=1
‖(bi × R) + T − xi‖ (A.11)
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ADC Apparent diﬀusion coeﬃcient
ADT Androgen deprivation therapy
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AS Active surveillance
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Titre Méthode de mise en correspondance tridimensionnelle entre des coupes IRM de la prostate et les
coupes histologiques des pièces de prostatectomie
Résumé Le cancer de la prostate est le cancer le plus fréquent chez l’homme en Europe, néanmoins il
n’existe actuellement pas de technique d’imagerie permettant de détecter avec précision les tumeurs dans
la glande. Sachant que les coupes histologiques contiennent la réalité de terrain concernant le diagnostic, il
est nécessaire de recaler les images de chaque technique d’imagerie aux coupes histologiques aﬁn de pouvoir
les évaluer. De plus, comme il n’existe pas de méthode permettant de contrôler précisément le plan de
coupe histologique, le recalage doit être considéré comme un problème 3D. Un dispositif permettant de
réaliser, de manière rapide et standardisée, des marqueurs internes dans les coupes histologiques a été
développé, de même qu’un algorithme permettant de détecter automatiquement ces marqueurs, de les
identiﬁer et d’aligner les coupes histologiques. La méthode a été testée sur 10 prostates, avec en moyenne
19.2 coupes par prostate, et a permis d’obtenir une précision de recalage moyenne de 0.18 ± 0.13 mm au
niveau des marqueurs. Un deuxième algorithme a été développé pour recaler les coupes histologiques, une
fois alignées, avec les images IRM. Ce recalage a été conçu pour être guidé par les canaux éjaculateurs, un
repère anatomique présent dans chaque prostate et visible à la fois en histologie et dans les images IRM
cliniques, acquises avec une résolution standard. L’algorithme a d’abord été testé en s’appuyant sur les
marqueurs artiﬁciels. La précision obtenue pour le recalage était en moyenne de 0.45± 0.25 mm au niveau
des marqueurs et de 1.04± 0.21 mm au niveau des canaux éjaculateurs. L’algorithme a enﬁn été testé en
guidant le recalage à l’aide de la position des canaux éjaculateurs. La précision moyenne obtenue était
alors de 0.16± 0.05 mm au niveau des canaux éjaculateurs et de 2.82± 0.41 mm au niveau des marqueurs.
Ces résultats suggèrent une valeur du facteur de rétrécissement de l’ordre de 1.07± 0.03 et une inclinaison
vis à vis du plan de coupe histologique de l’ordre de 13.6◦ ± 9.61◦, avec une variance importante pour ces
deux paramètres.
Mots-clés Alignement, marqueurs, histologie, IRM, cancer de la prostate, recalage 3D
Title 3D registration of prostate histology slices with MR images
Abstract Prostate cancer is the most frequently diagnosed cancer of men in Europe, yet no current
imaging technique is capable of detecting with precision tumours in the prostate. The histology slices are
the gold standard for the diagnosis. Therefore, in order to evaluate each imaging technique, the histology
slices must be precisely registered to the imaged data. As it cannot be assumed that the histology slices
are cut along the same plane as the imaged data is acquired, the registration must be considered as a 3D
problem. An apparatus has been developed that enables internal ﬁducial markers to be created in the
histology slices in a rapid and standardised manner. An algorithm has been developed that automatically
detects and identiﬁes these markers, enabling the alignment of the histology slices. The method has been
tested on 10 prostate specimens, with 19.2 slices on average per specimen. The accuracy of the alignment
at the ﬁducial markers was on average 0.18±0.13 mm. A second algorithm was developed to 3D register the
aligned histology slices with the MR images. The registration is designed to be guided by the ejaculatory
ducts, an anatomical landmark present in every prostate and visible in both histology and MR images
acquired at standard clinical resolution. The algorithm was ﬁrst tested by using the ﬁducial needles to
guide the registration. The average registration accuracy was 0.45 ± 0.25 mm at the ﬁducial needles and
1.04± 0.21 mm at the ejaculatory ducts. The algorithm was then tested by using the ejaculatory ducts to
guide the registration. The average registration accuracy was 0.16± 0.05 mm at the ejaculatory ducts and
2.82 ± 0.41 mm at the ﬁducial needles. The results suggest that the histology shrinkage factor is of the
order 1.07± 0.03 and the tilt of the histology slicing plane is 13.6◦ ± 9.61◦, with both parameters showing
signiﬁcant variance.
Keywords Alignment, ﬁducial markers, histology, MRI, prostate cancer, 3D registration
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